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Resumo 
Os principais objectivos desta dissertação foram: (1) estudar o prognóstico a curto e 
longo prazo dos doentes com um acidente vascular cerebral (AVC); (2) modelar a 
incidência diária de AVC em função de diferentes alterações nos parâmetros 
meteorológicos; (3) descrever os aspectos metodológicos utilizados no projecto ACINrpc 
e, (4) determinar a variação na incidência de AVC no Norte de Portugal. 
As bases de dados utilizadas neste trabalho pertencem aos dois projectos ACINrpc 
(1998-00 e 2009-11). Nestes estudos prospectivos de base populacional realizados no 
Norte de Portugal, todos os doentes com um primeiro AVC na vida ou com um sintoma 
neurológico focal transitório foram identificados usando métodos de detecção 
abrangentes, incluindo a referenciação directa pelos médicos das instituições envolvidas 
no estudo e a revisão dos registos do serviço de urgência e das altas hospitalares. Os 
profissionais de saúde foram encorajados a referenciar/notificar qualquer doente com um 
possível episódio deste tipo. Os doentes foram examinados no início do estudo e aos 
três meses. Os doentes da primeira coorte (1998-2000) também foram examinados aos 
12 meses e aos sete anos. 
Utilizando a mesma metodologia, foi recolhida informação sobre o perfil sócio-
demográfico, factores de risco vascular prévios ao evento, diagnóstico e meios de 
diagnóstico/tratamentos efectuados. A escala de Rankin modificada (mRS) foi utilizada 
para avaliar a capacidade funcional. Para avaliar a gravidade do AVC foi utilizada, no 
primeiro estudo a Unified for Neurological Stroke Scale e, no segundo estudo a National 
Institute of Health Stroke Scale. Para além destes dados, o Instituto de Meteorologia de 
Portugal forneceu, para o período compreendido entre Setembro de 1998 e Outubro de 
2000, informação diária sobre os parâmetros meteorológicos (temperatura, humidade e 
pressão atmosférica). Utilizou-se a definição de AVC da Organização Mundial de Saúde. 
Classificou-se o AVC segundo os tipos patológicos definidos Sudlow e Warlow. Para 
definir os subtipos de AVC Isquémico utilizou-se a classificação clínica OCSP 
(Oxfordshire Community Stroke Project) e a classificação etiológica TOAST (Trial of Org 
10172 in Acute Stroke Treatment) 
A distribuição de Poisson foi usada para modelar o número de eventos incidentes. No 
caso do número de eventos que se seguem a uma quantidade variável de exposição, 
como no caso dos valores dos parâmetros meteorológicos, utilizando diferentes períodos 
de risco, for usada uma regressão de Poisson. No caso de uma exposição constante 
(não relevante para o modelo) e das variáveis explanatórias serem categóricas, como na 
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modelação da incidência por grupo etário, sexo e período do estudo, os dados podem 
ser sumariados numa tabela de contingência com restrições nas frequências em cada 
cela, usando-se um modelo linear generalizado com uma função de ligação, um modelo 
log-linear. Esta distribuição foi também assumida para calcular os intervalos de confiança 
a 95% para as taxas de incidência brutas e padronizadas para a população portuguesa e 
europeia. Foi ainda usado um modelo binomial para contrastar o efeito dos parâmetros 
meteorológicos em subgrupos de doentes. 
Em relação ao prognóstico, o tempo de sobrevivência foi estimado utilizando o método 
de Kaplan-Meier, enquanto que o modelo de riscos proporcionais de Cox foi utilizado 
para identificar os preditores independentes de sobreviver livre de AVC ou de eventos 
vasculares. Com base no grau de incapacidade aos três meses medido numa escala 
ordinal variando entre zero e seis foi estimada a possibilidade de um pior prognóstico 
aos sete anos recorrendo a uma análise Ridit.  
A diferença na incidência de AVC entre o meio urbano e rural resulta do maior risco de 
AVC isquémico na população jovem do meio urbano e na população idosa do meio rural. 
Embora no meio rural os doentes sejam mais idosos, a menor prevalência de factores de 
risco vascular associada a uma igual gestão do doente com AVC, pode justificar o facto 
de não existirem diferenças no prognóstico a longo prazo no meio urbano e rural. Por 
outro lado, uma simplificação na avaliação do grau de incapacidade aos três meses 
permite avaliar o perfil de risco dos doentes com AVC Isquémico. Este estudo permitiu 
confirmar que uma ligeira diferença no estado funcional aos 3 meses está associada a 
um diferença significativa na sobrevivência e estado funcional aos 7 anos, o que tem 
implicações no planeamento e avaliação económica dos tratamentos para o AVC agudo. 
Esta investigação permitiu encontrar uma associação entre os parâmetros 
meteorológicos e a ocorrência de AVC e também com a sua gravidade. A variação do 
efeito da temperatura ambiental de acordo com o timing da exposição, a ausência de 
associação ao enfarte lacunar e a associação ao enfarte cardioembólico, reflectem a 
plausibilidade desta associação e podem explicar divergências nos resultados 
encontrados noutros estudos de base populacional ou hospitalar. 
Este trabalho destaca também a importância da avaliar os doentes com sintomas focais 
transitórios para identificar os que têm AVC, sendo um critério metodológico a considerar 
em estudos futuros. Para o declínio da taxa de mortalidade por AVC em Portugal, 
contribuiu uma diminuição na incidência de AVC entre 1998 e 2011. Observou-se um 
efeito de género no sentido em que a diminuição do risco de AVC, em particular do AVC 
hemorrágico ou incapacitante, foi muito superior nas mulheres. 
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Abstract 
The main objectives of the present work were: (1) to study short- and long-term prognosis 
of stroke patients; (2) to model the daily stroke incidence according to short- or long-term 
weather changes; (3) to describe the methodological aspects of stroke incidence studies 
used in the ACINrpc project and, (4) to determine changes in stroke incidence in Northern 
Portugal. 
The data used is part of the two ACINrpc projects (1998-2000 and 2009-2011). In these 
two prospective community-based studies implemented in Northern Portugal, all patients 
with a first-ever-in-lifetime stroke or focal neurologic transient symptoms were ascertained 
using comprehensive methods, including referrals from physicians working in the study 
area and data retrieved from emergency/discharge records. Physicians were encouraged 
to report/notify any patient who might have experienced such a kind of event. Patients 
were examined at baseline and followed-up at three months. For the first cohort (1998-
2000) patients were also followed at one and seven years. 
Information about socio-demographic characteristics, prior-to-stroke vascular risk factors, 
diagnostic and clinical evaluation/treatment and destination after discharge was collected 
using the same methodology throughout the two study periods. Functional status was 
assessed with the modified Rankin Scale (mRS) and stroke severity was measured using 
the Unified for Neurological Stroke Scale (first study) and the National Institute of Health 
Stroke Scale (second study). For the first study period, an additional dataset with 
information on daily temperature, humidity and air pressure, between September 1998 
and October 2000, was obtained from the National Meteorological Office. Stroke was 
defined according to the World Health Organization and classified into pathological types 
according to Sudlow and Warlow standard definitions. The Oxfordshire Community 
Stroke Project classification and the Trial of Org 10172 in Acute Stroke Treatment 
(TOAST) criteria were used to define ischemic stroke subtypes. 
The Poisson distribution was used for modeling the number of incident events. When the 
events related to varying amounts of exposure, as for values of meteorological 
parameters using different hazard periods, the Poisson regression was used. When 
exposure is constant (not relevant in the model) and explanatory variables are 
categorical, as in the model of incidence according to age-group, sex and study period, 
the data may be summarized in a contingency table with restrictions on cell frequencies. 
In this case a generalized linear model with a link function was used, a log-linear model. 
This distribution was also assumed for calculating the 95% confidence intervals for crude 
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and standardized incidence rates for the Portuguese and European population. The 
binomial model was used to contrast effects of meteorological parameters across 
subgroups of patients. 
As far as prognosis is concerned, the Kaplan-Meier estimates for overall survival were 
calculated and predictors of survival free from stroke or vascular events were determined 
using Cox proportional hazards models. Ridit analysis was used to estimate the odds of a 
more serious 7-year outcome according to adjacent values of the 3-month modified 
Rankin Score (mRS).  
The age pattern of ischemic stroke incidence marks the difference between rural and 
urban populations; the youngest urban and the oldest rural residents were at a higher 
risk. Although patients from rural areas were older, the relatively lower prevalence of 
simultaneously occurring risk and prognostic factors among them as well as the similar 
management of rural and urban patients may justify why rurality is not associated with 
long-term survival. It was also described that a three grade simplified mRS summarises 
the risk profile and stroke characteristics in 3-month survivors with ischaemic stroke. 
Moreover we found that modest differences in functional status at 3 months are 
associated with significant differences in survival and functional status over 7 years, 
results that have relevant implications for health care planning and economic assessment 
of treatments for acute stroke. 
We found that outdoor temperature and related meteorological parameters are 
associated with stroke occurrence and stroke severity. The different hazard periods for 
temperature effects, the absence of association with lacunar infarcts and the association 
with cardioembolic infarcts may explain the heterogeneous effects of weather on stroke 
occurrence found in community-based and hospital admission studies.
This work also highlights the importance of screening all transient focal episodes for 
identifying patients with stroke and this may be a methodological criterion to be included 
in future stroke incidence studies. The decline in stroke incidence between 1998 and 
2011 contributed for the decline in stroke mortality rates in Portugal. We may add that 
there was a gender decline in the sense that an overall stroke incidence, hemorrhagic 
stroke incidence and disabling stroke incidence was evidenced in women and not in men. 
Advances in the quality of inpatient care and primary/secondary prevention in the elderly 
contributed decisively for the better stroke outcome across the last decade. 
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INTRODUÇÃO
Embora as taxas de mortalidade por acidente vascular cerebral (AVC) tenham vindo a 
diminuir nas últimas décadas, o AVC continua a figurar como uma das principais causas 
de morte a nível mundial.1 O AVC é também responsável por um elevado número de 
hospitalizações, e as suas sequelas pós-AVC têm como consequência uma diminuição 
da qualidade de vida dos sobreviventes, incapacidade para o trabalho e/ou actividades 
diárias, e um alto consumo de recursos de saúde.2
Em Portugal, até finais do século XX, a informação disponível sobre o AVC baseava-se 
nas taxas de mortalidade publicadas pelo Instituto Nacional de Estatística. Com base 
nessa informação, Portugal apresentava, no período compreendido entre 1985 e 1994, 
uma das mais altas taxas de mortalidade por AVC da Europa Ocidental.3 Para além 
desta elevada mortalidade, num estudo realizado em 1992, a prevalência estimada do 
AVC era de 8% com cerca de 20% dos sobreviventes a apresentarem uma incapacidade 
grave.4 No que diz respeito à incidência de AVC e factores de risco associados, os 
primeiros estudos entretanto realizados apresentavam algumas limitações 
metodológicas, nomeadamente em termos de representatividade do AVC na 
comunidade e critérios de diagnóstico diferentes.5-6 No entanto, os estudos prospectivos 
na comunidade são os únicos que permitem determinar de forma real a taxa de 
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incidência de AVC e co-morbilidades associadas. Permitem ainda conhecer melhor a sua 
etiologia e deste modo desenvolver estratégias mais eficazes para a sua prevenção e 
tratamento.7 Tendo como objectivo investigar a elevada taxa de mortalidade por AVC no 
Norte de Portugal, foi realizado entre Outubro de 1998 e Setembro de 2000, um estudo 
de incidência de acidentes neurológicos (ACINrpc: Acidentes Neurológicos - registo 
prospectivo na comunidade), no qual tive a oportunidade de estar envolvido desde a fase 
inicial.8 A metodologia adoptada obedeceu aos critérios internacionais estipulados para a 
realização de um estudo de incidência "ideal”.9 Este estudo permitiu obter dados fiáveis 
sobre a taxa de incidência do primeiro acidente neurológico na vida, incluindo o AVC,10 o 
Acidente Isquémico Transitório (AIT)11 e o Acidente Neurológico Transitório não AIT 
(ANT).12 Permitiu ainda obter informação sobre a prevalência dos factores de risco 
vascular (FRV) mais relevantes e determinar o prognóstico a curto prazo, em populações 
urbanas e rurais (Tabela 1). A partir dos resultados obtidos, na Região Norte de Portugal, 
foi possível estimar que por ano 28.000 pessoas sofriam um primeiro AVC na vida, 
sendo este número ainda superior nas regiões rurais. 
Tabela 1. Taxa de incidência anual e indicadores de prognóstico no estudo decorrido entre 
1998 e 2000, em populações urbanas e rurais 
  Urbana Rural Global 
Evento Indicador taxa IC 95% taxa IC 95% taxa IC 95% 
AVC  Incidência (/100 000) 269 244-293 305 265-344 279 259-300
   Padronizada* 173 153-192 202 169-234 181 164-198
 28 dias 
  Letalidade (%) 14.6 10.2-19.3 16.9 13.7-20.6 16.1 13.6-19.1
 12 Meses 
  Recorrência (%) 7,6 5,5-10,4 11,5 8,0-16,3 8,9 7,0-11,2
  Mortalidade (%) 30,1 26,1-34,4 28,8 23,3-35,0 29,7 26,4-33,2
  Dependência** (%) 42,7 37,4-48,2 36,0 29,0-43,7 40,4 36,1-44,8
AIT  Incidência (/100 000 61 49-73 96 67-133 67 56-78
   Padronizada 40 23-69 67 45-104 44 26-73
 12 Meses 
  Recorrência (%) 21,9 15,1-30,7 27,8 15,9-44,0 23,4 17,2-31,0
  Mortalidade (%) 9,5 5,3-16,6 19,4 9,8-35,0 12,1 7,7-18,5
*População Europeia, **Valor na escala de Rankin modificada >2 
Em comparação com outras regiões da Europa Ocidental,13 a incidência de AVC em 
Portugal era tendencialmente mais elevada quer em zonas rurais (305/100.000) quer em 
zonas urbanas (269/100.000). Estes valores de incidência apenas eram superados por 
países do Leste da Europa.13-14 No entanto a alta incidência nos mais velhos verificava-
se em estudos realizados em ambientes rurais ou mistos (rural/urbano) contrastando 
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com estudos realizados em ambiente urbano e, por outro lado, a incidência nos mais 
novos era superior na cidade do Porto quando comparada com a de outros estudos em 
meio citadino.15 Estes resultados foram o ponto de partida para tentar compreender e 
melhorar a prevenção/tratamento precoce do AVC. Surgiram assim várias questões de 
investigação que constituíram o tema central desta tese. As primeiras questões que 
importava responder relacionam-se com a prevalência dos FRV e a incidência e 
prognóstico do AVC: 
Será que a população rural em comparação com a urbana tinha uma maior 
prevalência dos tradicionais factores de risco vascular? Será que por esse facto a 
incidência dos diferentes tipos de AVC era diferente nas duas populações? Será o 
seu prognóstico a longo prazo será diferente? 
Os primeiros resultados do estudo ACINrpc mostraram também que a elevada incidência 
era acompanhada por uma baixa taxa de letalidade aos 28 dias (14,6% no meio rural e 
16,9% no meio urbano), contrariamente ao que se poderia supor a partir das estatísticas 
oficiais de mortalidade que apontavam para uma taxa de mortalidade padronizada de 
154/100.000 habitantes.16 De notar que os valores encontrados para a taxa de letalidade 
no estudo eram similares aos de outros estudos de base populacional.15,17-18 Este facto 
poderá ser explicado quer pelas altas taxas de incidência nos mais jovens quer pela 
diferente distribuição de subtipos de enfarte cerebral.8,10 Surgiu, pois, daqui uma outra 
questão de investigação abordada no âmbito desta dissertação: 
Será que a elevada incidência de AVC era acompanhada por uma menor gravidade 
(incapacidade), especialmente no caso do enfarte cerebral?
Tendo como ponto de partida a sazonalidade na ocorrência de AVC encontrada em 
diferentes estudos,19-22 encontrou-se, no norte de Portugal, uma diferença ambiental 
marcada entre o meio urbano (Porto) e o meio rural (Vila Pouca de Aguiar) relacionada 
com os parâmetros meteorológicos, particularmente com as temperaturas mínimas e 
máximas em Vila Pouca de Aguiar.23 No Inverno, registou-se um pico na ocorrência de 
AVC em Vila Pouca de Aguiar, enquanto no Verão se verificou um menor número de 
AVCs no Porto. Vários estudos tinham já apontado para a associação entre a 
temperatura e mortalidade por AVC22,24-25 mas poucos tinham estudado a associação 
entre os parâmetros meteorológicos, em particular a temperatura, como despoletadores 
do AVC. Neste contexto surgiu uma outra questão de investigação: 
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Será que a exposição transitória com efeito transitório a valores extremos dos 
parâmetros meteorológicos, nomeadamente a temperatura ambiental, responsável 
pelo desencadear do AVC, isto é, por variações na incidência, em particular na 
população idosa? 
Embora reconhecendo que as estatísticas oficiais de mortalidade por AVC não são 
isentas de viés, é possível observar um declínio destas taxas entre os anos de 1999 e 
2012, tanto em Portugal Continental (de 154,2 para 62,8/100.000), como na Região 
Norte (de 164,2 para 66,7/100.000) (Figura 1).16,26-33 Variações na taxa de mortalidade 
podem resultar de variações na incidência e/ou prognóstico, quer actuando ao nível da 
prevenção dos FRV quer por ganhos significativos no tratamento precoce da patologia.  
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Figura 1. Evolução das taxas de mortalidade por doença cerebrovascular  
Desde a realização do primeiro estudo (1998-2000) verificaram-se avanços 
consideráveis ao nível da intervenção no AVC com o objectivo de alterar o seu "peso" na 
comunidade, destacando-se melhorias na prevenção dos principais FRV36 e a 
implementação de intervenções terapêuticas, nomeadamente a organização de 
Unidades de AVC e a utilização do tratamento trombolítico na fase aguda.34-35 Em 
resultado dessas estratégias o cidadão comum está mais informado quanto à 
conveniência de exercer uma vigilância regular dos FRV, em particular da tensão 
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arterial,37 mas é ainda insuficiente a divulgação e o alerta na população para a 
emergência do AVC. Após a organização das Unidades de AVC, foi criado um programa 
- "Via Verde do AVC" - cujo objectivo é minimizar o tempo decorrido entre o 
aparecimento dos sintomas e o início do tratamento do AVC, esperando-se que tenha 
reflexos nos indicadores de mortalidade e morbilidade. Este programa requer tanto a 
organização da emergência pré-hospitalar e hospitalar como o alerta da população, de 
modo a que a procura de ajuda médica seja a imediata ao início dos sintomas.38-40
Para monitorizar a eficácia das estratégias de prevenção primária/secundária, é crucial 
ter informação sobre a evolução do padrão da doença e suas causas. Os dados 
epidemiológicos sobre tendências temporais na incidência, etiologia e prognóstico dos 
acidentes neurológicos, fornecem indicadores sobre a eficácia da actuação dos sistemas 
de saúde na prevenção dos factores de risco modificáveis, partilhados com outras 
doenças relacionadas com o envelhecimento, e no tratamento dos doentes em ambiente 
de consulta ou internamento. Assim, uma década após a realização do estudo ACINrpc 
foi possível desenhar e concretizar, na região norte de Portugal, o projecto ACIN2: 
“Tendência da incidência e prognóstico dos acidentes neurológicos: o segundo estudo 
de base populacional no norte de Portugal” (PIC/IC/82858/2007). A implementação do 
estudo requereu um planeamento cuidadoso e eficaz, adequado à obtenção de dados 
actuais de forma comparável com o estudo anterior. No decurso deste estudo 
levantaram-se várias questões, nomeadamente no que diz respeito à comparação dos 
resultados dos dois estudos: 
Como planear o estudo de modo semelhante ao primeiro, de forma a obter 
resultados comparáveis, contemplando: (a) a reorganização do Serviço Nacional de 
Saúde entretanto ocorrida; (b) a utilização de meios informáticos no tratamento das 
diferentes fontes de informação, que apresentam diferentes níveis de 
informatização e, (c) a inclusão de critérios metodológicos adicionais entretanto 
publicados? Qual a variação na incidência e prognóstico a curto prazo do AVC que 
ocorreu no espaço de uma década no Norte de Portugal? 
Estrutura da Tese 
Para responder às primeiras questões apresenta-se no Capítulo 2 um artigo onde se 
estudou a incidência e prognóstico a curto e longo prazo (sete anos) do primeiro AVC na 
vida. Para o efeito, recorreu-se à modelação do tempo de sobrevivência e co-variáveis 
descritivas dos eventos ocorridos durante o follow-up, nomeadamente utilizando um 
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moedelo de riscos proporcionais de Cox (Cox Proportional Hazards Model). Nesta 
análise utilizou-se a informação recolhida durante a realização do primeiro estudo 
ACINrpc, referente a doentes com um primeiro AVC na vida, e a informação obtida no 
follow-up realizado aos sete anos. 
No Capítulo 3 apresenta-se um artigo cujo objectivo foi estudar a importância do grau de 
incapacidade aos três meses no prognóstico a longo prazo (sete anos) dos doentes com 
enfarte cerebral (EC). O grau de incapacidade foi aferido utilizando a escala de Rankin 
modificada. De acordo com os valores na escala de Rankin aos sete anos e utilizando 
uma análise Ridit, foi possível reduzir a escala para três níveis (sem incapacidade, 
incapacidade moderada e incapacidade severa). Para medir o efeito da incapacidade 
aos três meses no prognóstico a longo prazo foi utilizado um modelo de riscos 
proporcionais de Cox, ajustado para possíveis variáveis confundidoras.  
Para responder à questão seguinte apresenta-se no Capítulo 4 um artigo no qual se 
investigou a associação entre a incidência de AVC e determinados parâmetros 
meteorológicos na cidade do Porto. Para o efeito utilizaram-se modelos lineares 
generalizados adequados ao estudo de acontecimentos raros (distribuição de Poisson). 
A informação sobre os parâmetros meteorológicos pertence à série secular do 
Observatório da Serra do Pilar (Porto), incluindo os registos diários da temperatura 
máxima e mínima, pressão atmosférica, humidade relativa e precipitação, durante o 
período de 15 de Setembro de 1998 a 15 de Outubro de 2000. Relativamente a este 
tema, foi apresentado um trabalho numa reunião científica cujo objectivo foi estudar 
especificamente a relação entre temperatura ambiente e precipitação e o risco de ter 
uma hemorragia intracerebral primária (HICP), utilizando um estudo caso-cruzado (‘case-
crossover’, anexo II). 
Para reforçar a importância metodológica de avaliar os episódios neurológicos focais 
transitórios (ANT) na detecção de AVC/AIT, e realizar o seu seguimento no curto prazo, 
apresenta-se no Capítulo 5 um artigo sobre a incidência de AVC/AIT nos doentes com 
sintomas vestibulares. 
Para responder às últimas questões desta dissertação, apresenta-se no Capítulo 6 um 
artigo em que se comparam os aspectos metodológicos utilizados nos dois estudos 
ACIN, com o objectivo de estimar variações na incidência e prognóstico a curto prazo do 
AVC na população da cidade do Porto. Para estudar o padrão evolutivo da incidência por 
sexo e idade foram utilizados modelos lineares generalizados (distribuição de Poisson). 
No âmbito deste tema, foram ainda apresentados três trabalhos em reuniões científicas 
nos quais se descreve a evolução das taxas de incidência e letalidade do AVC, da HICP 
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e da hemorragia subaracnoideia, comparando o meio urbano com o rural (anexo II). 
Apresenta-se ainda, em anexo, um artigo com uma análise preliminar sobre a 
caracterização dos utentes da Via Verde do AVC, no qual se focam alguns aspectos 
metodológicos adoptados no segundo estudo. 
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 Abstract 
 Background/Aim: Differences in stroke incidence and mortality between regions could stem 
from differences in the incidence of particular stroke types and long-term prognosis. The aim 
of this study was to investigate whether different risk profiles and stroke types underlie the 
difference in stroke incidence and patient long-term survival in rural and urban populations. 
 Methods: All suspected first-ever-in-a-lifetime strokes occurring between October 1998 and 
September 2000 in 37,290 residents of rural municipalities and in 86,023 individuals living in 
the city of Porto were entered into a population-based registry. Standard definitions of stroke 
types and overlapping comprehensive sources of information were used for patient identifi-
cation. Patients were examined by neurologists at 3 months, 1 year and 7 years after the index 
event.  Results: From a total of 688 patients included (226 in rural and 462 in urban areas), 
76.2% had an ischaemic stroke (IS; 75.3 vs. 77.9%), 16.1% a primary intracerebral haemorrhage 
(PICH; 16.3 vs. 14.6%) and 3.3% a subarachnoid haemorrhage (SAH; 2.7 vs. 3.7%); in 4.4% (4.9 
vs. 4.1%), the stroke type could not be determined. The annual incidence rate per 1,000 was 
2.13 (95% CI, 1.95–2.31), 0.45 (95% CI, 0.37–0.53), 0.09 (95% CI, 0.06–0.14) and 0.12 (95% CI, 
0.08–0.17), respectively. The age-specific rural/urban incidence rate ratios for IS in the young-
est group (<55 years) was 0.27 (95% CI, 0.11–0.69), increasing to 1.47 (95% CI, 1.07–2.01) for 
those aged 65–74 years and to 1.87 (95% CI, 1.39–2.52) for those between 75 and 84 years. 
Rural compared to urban patients with an IS were predominantly men, had a prevalence ratio 
(PR) of 1.28 (95% CI, 1.05–1.56), were 65 years or older (PR = 1.18; 95% CI, 1.08–1.30) and had 
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in general a lower prevalence of risk factors. There was no evidence of rural/urban differenc-
es in 28-day case fatality for the stroke types, although IS tended to be less fatal among urban 
patients (10.3 vs. 13.1%), whereas PICH (33.3 vs. 24.2%) and SAH (35.3 vs. 16.7%) were less fa-
tal among rural patients. Independently of rural/urban residence, predictors of poor survival 
after the acute phase (28 days) were age >65 years (HR = 3.57; 95% CI, 2.6–4.9), diabetes 
(HR = 1.5; 95% CI, 1.2–1.9), ischaemic heart disease (HR = 1.8; 95% CI, 1.3–2.6), atrial fibrilla-
tion (HR = 1.5; 95% CI, 1.1–2.0) and smoking habits (HR = 1.6; 95% CI, 1.1–2.3).  Conclusions: 
The age pattern of IS incidence marks the difference between rural and urban populations; 
the youngest urban and the oldest rural residents were at a higher risk. Although patients 
from rural areas were older, the relatively lower prevalence of simultaneously occurring risk 
and prognostic factors among them as well as the similar management of rural and urban 
patients may justify why rurality is not associated with long-term survival. 
 © 2013 S. Karger AG, Basel 
 Introduction 
 Despite the continuous decrease in mortality rates from stroke in Portugal in the last two 
decades  [1] , disparities still remain in standardized rates among rural (77.1/100,000) and 
urban (71.8/100,000) areas in northern Portugal  [2] . We have shown that this excess 
mortality in rural areas could be partially explained by a higher incidence of stroke and not 
by short-term case fatality, i.e., 30.1% in rural areas compared to 27.9% in the city of Porto 
in the first year following the first-ever-in-a-lifetime stroke (FELS)  [3] . Rather than being a 
single pathological entity, stroke is a disease that includes distinct types having different inci-
dence rates, risk profiles, management guidelines and outcomes that may lead to different 
disease burdens in different regions. Comparing the incidence of different stroke types as 
well as the risk profiles and long-term survival of patients with these stroke types in rural and 
urban populations may add important knowledge about their aetiology, prevention and prog-
nosis. In order to accurately assess the incidence of different stroke types, studies investi-
gating stroke incidences must meet ideal criteria  [4, 5] , such as the use of diagnostic brain 
imaging for the majority (ideally for all) of the patients  [6] . In accordance to these criteria, a 
community-based prospective stroke registry was set up in northern Portugal  [3] . The aim of 
this article is to present data on stroke types regarding incidence, risk profile and long-term 
survival for understanding the patterns of stroke in rural and urban populations.
 Population and Methods 
 The ACINrpc was a community-based study of the incidence and outcome of FELS and 
transient neurological focal symptoms and signs. The overall design of the project has been 
described in detail elsewhere  [3] . In brief, the study population comprised 123,112 indi-
viduals registered and identified by a unique health service at five health centres on September 
30, 1999 (mid-study period): 37,089 in rural areas and 80,023 in the city of Porto. This popu-
lation was not significantly different from the corresponding geographic population  [3] . Case 
ascertainment lasted from October 1, 1998, to September 30, 2000, and included both ‘hot- 
and cold-pursuit data collection’ using a variety of overlapping sources of information. 
 A study neurologist examined all suspected cases as soon as possible, and a CT was 
performed after the event. Medical records from hospitals and/or general practitioners (GP) 
were checked for details of any previous event and vascular risk factors (VRF). The principal 
investigator reviewed the information of each patient and classified the type of stroke; 
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whenever appropriate, the classification was established after consensus between the neurol-
ogist who first examined the patient and the principal investigator.
 All patients were followed up by neurologists at 3 months, 1 year and 7 years after the 
index event. The long-term follow-up began in September 2005, and every attempt was made 
to include all patients alive at the 1-year follow-up ( fig. 1 ). The process began by updating the 
telephone contacts of the patients using health centre/hospital administrative files and all 
available information on patient medical records. This was followed by a first contact by 
phone made 15 days before the end of the 7-year period, and, when this failed, two letters 
were sent explaining the study purpose and suggesting a date for a consultation. Patients who 
collaborated but were not willing to complete the consultation were contacted by phone, and 
for those unable to come to the hospital, home visits were scheduled. For patients known to 
be deceased based on previous information, a family member/caregiver had to give infor-
mation about the date and circumstances of death; otherwise, a search was done in the 
computer files held at the Northern Regional Health Administration. In case of death, infor-
mation about date and circumstances of death was confirmed by manual inspection of written 
monthly reports at each health centre since current legislation forbids the use of death certif-
icates for research purposes. This information was linked to existing clinical records for 
assigning the underlying cause of death, determined by a study neurologist. If no contact or 
information could be obtained, the patient was considered lost to follow-up.
 Stroke was defined according to the World Health Organization  [7] , and stroke types 
were classified according to Sudlow and Warlow  [5] as ischaemic stroke (IS), primary intra-
1-year follow-up
(484 patients)
159 exclusions:
8 – out of study period
39 – out of study population
72 – other diagnosis
40 – prior stroke688 incident events
Identified as
26 TIA 
19 TNA
Long-term follow-up
(265 patients)
Face to face           (78.9%)209
183
25
4
7
(46.7%)
(40.3%)
(26.7%)
(46.7%)
138
49
8
15
(25.2%)
(44.1%)
(34.8%)
(50.0%)
21
26
9
By phone               (7.9%)
Clinical records      (9.8%)
Lost                        (3.4%)
204 died:
Ischaemic stroke
Intracerebral haemorrhage
Subarachnoid haemorrhage
Undetermined stroke type
219 Died:
Ischaemic stroke
Intracerebral haemorrhage
Subarachnoid haemorrhage
Undetermined stroke type
802 patients identified
 
 Fig. 1. Ascertainment and inclu-
sion of FELS in northern Portugal 
and details of the 7-year follow-
up. 
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cerebral haemorrhage (PICH) and subarachnoid haemorrhage (SAH). If no brain CT scan was 
performed within 30 days and no autopsy, lumbar puncture or angiography (in case of 
suspected SAH) results were available, stroke was classified as undetermined. For VRF, the 
following definitions were used: for hypertension, a history of high blood pressure (BP) or an 
anti-hypertensive treatment or systolic BP >160 mm Hg and/or diastolic BP >95 mm Hg on 
at least two different measures; for diabetes, a previous diagnosis/treatment of diabetes 
mellitus with oral anti-diabetic/insulin or fasting glycaemia >126 mg/dl, postprandial 
glycaemia  ≥ 200 mg/dl and/or a glucose tolerance test with values of glycaemia  ≥ 200 mg/dl 
at the second hour; for hypercholesterolaemia, a previous diagnosis/treatment of hypercho-
lesterolaemia or a serum total cholesterol level after 12 h of fasting  ≥ 240 mg/dl; and for 
cardiac disease, a previous diagnosis of angina, myocardial infarction (MI) or atrial fibril-
lation by EKG confirmation, a previous diagnosis of a transient ischaemic attack (TIA), and 
smoking, categorized as never smoked, smoked regularly but not in the preceding 12 months 
(ex-smoker) and current smoker.
 The Ethics Committee of the Hospital de Santo António, where the study coordination 
centre was located, approved the study. Informed consent was obtained from each partic-
ipant, or from the next of kin when appropriate, before any clinical assessment. Since medical 
records are part of the National Health Service institutions, for follow-up purposes clinical 
files were used whenever the patient could not be contacted.
 Statistical Analysis 
 The distribution of patient characteristics at baseline according to stroke type is described. 
The crude incidence rates age-standardized to the Portuguese  [8] and European populations 
 [9] are reported, and the 95% confidence intervals (CI) were calculated by the Poisson distri-
bution. The rural/urban ratios of VRF prevalence, stroke incidence and case fatality were 
calculated based on cross-tabulation and were used to compare rural and urban patients. The 
Kaplan-Meier estimates for the cumulative risk of death for stroke types over a period of 7 
years after the index event were calculated in rural and urban patients. After checking the 
assumption of proportional hazards with the Schoenfeld’s test, the rural/urban hazard ratios 
(HR) were calculated using a Cox model including the baseline risk profiles. Since this 
assumption failed when considering the time from the index event until death over the 7-year 
follow-up, this model was restricted to patients surviving the acute phase (28 days). 
 Results 
 Of the 688 FELS (226 in rural and 462 in urban areas), 76.2% were IS (75.3 in rural vs. 
77.9% in urban), 16.1% were PICH (16.3 vs. 14.6%), 3.3% SAH (2.7 vs. 3.7%) and 4.4% of 
undetermined stroke type (4.9 vs. 4.1%). More cases in rural compared to urban areas were 
ascertained by ‘hot-pursuit’ and sooner after the event. Nearly 56% of the patients were 
admitted to the hospital, with a similar proportion for IS in both rural and urban areas but a 
lower proportion of PICH in the rural area (69.7 vs. 96.2%). Overall, a CT scan was performed 
in 96.9% of the patients (not done in 12 urban and 9 rural patients) and in 70.3% within 
24 h following the event.
 Vascular Risk Profiles and Incidence 
 Although patients were mostly women (58.7%), men predominated in rural areas (48.2 
vs. 37.9%) either with an IS or PICH; patients from rural areas were older than patients from 
urban areas, especially those with an IS ( table 1 ). Hypertension was the most prevalent VRF 
(60.9%), whereas a previous TIA was seldom registered (8.6%). In general, the prevalence of 
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VRF was lower in rural compared to urban patients, namely cardiac disease (IS and ICH), 
hypercholesterolaemia and smoking habits (IS).
 The crude overall annual incidence rate per 1,000 population was 2.13 (95% CI, 1.95–
2.31) for IS, 0.45 (95% CI, 0.37–0.53) for PICH, 0.09 (95% CI, 0.06–0.14) for SAH and 0.12 
(95% CI, 0.08–0.17) for strokes of undetermined type; adjusted for the European population, 
these rates were 1.33 (95% CI, 1.19–1.48), 0.33 (95% CI, 0.25–0.41), 0.07 (95% CI, 0.04–0.12) 
and 0.07 (95% CI, 0.04–0.11), respectively ( table 2 ). The ratio of rates indicates that the inci-
dence of IS in the youngest group (<55 years) was lower in rural compared to urban popula-
tions, particularly in men (0.12; 95% CI, 0.02–0.91). The opposite trend was found among 
those aged 65–84 years (2.19; 95% CI, 1.37–3.49 in men and 1.65; 95% CI, 1.12–2.45 in 
women; results not shown). For the remaining stroke types, there was no evidence of differ-
ences in the age pattern of incidence rates between the rural and urban environment.
 Short- and Long-Term Survival 
 Of the 688 FELS patients, 204 (29.7%) died during the first year; the 7-year follow-up 
details for the 484 survivors are described in  figure 1 . Nine patients were lost after the 1-year 
follow-up (1.1–2.4 years), mostly because they had changed residence or went abroad (7 IS, 
1 PICH and 1 SAH). Among the 209 (78.9%) patients examined by the neurologist, 21 (10%) 
were visited at their homes. The follow-up time ranged from 7 to 8.6 years.
 By day 28, 59 (11.3%), 34 (30.6%), 7 (30.4%) and 11 (36.7%) patients had died after the 
first IS, PICH, SAH and undetermined stroke, respectively. There was no evidence of rural/
urban differences in 28-day case fatality for the different stroke types, although IS tended to 
be less fatal among urban patients (10.3 vs. 13.1%), whereas PICH (33.3 vs. 24.2%) and SAH 
(35.3 vs. 16.7%) were less fatal among rural patients, corresponding to rural/urban ratios of 
1.26 (95% CI, 0.77–2.06), 0.73 (95% CI, 0.37–1.44) and 0.47 (95% CI, 0.07–3.16), respec-
tively. The cumulative risk of death at 7 years followed the same pattern: IS was less fatal in 
urban patients (57.4 vs. 61.5%), and PICH (67.4 vs. 64.6%) or SAH (61.2 vs. 33.3%) were less 
fatal in rural patients. The proportional mortality from stroke (first or recurrent stroke) was 
74.8% (83/111) at 28 days, 48.0% (98/204) during the first year and 30.3% (128/423) at 
the end of follow-up after 7 years.  Figure 2 shows the risk of death at 28 days and by year for 
ischaemic and haemorrhage stroke (PICH and SAH), indicating a relatively constant yearly 
risk after 3 years in patients with an IS.  Table 3 shows the independent baseline predictors 
of long-term survival after the acute phase. Besides age, diabetes (HR = 1.48; 95% CI, 1.15–
1.92), MI/angina (HR = 1.80; 95% CI, 1.25–2.58), atrial fibrillation (HR = 1.47; 95% CI, 1.07–
2.00) and being a current smoker (HR = 1.60; 95% CI, 1.13–2.28) increased the risk of death, 
whereas hypercholesterolaemia was a protective factor (HR = 0.45; 95% CI, 0.34–0.59). 
Stroke type and rural/urban residence were not associated with survival after the acute 
phase.
 Discussion 
 This is the first study to present a comprehensive picture of the burden of stroke among 
rural and urban populations, looking at the incidence of stroke types as well as at vascular 
risk profiles and long-term survival of patients. A high proportion of patients were ascer-
tained by ‘hot-pursuit’; almost all underwent a CT soon after the initial symptoms, thus 
improving the reliability of the results for the incidence of stroke types  [5] . Differences in 
procedural aspects mostly stem from the organization of the National Health Service; health 
centre services are more readily available than hospital services for rural populations, and in 
the city this is mainly a question of choice since there are no barriers of distance. Almost all 
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Stroke type 0 – 28 days 29 days to
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Ischemic
At risk, n 524 465 392 351 331 301 266 242
Death, n (N) 59 (59) 73 (132) 38 (170) 17 (187) 30 (217) 35 (252) 23 (275) 28 (303)
Risk, % 11.3 15.7 9.8 4.9 9.1 11.6 8.7 11.6
95% CI 8.8 – 14.3 12.7 – 19.3 7.2 – 13.1 3.1 – 7.7 6.4 – 12.6 8.5 – 15.7 5.9 – 12.7 8.1 – 16.2
Hemorrhagic
At risk, n 134 93 77 66 61 61 56 54
Death, n (N) 41 (41) 16 (57) 9 (66) 5 (71) 0 (71) 5 (76) 2 (78) 7 (85)
Risk, % 30.6 17.2 12.0 7.6 0.0 8.2 3.6 13.0
95% CI 23.4 – 38.9 10.9 – 26.1 6.4 – 21.3 3.3 – 16.5 0.0 – 5.9 3.6 – 17.8 1.0 – 12.1 6.4 – 24.4
 Fig. 2. Kaplan-Meier estimates of the cu-
mulative death risk for all patients ( a ) and 
the cumulative death risk in 28-day stroke 
survivors by stroke type ( b ). N = Cumula-
tive number of patients. 
D
ow
nl
oa
de
d 
by
: 
19
3.
13
6.
36
.1
34
 - 
10
/2
3/
20
13
 1
:0
6:
47
 P
M
145Cerebrovasc Dis Extra 2013;3:137–149
 DOI: 10.1159/000354851 
E X T R A
 Correia et al.: Stroke Types in Rural and Urban Northern Portugal: Incidence and 
7-Year Survival in a Community-Based Study 
www.karger.com/cee
© 2013 S. Karger AG, Basel
patients (91–92%) were seen at an ‘emergency service’; however, in rural areas it was mostly 
at the health centre (open 24 h) and this is why these patients are more often observed within 
3 h after the stroke. Nevertheless, in case of a PICH, there were fewer hospital admissions of 
rural compared with urban patients, though they remained in-patients in the health centre. 
Overall, the health services provided were similar for rural and urban patients, and based on 
previous studies we know that individuals living in rural areas are more prone to attend the 
family doctor at the health centre in case of most stroke warning signs than individuals living 
in urban areas  [10] .
 There was a higher incidence of both IS and PICH in rural than urban areas. Nevertheless, 
the comparison of standardized rates obscured the differences in the incidence age pattern 
in the two populations, particularly in IS. On average, the first IS happened almost 3 years 
earlier in life among the urban population, leading to a higher IS incidence in the youngest 
group (<55 years), especially in men, whereas for those aged 75–84 years living in rural areas, 
the average risk is almost twice as high than in the city. Although patients living in rural areas 
were older, they had, in general, less traditional VRF than patients living in urban areas, in 
particular cardiac disease and hypercholesterolaemia in patients with IS. The reduced infor-
mation and awareness of VRF  [10] in rural areas and the consequent lack of monitoring 
probably led to an under-reporting and/or under-diagnosis, mainly by GPs, since by 
description of ascertainment, health centre services are ‘more accessible’ in rural areas. On 
the other hand, our results go in the same direction than those from a Dutch study  [11] , in 
which self-reported health problems pointed to a better health in rural areas, although this 
could not be confirmed by the information available on GP records.
 Figure 3 shows the joint distribution of IS and PICH incidence across community-based 
studies with standardized rates (European population) or if data were available for calcu-
lation  [12–34] . The IS incidence ranged from 57/100,000 in Menorca  [29] to 255/100,000 in 
Table 3. HR for the association between factors at presentation and death among 28-day survivors
Univariate Multivariate 
HR 95% CI HR 95% CI
Sociodemographics
Rural versus urban 1.18 0.93 – 1.49 1.00 0.79 – 1.29
Men versus women 1.00 0.80 – 1.26 0.94 0.71 – 1.24
Age >65 versus ≤65 years 3.58 2.62 – 4.90*** 3.57 2.58 – 4.95***
Risk factors (yes vs. no)
Hypertension 0.81 0.64 – 1.02 0.86 0.68 – 1.09
Diabetes 1.21 0.94 – 1.56 1.48 1.15 – 1.92**
Atrial fibrillation 2.01 1.49 – 2.72*** 1.47 1.07 – 2.00*
MI/angina 1.58 1.11 – 2.23** 1.80 1.25 – 2.58**
TIA 0.92 0.61 – 1.37 0.99 0.66 – 1.47
Hypercholesterolaemia 0.46 0.36 – 0.60*** 0.45 0.34 – 0.59***
Smoking habits
Ex-smoker 0.65 0.42 – 1.02 0.80 0.49 – 1.31
Current smoker 1.07 0.80 – 1.43 1.60 1.13 – 2.28**
Diagnosis (vs. IS)
PICH 0.96 0.69 – 1.34 1.12 0.79 – 1.58
SAH 0.52 0.21 – 1.25 0.63 0.26 – 1.75
Undetermined stroke type 1.15 0.63 – 2.10 1.28 0.69 – 2.36
* p < 0.05; ** p < 0.01; *** p < 0.001.
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Mashhad  [33] , and the incidence of PICH ranged from 6/100,000 in Dijon  [29] to 39/100,000 
in Tbilisi  [26] . Both Portuguese urban and rural populations are in the upper-right quadrant, 
indicating a relatively high incidence of both IS and PICH, with the first being only higher in 
Mashhad, Kaunas, Orebro and Matão  [23, 28, 29, 33] and the latter in Mashhad, Tbilisi and 
Takashima  [14, 26, 33] . Apart from Japan, studies in Greece  [16] , Italy  [15, 19, 21] and Georgia 
 [26] also reported a relatively high incidence of PICH, probably linked to the high prevalence 
of hypertension and excess of salt in the Mediterranean diet, similar to the Japanese diet with 
a high consumption of salted fish  [35] . The standardized incidence of SAH in this group of 
studies ranged from 1 to 16/100,000 (median = 6/100,000), and the values in Portugal are 
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close to the median. The comparison of the incidence of stroke types may be biased since the 
incidence of undetermined strokes could be as high as 59/100,000 (Trivandrum  [30] ), 
resulting from the low proportions of patients investigated with brain CT/MR scan and/or 
with a postmortem examination. Though we verified that there was no linear correlation 
between the year of the study and the standardized incidence of the different stroke types, 
the same could not be said in relation to the prevalence of VRF as a trend towards a lower 
incidence of PICH was found in repeated studies in Takashima  [14] , South London and Dijon 
 [18, 29] ( fig. 2 ). Nevertheless, in comparison with other studies, the prevalence of hyper-
tension in patients from an urban area, representing a population-attributable risk for IS of 
45.2% and for PICH of 73.6%  [36] , is among the highest (only exceeded in Oxfordshire  [12] 
and Iquique  [24] ) for IS, and is the highest among Portuguese patients with PICH  [15, 27, 37] ; 
the same was found for diabetes mellitus, though the proportion of active smokers was rela-
tively low compared to other studies  [12, 15] . Besides traditional risk factors, environmental 
factors such as cold weather  [38] and dietary habits may explain the relatively high variation 
shown in incidence rates.
 There was no evidence of rural/urban differences in short- and long-term case fatality 
for the stroke types, though IS tended to be less fatal in patients from urban areas, whereas 
PICH and SAH were less fatal in patients from rural areas. The overall early case fatality after 
an IS (11.3%) found in this study is among the lowest values reported in all studies (range 
10–26%)  [12, 13, 15–26, 28, 32, 34] ; the values for PICH (30.6%) and SAH (30.4%) are also 
among the lowest within the respective ranges (20–61% for PICH  [23, 25] and 8–50% for 
SAH  [15, 18, 20] ). The cumulative risk of death at 7 years follows an identical pattern as the 
28-day case fatality in rural/urban populations, and the values are close to those reported 
in Perth after a FELS and higher than in Oxfordshire after an IS and lower for haemorrhagic 
stroke for a 5-year follow-up  [39, 40] . As in these studies, the proportional mortality from 
stroke in this study abruptly decreased after the acute phase. Neither stroke type nor resi-
dence was a predictor of long-term survival after the acute phase, but most risk factors were 
at the same time prognostic factors. Besides age <65 years, diabetes, atrial fibrillation, heart 
disease and smoking habits were predictors of poor survival, while hypercholesterolaemia 
was not. These results confirm recent findings  [41, 42] and may justify why long-term 
survival is not associated with urban/rural environment. Since the stroke care chain is 
similar for patients from rural and urban areas, the older rural patients may have indeed a 
better survival than expected because risk/prognostic factors are less prevalent among 
them.
 We have shown that the high incidence of stroke in rural compared to urban populations 
from northern Portugal is largely accounted for by the high incidence of cerebral infarcts, 
particularly in the rural elderly. The relatively better prognosis of IS and PICH in northern 
Portugal compared to other regions may result from the relatively high incidence of IS among 
the youngest age group living in the city as well as the relatively low prevalence of VRF in the 
eldest rural patients, pointing to different public health strategies. For better understanding 
the rural/urban differences in IS incidence, future analysis should be focused on the incidence 
of clinical subtypes of IS, aetiology and associated VRF.
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Abstract 
Background: The impact of public health interventions to reduce disability after stroke 
may be underestimated if only the modest effects on short-term disability are measured. 
We estimated the impact of differences in short-term functional outcome on long-term 
functional outcome. 
Methods: In a prospective community-based study from October 1998 to September 
2000, the first-ever ischemic strokes were registered in a population of 95,816 in Northern 
Portugal. Patients were examined at baseline and followed-up at three months, one and 
seven years. The Oxfordshire classification and the Unified Neurological Stroke Scale 
were used to define the stroke type and the severity of neurological impairments. The 
functional status was assessed with the modified Rankin Scale (mRS). Ridit analysis was 
used to estimate the odds of a more serious 7-year outcome based on the adjacent 
values of the 3-month mRS. Cox proportional hazards models were used for estimating 
the effect of 3-month mRS on survival, adjusting for patients’ characteristics, stroke type 
and severity.  
Results: The odds of a more serious 7-year outcome was different among patients with 
mRS=1 and 2 and also with mRs=3 and 4, defining the no significant (mRS=0-1), 
moderate (mRS=2-3) and severe disability (mRS=4-5). Of the 380 first-ever strokes, at 3 
months, 126 (33.2%) had mRS<2, 114 (30.0%) mRS=2-3, 73 (19.2%) mRS=4-5, and 67 
(17.6%) had died. We found linear relations between the 3-month mRS and the patient’s 
baseline profile, stroke type and severity. The Kaplan-Meier 7-year survival estimates for 
3-month survivors with mRS 0-1, 2-3 and 4-5 were 67, 50 and 23%, respectively. For 
mRS at 3 months of 2-3 versus 0-1 the hazard ratio (HR) for death was 1.61, (95% CI: 
1.10-2.38) and for mRS=4-5 versus 2-3 the HR was 2.20 (95% CI: 1.52-3.20); after 
adjustment the HRs were 1.19 (95% CI: 0.77-1.84) and HR=1.87 (95% CI: 1.18-2.95), 
respectively. A change in the 3-month mRS from 4-5 to 2-3 would have a “number 
needed to change” of 9 (95% CI: 6-18) patients to avoid one death in the long run; 
identical outcome is obtained by shifting the mRS from 2-3 to 0-1 in 27 (95% CI: 15-141) 
patients. 
Conclusions: In patients with ischemic stroke who survive to 3 months, a three grade 
simplified mRS summarizes the patient risk profile and stroke characteristics. These data 
confirm that modest differences in functional status at 3 months are associated with 
significant differences in survival and functional status over 7 years follow-up and have 
implications for health care planning and the health economic assessment of treatments 
for acute stroke. 
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Introduction 
By the year 2015, it is estimated that there will be 67 million stroke survivors worldwide 
[1], a majority of them with some disability. Treatments for acute ischemic stroke make 
only modest gains in short-term disability. However, small changes in short-term disability 
might translate into longer-term improvements in survival and functional status. If 
differences in functional outcome at three months are associated with differences in long-
term survival, or prolonged differences in levels of independence, then such data could 
materially influence estimates of the cost-effectiveness of many interventions. The 
modified Rankin Scale (mRS) has been widely used to measure functional outcome of 
stroke patients as an endpoint either in randomized clinical trials [2] or in the early months 
after stroke [3]. Further studies have shown its prognostic value for long-term survival in 
short-term survivors, that is, between 3 and 6 months and seven or more years [4-6]. Yet 
mortality from stroke has constantly declined in the last two decades as well as the 
mortality-to-incidence ratio, indicating the success of stroke management in the acute 
phase and the consequent increase in the number of stroke survivors [7]. Therefore, it is 
important to discriminate short-term levels of disability (cut-points) that evolve to a worse 
long-tem mRS score. We aim to optimize mRS cut-points for estimating the impact of 
functional status three months after a stroke on long-term functional outcome and survival 
in a prospective, population-based cohort of patients with ischemic stroke.Patients and 
Methods 
In a prospective population-based study, all patients with a first-ever-in-lifetime ischemic 
stroke were registered in four primary healthcare centers (HC) in Northern Portugal (two 
urban and two rural centers with 58,727 and 37,089 users, respectively) between 1st
October 1998 and 30th September 2000. The study was designed to meet the criteria of 
an “ideal” population-based study [8]. We aimed to comprehensively ascertain stroke 
cases by monitoring the (i) referrals from general practitioners (GP) and other hospital 
physicians working at the healthcare centers and hospitals; (ii) data retrieved from 
admission/discharge records; (iii) hospital outpatient records; (iv) nursing homes, private 
hospitals/practices and seniors residences; and (v) death certificates/autopsy. The study 
is described in more detailed elsewhere [9]. All patients gave written informed consent. 
The Ethics Committee of Hospital Santo António, where the study Coordination Centre
was located, approved the study. Before any clinical assessment, informed consent was 
obtained from each participant, or from the next of kin when appropriate.  
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Baseline Assessment 
All patients were assessed by a study neurologist immediately after the index event [9]. 
Definite ischemic stroke was defined as a focal neurological deficit lasting for more than 
24 h with no evidence of hemorrhage on brain imaging [10]. We registered demographic 
details, vascular risk factors (VRF), radiological and laboratory investigations, treatment 
patterns and destination details after discharge. CT brain lesions were read by a neuro-
radiologist blind to clinical symptoms/signs; based on the description of the CT, the 
neurologist assigned any acute lesion compatible with neurological symptoms and signs. 
To quantify neurological impairments at baseline, we used the Unified for Neurological 
Stroke Scale (UNSS), which is a continuous scale of stroke impairment that had good 
inter-rater agreement [11] and validity [12]. As our investigative resources were limited, 
and most classification systems available at the time of the inception of the study failed to 
classify patients into causal groups, we classified the subtype of stroke according to the 
Oxfordshire Community Stroke Project Classification [13] as: Total Anterior Circulation 
Infarct (TACI), Partial Anterior Circulation Infarct (PACI), LaCunar Infarct (LACI) or 
Posterior Circulation Infarct (POCI). The criteria used to define VRF were for 
hypertension, a history of high blood pressure (BP) or anti-hypertensive treatment or 
systolic BP >160 mm Hg and/or diastolic BP >95 mm Hg in at least two different 
measures; for diabetes, a previous diagnosis/treatment of diabetes mellitus with oral anti-
diabetic/insulin or fasting glycaemia >126 mg/dl, postprandial glycaemia 200 mg/dl 
and/or glucose tolerance test with values of glycaemia 200 mg/dl at the 2nd hour; for 
hypercholesterolemia, a previous diagnosis/treatment of hypercholesterolemia or serum 
total cholesterol level after 12 h fasting 240 mg/dl; for atrial fibrillation, evidence from the 
electrocardiogram (ECG) or registration in patient’s record of atrial fibrillation; patients  
were classified as current smokers if they smoked at the event date or at any time during 
the preceding 12 months [14]. 
Long-term Follow-up 
All patients were followed-up prospectively at three months, one and seven years. The 
long-term follow-up began by updating telephone contacts using HC/hospital 
administrative records; first a phone contact was made and when it failed, patients were 
contacted by mail (at least two consecutive attempts) [14]. For patients known to have 
died, we asked a family member or caregiver to inform us of the date and circumstances 
of death; otherwise, we searched the computerized files held at the Northern Regional 
Health Administration. This information was linked to existing clinical records, and the 
underlying cause of death was assigned by a study neurologist. A vascular cause of 
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death was defined as (a) death due to first or recurrent stroke, (b) death due to acute 
myocardial infarction (MI) whenever the event was confirmed by ECG, myocardial 
necrosis markers or necropsy and (c) death due to other vascular causes: suspected but 
not confirmed MI, heart failure, thoracic/abdominal aortic aneurysm rupture or sudden 
death of presumed vascular origin. 
Patients were examined at the neurological outpatient clinic and those who were unable 
to visit the clinic were examined at home. If no contact could be established, information 
was obtained from the health center or hospital records. Whenever these initiatives failed, 
the patient was considered lost to follow-up. Functional status at discharge and at 3 
months, 1 and 7 years was assessed with the modified Rankin Scale (mRS). 
Data Analysis 
Ridit analysis [15] was used to estimate the odds of a more serious outcome (distribution 
of mRS scores 7 years post-stroke) according to adjacent values of mRS at 3 months, 
that is, by comparing the outcome between patients with mRS=i and mRS=i-1, for i=1 to 
5. On the basis of this analysis, groups of patients with an equally likely long-term 
outcome were created (a simplified version of the mRS at 3 months). The distribution of 
patients’ characteristics, VRF and clinical evaluation at baseline across these groups was 
tested for linear trend. The Kaplan-Meier estimates for overall survival were calculated 
according to the original and grouped mRS scores in 3-month survivors. Cox proportional 
hazards models were used for estimating the effect of mRS scores on survival, adjusting 
for possible confounding variables (gender, age, VRF, pre-stroke mRS, UNSS score and 
OCSP subtype), after checking the assumption of proportionality with the Schoenfeld’s 
test. Patients where censored at the time of the last contact with the HC/Hospital if no 
information on vital status was available at the 7-year follow-up. Using death 
rates/person-years at 7 years, we estimated the number of patients who would need to 
have a lower mRS score at 3 months to avoid one death at 7 years. The number needed 
to change (NNC) to avoid one death at 7 years is given by 1/(mortality rate in the mRS=i 
group – mortality rate in mRS=i-1 group). 
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Results 
From the 623 patients suspected of stroke registered at the 4 HC, 124 were excluded and 
among the 499 included, 380 had an ischemic stroke (figure 1). At 3 months 126 (33.2%) 
had a mRS score <2, 114 (30.0%) a 2-3 mRS score, 73 (19.2%) a 4-5 mRS score, and 
67 (17.6%) died (table 1). A worse functional status at 3 months was associated with age, 
increasing from a median of 70 to 79 years, prevalence of atrial fibrillation, increasing 
from 9.5% to 34.3% and pre-stroke mRS 2, increasing from 1.6% to 43.8%. A more 
favourable functional status at 3 months was associated with male gender, the proportion 
decreasing from 59.5% to 37.3% and the prevalence of hypercholesterolemia, decreasing 
from 49.2% to 16.4%. All patients had a CT scan; 245 (64.5%) in the first 24 h and 62 
(16.3%) between 24 and 48 h after stroke onset; the proportion of patients with a 
symptomatic lesion on CT ranged from 34.1% in patients with mRS=0-1 to 54.8% when 
mRS=4-5. Stroke type and severity were also associated with a poor 3-month outcome, 
the proportion of TACI increasing from 2.4% to 52.2% contrasting with LACI, decreasing 
from 61.1 to 11.9%. 
Assessed for eligibility
(n=623)
Strokes included
(n=499)
Long-term follow-up
modified Rankin Scale 0-1 2-3 4-5 All
- Lost 3 6 5 14
- Died 46 58 53 157
- Alive
- Face to face 69 39 10 118
- By phone 1 5 2 8
- Clinical records 7 6 3 16
Exclusions (n=124)
Logistic reasons 
- Out of study period (n=8)
- Out of study population (n=26)
After neurological assessment
- Recurrent episode (n=31)
- Other diagnosis (n=59)
Ischaemic Stroke
(n=380)
mRS 0-1
(n=126)
mRS 2-3
(n=114)
mRS 6
(n=67)
mRS 4-5
(n=73)
Figure 1. Flowchart of inclusion of patients and details of 7-year follow-up
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Of the 313 three-month survivors, 157 (50.2%) died before 7-year follow-up and 14 
(4.5%) were lost either because they could not be traced after the first year (9) or had 
unknown mRS (5). Of the 142 patients alive 7 years post-stroke, 118 (83.1%) were 
examined by a neurologist of the research team (6 of them at home and the remainder at 
the hospital), 8 (5.6%) were contacted by phone and for the remaining 16 information was 
sought at hospital/HC records (figure 1). For the 299 patients with known 7-year status, 
Ridit analysis indicated that the odds of a worst functional status at 7 years was 1.71 
(z=3.1, p<0.001) when comparing a patient with mRS=2 to mRS=1, and 1.55 (z=2.3, 
p<0.02) for mRS=4 versus mRS=3; this analysis was repeated for the 142 that survived 7 
years and the corresponding odds were 1.93 (z=2.7, p<0.007) and 4.06 (z=3.4, p<0.001), 
respectively.  
Table 1. Distribution of patients’ characteristics at baseline and according to status at three 
months 
   Status at three months 
   Alive   
 All 
(n=380) 
All 
(n=313) 
mRS 0-1 
(n=126) 
mRS 2-3 
(n=114) 
mRS 4-5 
(n=73) 
mRS 6 
(n=67) 
P value 
linear 
trend 
Characteristics N % N % N % N % N % N % 
Men 170 44.7 145 46.3 75 59.5 46 40.4 24 32.9 25 37.3 <0.001 
Median age (IQD) 73.0 (7.5) 72.0 (7.3) 70.0 (7.3) 73.0 (8.1) 77.0 (7.8) 79.0 (6.5) <0.001 
Hypertension 229 60.3 36 53.7 76 60.3 71 62.3 46 63.0 36 53.7 0.6 
Hypercholesterolemia 136 35.8 11 16.4 54 49.2 50 43.9 21 28.8 11 16.4 <0.001 
Diabetes 100 26.3 23 34.3 29 23.0 26 22.8 22 30.1 23 34.3 0.07 
Atrial fibrillation 60 15.8 23 34.3 12 9.5 12 10.5 13 17.5 23 34.3 <0.001 
Previous TIA 38 10.0 6 9.0 15 11.9 11 9.6 6 8.2 6 9.0 0.4 
Current smoker 50 13.2 3 4.5 19 15.1 22 19.3 6 8.2 3 4.5 0.02 
Pre-stroke mRS* <0.001 
0-1 296 78.5 260 83.1 124 98.4 88 77.2 48 65.8 36 56.3
2-3 71 18.8 46 14.7 2 1.6 25 21.9 19 26.0 25 39.1
4-5 10 2.7 7 2.2 - - 1 0.9 6 8.2 3 4.7
Symptomatic lesion on CT 170 44.7 137 43.8 43 34.1 54 47.4 40 54.8 33 49.3 0.006 
Mean UNSS (sd) 23.3 (9.0) 29.2 (3.7) 29.2 (3.7) 26.2 (5.8) 17.3 (8.7) 14.0 (9.5) <0.001 
OCSP Classification <0.001 
TACI 87 22.9 35 52.2 3 2.4 17 14.9 32 43.8 35 52.2
PACI 70 18.4 12 17.9 20 15.9 23 20.2 15 20,5 12 17.9
LACI 154 40.5 8 11.9 77 61.1 53 46.5 16 21.9 8 11.9
POCI 69 18.2 12 17.9 26 20.6 21 18.4 10 13.7 12 17.9
*Three missings in the mRS=6 group; IQD=Interquartile deviation 
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Figure 2 shows the distribution of functional status at 7 years according to the 3-month 
mRS scores compared in the Ridit analysis; the shading in the left side draws attention to 
the similar 7-year functional outcome of survivors for patients with mRS=0-1, 2-3 and 4-5 
at 3 months, while the right side shows the proportion of patients deceased at 7 years 
according to mRS at 3 months. The proportions of patients with severe disability (mRS=4-
5) were 8.1, 9.3 and 17.6% according to mRS at 3 months 0-1, 2-3 and 4-5 contrasting 
with no significant disability (mRS=0-1), 36.6, 13.9 and 0% (table 2). 
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Figure 2. Distribution of mRS at 7 years according to mRS at 3 months; left side shows the mRS 
for survivors at 7-years by an increasing order of mRS score and the right side shows 
proportion of deceased. Number of patients in squares 
Table 2. Distribution of status at 7 years for 3-month survivors and number needed to change to 
avoid one death at 7 years (NNC)  
 Status at seven years    
Status 
at 3 months 
mRS 0-1 mRS 2-3 mRS 4-5 mRS 6 Person-
years 
Mortality 
rate/1000 
NNC mRS 
N % N % N % N % N 95%CI 
mRS 0-1 45 36.6 22 17.9 10 8.1 46 37.4 725.4 63.4 
mRS 2-3 15 13.9 25 23.1 10 9.3 58 53.7 575.1 10.1 27 15-141
mRS 4-5 0 0.0 3 4.4 12 17.6 53 77.9 248.8 21.3 9 6-18
Test for linear trend = 50.1, df=1, p<0.001 
For the 3-month survivors, the median survival time was 6.9 years. The proportional 7-
year survival for patients with 3-month mRS of 0, 1, 2, 3, 4, 5 was 56, 67, 52, 43, 29 and 
14%, respectively; for the simplified mRS (0-1, 2-3, 4-5) the values were 77, 50 and 23% 
(figure 3). The main causes of death were vascular (43.3%); they were a recurrent stroke 
(20.4%), an acute MI (14.6%), a sudden death (5.1%) or other vascular causes (3.2%). 
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(A)
 No at risk (% surviving) 
mRS 3 months 1st year 2nd year 3rd year 4th year 5th year 6th year 7th year 
0 50 (100) 47 (94) 42 (88) 40 (84) 36 (75) 33 (69) 30 (63) 27 (61) 
1 76 (100) 75 (99) 71 (93) 70 (92) 68 (90) 59 (78) 53 (74) 50 (72) 
2 50 (100) 48 (96) 44 (92) 42 (88) 39 (81) 34 (71) 28 (61) 24 (52) 
3 64 (100) 61 (95) 50 (81) 47 (76) 41 (66) 34 (57) 29 (48) 26 (43) 
4 43 (100) 39 (91) 30 (76) 26 (68) 21 (55) 18 (47) 15 (39) 11 (29) 
5 30 (100) 18 (60) 14 (47) 9 (33) 7 (25) 6 (22) 5 (18) 4 (14) 
(B)
 No at risk (% surviving) 
mRS 3 months 1st year 2nd year 3rd year 4th year 5th year 6th year 7th year 
0-1 126 (100) 122 (97) 113 (91) 110 (89) 104 (84) 92 (74) 83 (69) 77 (67) 
2-3 114 (100) 109 (96) 94 (86) 89 (81) 80 (73) 68 (63) 57 (54) 50 (50) 
4-5 73 (100) 57 (78) 44 (64) 35 (53) 28 (43) 24 (37) 20 (30) 15 (23) 
Figure 3. Long-term survival from assessment at three-month after an ischemic stroke according 
to (A) functional status at three months (mRS: modified Rankin Scale), (B) simplified 
mRS (0-1, 2-3, 4-5) 
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Patients with mRS=2-3 compared to mRS=0-1 at 3 months had a higher death hazard 
(HR=1.61, 95% CI: 1.10-2.38) as well as those with mRS=4-5 compared to mRS=2-3 
(HR=2.20, 95% CI: 1.52-3.20) (table 3). After controlling for pre-stroke mRS, patient’s 
profile at baseline, presence/absence of symptomatic lesion, UNSS score and OCSP 
classification, the death hazard for a patient with mRS=4-5 at 3 months compared to 
mRS=2-3 was 1.87 (95% CI: 1.18-2.95). Age, male gender, diabetes, current smoking, 
pre-stroke mRS 2 and stroke type (TACI or PACI vs. LACI) are associated with shorter 
survival times, hypercholesterolemia with longer survivorship and stroke severity (UNSS) 
is not associated with long-term survival. 
Table 3.  Cox’s regression models estimates of the hazard ratios for death at seven years 
according to baseline characteristics for patients alive at three months after a first-ever-
in-a-lifetime ischemic stroke 
  Univariate Multivariate 
Characteristics  HR 95%CI P value HR 95%CI P value 
Men vs. Women  1.29 0.94-1.76 0.1  1.87 1.27-2.74 0.001 
Age (10 years)  2.14 1.78-2.58 <0.001  2.18 1.78-2.67 <0.001 
Risk factors (yes vs. no)    
Hypertension  0.79 0.57-1.08 0.1  1.05 0.75-1.47 0.8 
Diabetes  1.29 0.91-1.84 0.2  1.90 1.29-2.81 0.001 
Hypercholesterolemia  0.52 0.37-0.73 <0.001  0.56 0.38.0.82 0.003 
Atrial fibrillation  1.86 1.22-2.84 0.004  0.88 0.54-1.41 0.6 
Previous TIA  0.68 0.37-1.26 0.2  1.09 0.56-2.10 0.8 
Current smoker  1.59 1.07-2.36 0.021  2.47 1.53-4.00 <0.001 
Pré-stroke mRS: 2-5 vs. 0-1  2.87 2.00-4.10 <0.001  2.01 1.31-3.08 0.001 
Symptomatic lesion on CT  1.27 0.93-1.74 0.1  1.18 0.84-1.66 0.4 
UNSS (for 1 point less)  1.04 1.02-1.06 <0.001  0.98 0.95-1.02 0.4 
OCSP Subtype (vs. LACI)  (<0.001)  (0.011) 
TACI  2.51 1.66-3.81 <0.001  2.16 1.14-4.11 0.019 
PACI  2.22 1.47-3.34 <0.001  1.88 1.21-2.92 0.005 
POCI  1.05 0.65-1.69 0.8  0.95 0.57-1.16 0.9 
3-month mRS  (<0.001)  (0.008) 
2-3 vs. 0-1  1.61 1.10-2.38 0.015  1.19 0.77-1.84 0.4 
4-5 vs. 2-3  2.20 1.52-3.20 <0.001  1.87 1.18-2.95 0.008 
For one extra 7-year survivor, a change in the 3-month mRS from 5 to 4 would be needed 
in 6 (95% CI: 3-19) patients; using the simplified mRS scores the NNC=9 (95% CI: 6-18) 
in the 3-month mRS from 4-5 to 2-3 or NNC=27 (95% CI: 15-141) in mRS from 2-3 to 0-1 
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(table 2). In the same way, we may calculate NNC to avoid disability/death (mRS 4-6) 
and the respective NNC are 7 (95% CI 5-12) and 24 (95% CI 14-121). 
Discussion 
We have found that differences in functional status at 3 months after stroke, from no 
significant (mRS: 0-1) to moderate disability (mRS: 2-3) or from moderate-to-severe 
disability (mRS: 4-5), are associated with important differences both in long-term survival 
and functional ability. After accounting for confounding by patient’s characteristics at 
baseline, stroke severity and stroke type, functional status at 3 months was an important 
predictor of long-term outcome following ischemic stroke. A simplified version of the mRS 
at 3 months (no significant, moderate and severe disability), captures the patient’s 
baseline profile and stroke presentation and is a long-term predictor of functional 
outcome. Because the patient’s vascular risk profile, namely, age, gender, diabetes, 
hypercholesterolemia, smoking habits, pre-stroke dependence and stroke type, is a 
predictor of long-term survival, it seems that a 3-month mRS is a mediator variable 
between stroke and long-term outcome. Indeed the mRS has been considered not just a 
pure handicap measure, but rather a global health index with strong accent on physical 
disability that may be used as a time-efficient functional outcome measure [16]. A small 
difference in 3-month disability leads to important differences in long-term survival. We 
have tried to show it with the “number needed to change”; for example, our data suggest 
that a treatment in the acute phase that results in a difference in mRS at 3 months from 
severe (4-5) to moderate disability (2-3) would have a ‘number needed to change” of 9 
patients to avoid one death in the long run.  
Another important issue is the long-term disability in survivors. Our data confirms that the 
mRS at 3 months is also strongly associated with the mRS at 7 years post-stroke, since 
the odds are approximately 2 to 1 that a patient with moderate disability will have a more 
serious disability than a patient with no significant disability and 4 to 1 that a patient with 
severe disability has a poor outcome in comparison with one with moderate disability. By 
7 years, 22.5% (32/142) of patients were severely disabled and 37.5% of them were 
already dependent at three months; this proportion is similar to the one found in the only 
study reporting 5-year long-term disability in stroke survivors [17]. Again, we may use the 
concept of “improving” survival/disability by shifting the mRS score at 3 months to lower 
categories, and by doing a shift from severe (4-5) to moderate (2-3) disability, we may 
avoid disability/death in one patient. At present this gain is obtained by the existing acute 
treatments (first hours pos-stroke) [18] and inpatient admission to stroke units [19], 
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procedures that were adopted in Portugal in the last decade. Public campaigns on 
surveillance of vascular risk factors, stroke awareness and stroke code activation 
implemented in Portugal [20-21] and in most European countries since the beginning of 
this century, may contribute as well for an expected gain. So, if the relationship between 
the short and long-term mRS holds, we may expect a decreasing trend in the disability-
adjusted life-years, as remarked in the recent results for the 1990-2010 period [7]. 
The results of this population-based study are in agreement with others showing that 
patients surviving the acute phase but with higher grades of disability have shorter 
survivals than those with no significant disability [4-6]. Besides the mRS at 3 months, the 
other factors associated with long-term survival are also identical to those we have found, 
namely age, male gender, vascular risk factors and pre-stroke dependence [4-6, 22-25]. 
Stroke subtype has also been consistently associated with long-term survival; usually 
patients with TACI and/or PACI have shorter survivals [4, 22, 26]. The long-term 
prognostic value of stroke severity seems to depend upon the scale used. While the 
Scandinavian stroke scale score was not associated with long-term survival [5], the 
National Institutes of Health Stroke Scale (NIHSS) was strongly associated with 3-year 
mortality [22]. In this study, stroke severity was associated with long-term survival but was 
not an independent predictor of survival after adjusting for short-term functional status. 
Since stroke severity was strongly associated with mRS at 3 months, we may conclude 
that the long-term effect of functional status at 3 months includes and adds predictive 
value to stroke severity. In comparison with the NIHSS, the UNSS has some limitations, 
since it is not restricted to measure the extension of the cerebral lesion, including 
activities like walking that measure functionality. However, we used UNSS to measure 
stroke severity because it was the only one adequately tested for validity and reliability 
[11-12] at the time of the incidence study (1998). On the other hand and independently of 
the scale used, the evaluation was not done at the same time point after symptoms onset 
in every patient. It should be taken into consideration that this is a population-based 
study, with a consequent difficulty to observe the patients shortly after symptoms onset; 
however 67% of them were observed in the first 24 h [9]. However, because this was a 
population-based study, some bias of hospital-based studies, namely reference bias, was 
avoided. 
The results of our study are important when estimating the cost-effectiveness of 
interventions in the acute phase, since modest short-term improvements may translate 
into substantial long-term gains [27-28]. Given the close relationship between functional 
status measured on the mRS and health related quality of life [29], these data have 
implications for both clinical care and for health economics. 
Tendências na Incidência e Prognóstico do AVC 
- 40 - 
In conclusion, our data confirm that the level of disability at three months is a strong 
independent predictor not only of survival but also of long-term functional outcome. We 
think that early (3-month) functional status is an important predictor (perhaps the most 
important) of long-term functional outcome, but further studies with enlarged sample size 
are needed to corroborate these results. Our results can keep stroke survivors and their 
relatives updated about stroke long-term prognosis and have implications on the study of 
cost-effectiveness of acute stroke treatments, health care planning policies and research. 
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patients registered, 19.6% had a primary intracerebral haem-
orrhage (PICH) and 75.3% an IS. Among patients with IS, 
21.6% were total anterior circulation infarcts (TACIs), 19.8% 
partial anterior circulation infarcts (PACIs), 19.5% posterior 
circulation infarcts (POCIs) and 39.1% were lacunar infarcts 
(LACIs). The aetiology of IS was large artery atherosclerosis in 
6.9%, cardioembolism in 23.3% and small artery occlusion in 
35.6%. The incidence of PICH increased by 11.8% (95% CI: 
3.8–20.4%) for each degree drop in the diurnal temperature 
range in the preceding day. The incidence of IS increased by 
3.9% (95% CI: 1.6–6.3%) and cardioembolic IS by 5.0% (95% 
CI: 0.2–10.1%) for a 1 ° C drop in minimum temperature in the 
same hazard period. The incidence of TACIs followed the IS 
pattern while for PACIs and POCIs there were stronger ef-
fects of longer hazard periods and no association was found 
for LACIs. The relative risk of a fatal versus a non-fatal stroke 
increased by 15.5% (95% CI: 6.1–25.4%) for a 1 ° C drop in max-
imum temperature over the previous day.  Conclusions: Out-
door temperature and related meteorological parameters 
are associated with stroke occurrence and severity. The dif-
ferent hazard periods for temperature effects and the ab-
sence of association with LACIs may explain the heteroge-
neous effects of weather on stroke occurrence found in com-
munity-based and hospital admission studies. Emergency 
services should be aware that specific weather conditions 
are more likely to prompt calls for more severe strokes. 
 Copyright © 2011 S. Karger AG, Basel 
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 Abstract 
 Background: Changes in meteorological parameters have 
been associated with cardiovascular mortality and stroke. 
The high incidence of stroke in Portugal may be modelled by 
short- or long-term weather changes whose effect may be 
different across stroke types and severity.  Methods: Data in-
clude all patients with a first-ever-in-a-lifetime stroke regis-
tered in a population of 86,023 residents in the city of Porto 
from October 1998 to September 2000. Specific stroke types 
were considered and ischaemic stroke (IS) subtype was de-
fined according to the Oxfordshire Community Stroke Projet 
classification and the Trial of Org 10172 in Acute Stroke Treat-
ment (TOAST) criteria. Information on daily temperature, hu-
midity and air pressure was obtained from the National Me-
teorological Office. The Poisson distribution was used to 
model the daily number of events as a function of each 
weather parameter measured over different hazard periods, 
and the binomial model to contrast effects across sub-
groups. Differential effects of meteorological parameters 
and hazard periods upon stroke occurrence and outcome 
were analysed in a stepwise model.  Results: Among the 462 
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 Introduction 
 The association between temperature and mortality 
from all causes was described in a cross-country Euro-
pean study, showing that Portugal has the highest coeffi-
cient of seasonal variation in mortality among 14 coun-
tries despite having the highest mean winter temperature 
(–3.5 to 13.5   °   C)  [1] . Deaths from acute myocardial and 
cerebral infarction contribute to the excess winter mortal-
ity  [2–4] , but routine mortality statistics may over-report 
the number of stroke deaths  [5, 6] confounded by post-
stroke complications. On the other hand, the incidence of 
stroke in most countries has a seasonal pattern, peaking 
during winter  [7–9] , with a lesser frequency in spring  [10, 
11] , autumn  [12] or summer months  [13] . These seasonal/
monthly effects are important to adopt preventive mea-
sures and to estimate the overall hospital and/or stroke 
units’ workload, but fell short of demonstrating meteoro-
logical factors underlying and triggering stroke occur-
rence, in particular a first-in-a-lifetime stroke.
 Irrespective of a seasonal effect, an association between 
weather parameters and hospital admissions for stroke 
was found in several studies  [14–18] , pointing out the 
short-term effects of temperature, atmospheric pressure as 
well as their short-term variations (24–48 h). In prospec-
tive community-based incidence studies, heterogeneous 
results concerning the effect of outdoor temperature on 
the incidence of stroke have been reported  [12, 19, 20] . The 
high incidence of stroke in Portugal  [5] may in part be ex-
plained by exposure to aggressive meteorological condi-
tions. Moreover, it has been suggested that mortality in-
creases to a greater extent during falls in temperature in 
regions with warm winters and in populations with cooler 
homes  [21] . Portugal, and in particular the city of Porto, 
with its maritime climate and traditionally unheated 
homes, represents a ‘natural experimental environment’ 
to test whether outdoor temperature or other meteorolog-
ical parameters are associated with the occurrence of 
stroke. Since different aetiological mechanisms/risk pro-
files are present in specific stroke types, we may hypoth-
esize that these effects will be different according to stroke 
type and severity. Moreover, the effects of each parameter 
may be different according to the hazard period.
 Materials and Methods 
 Identification and Classification of Stroke Patients 
 All first-ever-in-a-lifetime strokes registered in a population 
of 86,023 residents in the city of Porto between October 1998 and 
September 2000 were included. Case ascertainment methods in-
cluded direct referrals by general practitioners and hospital ad-
missions as well as routine checking contacts with nursing homes, 
private hospitals/practices and review of death certificates/autop-
sy findings. Details on methods for identification of patients have 
been provided elsewhere  [5] . All patients were examined by neu-
rologists, and CT scans were performed; for those who died soon 
after the event or were identified by death certificates, informa-
tion was given by relatives or an eye witness. Stroke was defined 
according to the WHO as ‘rapidly developing clinical symptoms 
and/or signs of focal, and at times global loss of cerebral function 
(patients in deep coma or cerebral haemorrhage), with symptoms 
lasting more than 24 h or leading to death, with no apparent cause 
other than of vascular origin’  [22] . Pathological types of stroke 
were defined according to Sudlow and Warlow  [23] and the isch-
aemic stroke (IS) subtype by the Oxfordshire Community Stroke 
Project (OCSP) classification  [24] and the aetiology according to 
the Trial of Org 10172 in Acute Stroke Treatment (TOAST) crite-
ria  [25] . For patients identified away from the event onset, classi-
fication relied primarily on medical record documentation. A 
stroke was considered to be fatal if death occurred within 28 days.
 Meteorological Characteristics and Data 
 The city of Porto is situated on the right bank and very close 
to the mouth of the river Douro, in northern Portugal, and had a 
population of about 250,000 in the 2001 Census, comprising 15 
administrative divisions. The study evolved in 10 of these divi-
sions, the catchment area of the Hospital de Santo António. Porto 
has a Mediterranean climate, with warm dry summers and mild 
rainy winters, but unlike the coastal south of Europe, it is often 
windy and usually cooler in winter with rainy weather for long 
periods. Daily maximum (T max ) and minimum temperature 
(T min ) (°  C), relative humidity (%), atmospheric pressure at sea lev-
el (hPa), and total precipitation (mm/m 2 ) at the Observatório da 
Serra do Pilar were obtained from the National Meteorological 
Office. This weather station provides data representative of the 
southeast Porto catchment area. Besides the crude values of me-
teorological data available we have also considered temperature 
variations within 1 day, i.e. diurnal temperature range (DTR), 
since it has been described to be associated with acute stroke
death  [26] .
 Statistical Analysis 
 The description of stroke types and IS subtypes includes the 
daily mean of events and the respective 95% confidence interval 
(95% CI), stratified by season. Case fatality by season is also de-
scribed. The Poisson distribution was used to model the daily 
number of events as a function of each weather parameter using 
a log-link function  [27] . Generalized additive Poisson models 
were used alternatively, to check whether explanatory variables 
should enter the model as linear terms or smoothed functions 
with varying degrees of freedom (d.f.), enabling some flexibility 
in the shape of the function describing the relation. For ascertain-
ing the effect of meteorological variables on daily stroke occur-
rence, a series of models were considered for exposure at different 
hazard periods before the event – the previous 24-hour value and 
the averaged values for the previous 7- and 14-day periods. Using 
a stepwise procedure, the final model for the specific event was 
built, considering as predictors the values for the three periods, 
besides the seasonal effect. Finally, the binomial distribution (lo-
gistic model) was used to es timate the relative risk of a fatal stroke 
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under different weather conditions. The effects (General Linear 
Model coefficients) are presented as the rate ratio for a unit drop 
in the temperature parameters (T max , T min , DTR) and unit in-
crease in the other parameters for Poisson models and as the odds 
ratio for binomial models, with the respective 95% CI. The likeli-
hood ratio   2 was used for comparing the fitted models against 
the intercept-only model. All analyses were done with the PASW 
Statistics 17.0 and by R statistical software Version 2.8.1. For sta-
tistical tests, a value  ! 0.05 was used to indicate a significant as-
sociation. For all analyses, we assumed a stable population at risk 
throughout the study period and so no adjustment for deaths and 
births were made.
 Results 
 Patients’ Characteristics 
 Based on a detailed clinical examination, including 
CT scans (97.4% of the patients and 83.5% within the first 
48 h) and/or autopsy or lumbar puncture findings, a total 
of 462 patients were diagnosed with a first stroke. The 
stroke was fatal in 78 patients (16.9%) and 83.3% of them 
were  6 65 years old. The distribution according to patho-
logical types and subtypes is described in  table 1 . Patients 
with primary intracerebral haemorrhage (PICH) were 
younger than those with IS (  2 = 7.5, d.f. = 1, p = 0.006) 
and those with a lacunar (LACI) or posterior circulation 
infarct (POCI) were younger than those with total circu-
lation (TACI) or partial circulation infarct (PACI) (  2 = 
22.9, d.f. = 3, p  ! 0.001). TACIs were more frequent in 
women compared with the remainder (  2 = 16.4, d.f. = 3, 
p  ! 0.001) and cardioembolism was more frequent in the 
oldest (  2 = 24.8, d.f. = 3, p  ! 0.001).
 Seasonal Patterns in Weather Parameters and the 
Incidence of Stroke  
 Weather parameters varied across seasons as expect-
ed, low values of T max , T min and relative humidity and 
high values of atmospheric pressure in winter contrasting 
with high temperatures in summer, high relative humid-
ity in summer and autumn and low atmospheric pressure 
in summer and spring ( table 2 ). Precipitation attains the 
highest values in spring and autumn. There was no sea-
sonality in the overall number of strokes, PICH or IS in 
spite of the increasing trend from summer to spring in the 
number of POCI (  2 = 8.8, d.f. = 3, p  ! 0.04). There was 
seasonality in case fatality from PICH, higher in summer 
(62.5%) compared to the remaining seasons (  2 = 8.0,
d.f. = 3, p  ! 0.05). The overall trend in PICH, IS and the 
incidence of fatal stroke throughout the study period are 
shown in  figure 1 together with the values of the meteo-
rological parameters. T max and T min (not shown) were 
highly correlated (r = 0.78) as well as relative humidity 
and DTR (r = –0.63); DTR increased with T max (r = 0.38) 
and decreased with precipitation (r = –0.45), while rela-
tive humidity increased with precipitation (r = 0.31). The 
Table 1.  Distribution of patient characteristics and vascular risk factors by types and subtypes of IS
Diagnosis/prognosis All Age ≥65 years W omen
n % n % n %
All strokes 462 331 71.6 287 62.1
Fatal stroke1 78 16.9 65 83.3 54 69.2
Pathological types
PICH 78 16.9 46 59.0 48 61.5
IS 348 75.3 259 74.4 215 61.8
OCSP classification
TACI 75 21.6 66 88.0 59 78.7
PACI 69 19.8 60 87.0 47 68.1
LACI 136 39.1 86 63.2 74 54.4
POCI 68 19.5 47 69.1 35 51.5
TOAST criteria
Large artery atherosclerosis 24 6.9 18 75.0 14 58.3
Cardioembolism 81 23.3 76 93.8 56 69.1
Small artery occlusion 124 35.6 78 62.9 69 55.6
Other determined/undetermined 119 34.2 87 73.1 76 63.9
1 D eath within 28 days from onset.
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relative peaks in PICH ( fig. 1 ) and fatal strokes closely fol-
lowed the constant drop and relative trough in T max and 
DTR.
 Meteorological Parameters and the Incidence and 
Outcome of Stroke 
 The incidence of PICH was associated with DTR and 
precipitation; for 1   °   C drop in DTR over the preceding
24 h, the incidence increased by 11.8%, and for each mil-
limetre of precipitation it increased by 3.1%, reaching 
5.7% (95% CI: 0.7–11.1%) when considering the average 
14-day period ( table 3 ). The incidence of IS, on the other 
hand, was associated with both Tmax and T min for the 
three hazard periods considered; for a 1  °  C drop in tem-
perature, the incidence increased between 3.3 and 4.3%. 
There were nevertheless different hazard periods for the 
effects of T max and T min according to IS subtype; the inci-
dence of TACI increased by 5.9% for a 1  °  C drop in T max 
over the preceding 24 h, the incidence of PACI increased 
by 6.6% after a 1  °  C drop in T min over the previous 24 h or 
7-day period and that of POCI increased between 5.8 and 
7.4% when T max /T min drops over different hazard periods. 
The incidence of LACI was not associated with any me-
teorological parameter. According to aetiology, only the 
incidence of cardioembolic IS increased by 5.0% (95% CI: 
0.2–10.1%) for a 1  °  C drop in T min . In the stepwise models, 
the most important predictors of PICH and IS were DTR 
and T min in the previous 24 h, respectively ( table 4 ). A 24-
hour short-term effect of T min and relative humidity was 
only associated with the incidence of TACI, while for 
PACI and POCI only the average 7/14 days effect of DTR, 
relative humidity and T max were included in the model. 
Despite the effects of relative humidity in the incidence 
of LACI, the fit was no better than for the intercept-only 
model. Using the binomial model, the odds of a fatal ver-
sus non-fatal stroke increased by 15.5% (6.1–25.4%) after 
a 24-hour drop in T max , and no significant differences 
were found across age and gender for IS. The contrasting 
short-term effects of DTR and T min on the incidence of 
PICH and IS are displayed in  figure 2 a, b, and the effects 
of T max on fatal and non-fatal strokes are displayed in  fig-
ure 2 c.
Table 2.  Description of weather parameters, incident events and case fatality by season
Weather and population
characteristics
All (n = 731) Summer (n = 188) Autumn (n = 178) Winter (n = 181) S pring (n = 184)
mean 95% CI mean 95% CI mean 95% CI mean 95% CI mean 95% CI 
Weather parameters
Temperature, ° C
Maximum 19.0 18.6–19.3 23.7 23.2–24.1 17.7 17.2–18.2 15.5 14.9–16.0 18.9 18.3–19.5
Minimum 10.3 10.0–10.6 14.7 14.4–15.0 9.1 8.5–9.7 6.2 5.7–6.7 10.9 10.4–11.4
Diurnal range 8.7 8.5–8.9 8.9 8.5–9.4 8.6 8.2–9.0 9.3 8.8–9.7 8.0 7.5–8.4
Relative humidity, % 77.0 76.2–77.9 78.1 76.6–79.5 78.8 77.3–80.3 74.2 72.2–76.2 77.1 75.6–78.6
Precipitation, mm/m2 3.1 2.6–3.7 2.0 1.1–2.9 3.6 2.4–4.8 2.1 1.4–2.9 4.6 3.4–6.1
Rainy days, % 43.6 40.0–47.2 20.7 14.9–26.6 55.6 48.8–63.5 43.6 36.4–50.9 54.9 47.6–62.2
Atmospheric pressure
(above 1,000 hPa) 19.4 18.9–19.9 16.3 15.8–16.9 21.5 20.5–22.5 23.8 22.8–24.9 16.2 15.3–17.1
Daily incident events1
All strokes 7.3 6.6–8.0 5.9 4.8–7.2 7.4 6.0–8.8 7.9 6.5–9.3 8.1 6.7–9.5
PICH 1.3 0.9–1.5 1.1 7.6–1.6 1.3 0.8–2.0 1.2 0.7–1.9 1.5 0.9–2.2
IS 5.6 5.0–6.2 4.3 3.4–5.5 5.8 4.7–7.2 5.9 4.8–7.3 6.0 4.9–7.4
LACI 2.2 1.7–2.6 2.1 1.4–2.9 2.0 1.4–2.9 2.2 1.5–3.0 2.4 1.7–3.3
TACI 1.2 0.9–1.5 0.8 0.7–1.9 1.7 1.2–2.6 0.9 0.6–1.6 1.2 0.7–1.9
PACI 1.1 0.8–1.4 0.8 0.5–1.4 1.2 0.7–1.7 1.5 0.9–2.2 0.9 0.6–1.5
POCI 1.1 0.8–1.4 0.6 0.2–1.1 0.9 0.5–1.5 1.4 0.8–2.1 1.5 0.9–2.2
Case-fatality, %
All strokes 16.9 13.5–20.3 21.9 13.6–30.1 14.0 7.7–20.4 14.6 8.4–20.9 17.8 11.2–24.4
PICH 33.3 22.9–43.8 62.5 38.8–86.2 30.0 9.9–50.1 22.2 3.0–41.4 25.0 7.7–42.3
IS 10.9 7.6–14.2 8.6 2.0–15.1 9.0 3.0–14.9 9.7 3.7–15.7 15.6 8.4–22.9
1 I ncidence per 1,000,000 population.
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 Discussion 
 This study shows that the high incidence of a first-
ever-in-a-lifetime stroke in Portugal may be related to ad-
verse effects of meteorological conditions. Moreover, ir-
respective of seasonal variations, these effects varied ac-
cording to pathological type. The incidence of PICH was 
associated with precipitation and DTR while the inci-
dence of IS was associated with temperature (T max /T min ) 
and relative humidity. Moreover, the relative importance 
of the hazard period was associated with stroke severity 
and the OCSP classification. The predominant effects af-
ter a 24-hour hazard period were observed in the inci-
dence of PICH, TACI, cardioembolic IS and fatal strokes. 
The effect of DTR and relative humidity was more impor-
tant after a 7-day hazard period for PACI and after a 14-
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 Fig. 1. LOWESS smoothed values of daily 
incidence of events (per million per day) 
and meteorological parameters (Tmax, 
DTR, relative humidity, atmospheric pres-
sure and precipitation) at Porto during the 
study period. 
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day period for POCI. No association was found for LACI, 
irrespective of the hazard period.
 Despite an overall increase from summer to spring in 
the incidence of stroke, there was no evidence for a sea-
sonal effect in our region, either for PICH or for IS. This 
pattern of variation has been previously described in 
other population-based studies undertaken in England, 
Italy, France and Russia  [12, 19, 20, 28] , while most stud-
ies based on registers of hospital admissions found evi-
dence of seasonality  [10, 11, 14] . This may reflect the fact 
of being ‘community-based’ thus including events, some 
of them reported by general practitioners, that other-
wise would be excluded. Moreover, they report only as-
sociations for a first-ever-in-a-lifetime event, usually 
with low proportions of severe cases compared to hospi-
tal admission studies or emergency transport events, the 
latter also being more subject to misclassification bias 
 [29–31] . The lack of seasonality in community-based 
studies may also result from the different seasonal ef-
fects on PICH and OCSP subtypes and their case mix in 
different populations. The incidence of PICH and TACI, 
peaking in spring and autumn compared to summer, 
points to the apparently steepest variation in Tmax/T min 
in these seasons whilst the incidence of PACI peaks in 
autumn and winter, pointing to possibly less acute ef-
fects of temperature. In addition, there appears to be a 
seasonal pattern in POCI and complete absence of sea-
sonality in LACI, which represents as much as 39% of IS 
in this study.
Table 3.  Association between incident stroke events and meteorological parameters according to exposure period
Weather
parameter/
hazard period
PICH IS
all TACI PACI LACI P OCI
RR 95% CI RR 95% CI RR 95% CI RR 95% CI RR 95% CI RR 95% CI
Season
Autumn 1.32 0.68–2.55 1.34* 0.98–1.84 2.04† 1.07–3.88 1.28 0.63–2.60 0.99 0.61–1.62 1.64 0.71–3.80
Winter 1.17 0.60–2.29 1.38† 1.01–1.88 1.11 0.54–2.31 1.71 0.88–3.32 1.07 0.66–1.73 2.42† 1.11–5.29
Spring 1.53 0.81–2.89 1.40† 1.03–1.91 1.39 0.70–2.77 1.10 0.53–2.27 1.18 0.74–1.88 2.73† 1.27–5.86
Temperature, f 1° C
Maximum
Previous 24 h 1.05* 1.00–1.10 1.03‡ 1.01–1.06 1.06† 1.01–1.12 1.03 0.98–1.08 1.02 0.98–1.06 1.04 0.98–1.09
Mean 7 days 1.04 0.98–1.10 1.04‡ 1.01–1.07 1.04 0.98–1.10 1.04 0.98–1.11 1.02 0.98–1.07 1.07† 1.01–1.14
Mean 14 days 1.04 0.99–1.11 1.04‡ 1.01–1.07 1.03 0.97–1.10 1.06* 1.00–1.13 1.02 0.98–1.07 1.07† 1.00–1.14
Minimum
Previous 24 h 1.00 0.95–1.05 1.04§ 1.02–1.06 1.04 0.99–1.09 1.07† 1.01–1.12 1.02 0.98–1.05 1.06† 1.01–1.11
Mean 7 days 1.02 0.96–1.08 1.04‡ 1.01–1.07 1.02 0.97–1.08 1.07† 1.01–1.13 1.02 0.98–1.06 1.07† 1.01–1.14
Mean 14 days 1.03 0.98–1.09 1.04‡ 1.02–1.07 1.03 0.97–1.09 1.06* 1.00–1.13 1.03 0.99–1.07 1.07† 1.00–1.13
Diurnal range
Previous 24 h 1.12‡ 1.04–1.20 0.99 0.95–1.02 1.04 0.96–1.12 0.92† 0.85–1.00 1.01 0.96–1.07 0.96 0.88–1.03
Mean 7 days 1.10 0.98–1.23 1.00 0.94–1.05 1.06 0.94–1.20 0.89* 0.78–1.01 1.02 0.94–1.12 0.98 0.86–1.11
Mean 14 days 1.07 0.92–1.24 0.98 0.91–1.05 1.02 0.88–1.19 0.97 0.83–1.14 0.95 0.84–1.06 0.99 0.84–1.16
Relative humidity, %
Previous 24 h 1.02 0.99–1.04 1.00 0.99–1.01 1.03† 1.00–1.05 1.00 0.98–1.02 1.00 0.98–1.01 1.00 0.98–1.02
Mean 7 days 1.01 0.98–1.04 1.01 1.00–1.02 1.01 0.98–1.04 1.01 0.98–1.04 1.01 0.98–1.03 1.01 0.98–1.05
Mean 14 days 1.00 0.96–1.04 1.00 0.99–1.02 1.01 0.97–1.05 1.02 0.98–1.06 0.99 0.96–1.01 1.02 0.98–1.06
Precipitation, mm/m2
Previous 24 h 1.03‡ 1.01–1.05 1.00 0.99–1.02 0.99 0.96–1.03 1.00 0.97–1.03 1.00 0.98–1.02 1.02 1.00–1.05
Mean 7 days 1.04* 1.00–1.08 1.00 0.98–1.03 1.01 0.97–1.06 0.97 0.91–1.03 1.01 0.97–1.04 1.02 0.97–1.07
Mean 14 days 1.06† 1.01–1.11 1.00 0.97–1.03 1.02 0.96–1.08 0.97 0.91–1.04 0.98 0.93–1.03 1.03 0.97–1.09
Atmospheric pressure, hPa
Previous 24 h 1.00 0.97–1.03 1.01 0.99–1.02 1.02 0.98–1.05 1.02 0.98–1.05 1.00 0.98–1.02 1.01 0.97–1.04
Mean 7 days 1.00 0.97–1.04 1.01 0.99–1.03 1.01 0.98–1.05 1.03 0.99–1.08 1.00 0.98–1.02 1.02 0.98–1.06
Mean 14 days 0.99 0.97–1.01 1.01 0.99–1.02 1.00 0.98–1.02 1.04* 0.99–1.08 1.00 0.98–1.02 1.03 0.99–1.07
*  p < 0.1, † p < 0.05, ‡ p < 0.01, § p < 0.001, otherwise p > 0.1; f = decrease; RR = rate ratio
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 It was hypothesized that the effect of meteorological 
parameters would be evidenced in specific stroke types 
since the prevalence of different risk factors varies ac-
cording to aetiology and clinical type  [32, 33] . Despite the 
reduced number of events, PICH and TACI are more 
closely related to temperature in shorter hazard periods. 
Since their prognosis is worst, it is not surprising that a 
cold diurnal temperature (T max ) is associated with the 
likelihood of a fatal stroke. The fact that T min (nocturnal) 
rather than T max is a better predictor of overall and in 
particular cardioembolic IS, the incidence of IS may be 
related to the already reported circadian rhythm of IS, 
peaking in the morning and closely following the morn-
ing surge in blood pressure  [34, 35] . Other factors that can 
trigger a stroke after cold exposure, such as activation of 
coagulation-related factors  [36] , haemoconcentration 
and increased blood viscosity  [37] may have a greater im-
pact in cardioembolic IS, the more frequent aetiological 
mechanism of TACI and PACI. On the other hand, the 
incidence of PICH is consistently associated with precip-
itation, increasing with the hazard period (24 h, 7 and 14 
days). This is the empirical evidence of a fact already 
mentioned by neurologists at emergency departments all 
over the country – why do we see more strokes on rainy 
days? Our data confirm this hypothesis, but when con-
sidering the effect of all-weather parameters, DTR in the 
previous day seems to explain this effect. This triggering 
effect of drops in DTR, characteristic of spring months 
might be explained by the concurrence of other atmo-
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 Fig. 2. Fitted number of PICH (black) and IS (grey) (scaled to be a percentage of mean daily strokes) plotted 
against DTR ( a ) and Tmin ( b ); fitted number of fatal (black) and non-fatal (grey) strokes plotted against Tmax ( c ). 
(Poisson models for the specific events). Dashed lines represent 95% CI. 
Table 4.  Association between incident stroke events and meteoro-
logical parameters according to exposure period (multiple-re-
gression models)
Stroke type/weather parameter RR 95% CI p
PICH (0.003)1
DTR – previous 24 h 1.12 1.04–1.20 0.003
IS (0.001)
Tmin – previous 24 h 1.04 1.02–1.06 0.001
IS subtype
TACI (0.011)
Tmin – previous 24 h 1.05 1.00–1.11 0.045
RH – previous 24 h 1.03 1.01–1.06 0.018
PACI (0.006)
DTR – mean 7 days 0.78 0.66–0.92 0.003
RH – mean 7 days 1.05 1.00–1.10 0.034
Tmax – mean 14 days 1.07 1.00–1.14 0.037
LACI (0.061)
RH – mean 7 days 1.04 1.00–1.08 0.029
RH – mean 14 days 0.95 0.91–0.99 0.018
POCI2 (0.016)
DTR – mean 14 days 0.80 0.64–1.00 0.045
RH – mean 14 days 1.06 1.00–1.12 0.037
Fatal stroke2 (0.001)
Tmax – previous 24 h 1.17 1.08–1.26 0.0001
Nonfatal stroke2 (0.004)
RH – mean 7 days 1.02 1.01–1.04 0.010
DTR – mean 14 days 0.88 0.81–0.96 0.005
F or temperature (Tmax, Tmin, DTR), the coefficients are for a
1° C drop. RH = Relative humidity; RR = rate ratio.
1 (value of p for the overall model).
2 Coefficients adjusted for seasonal effect.
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spheric parameters since they coincide with rises in pre-
cipitation, relative humidity and steepest drops in T max 
(inversely correlated with DTR) and atmospheric pres-
sure ( fig.  1 ). An inverse relationship with atmospheric 
pressure was found in Siberia  [19] as well as an increase 
in the incidence associated with a mild ambient tempera-
ture. In our study, this effect was found when T max ap-
proached T min , characterizing spring time with cold days 
but not so cold nights. These extreme climate features 
were apparent in the second spring of the study period 
and not so marked in the first year, a pattern also found 
in the incidence of PICH. When dealing with weather ef-
fects on health events, it is important to look for unusual 
combinations of meteorological parameters and some-
times characterize the days based on these combinations, 
as in the study undertaken in Israel  [29] . These triggering 
exposures were rare and usually concentrated, and their 
effects might be detected by an adequate data smoothing 
of events as shown in  figure 1 . They may be overlooked 
when dealing with extended time series data. Indeed, this 
fact might explain why contradictory findings on the ef-
fects of meteorological parameters have been reported in 
several studies, most of them finding an inverse relation 
between incidence and temperature, others a direct rela-
tion  [15, 31] and both direct and indirect relations across 
different regions within the country  [30] . The right an-
swer is probably given by an Australian study  [28] report-
ing an increase in incidence for extreme temperature val-
ues.
 Until now, few community-based studies have exam-
ined the relation between first-ever-in-a-lifetime stroke 
and weather parameters. In England  [20] and Italy  [28] , 
only the incidence of specific events increased with falls 
in temperature, PICH and fatal stroke, respectively, while 
in Russia  [19] the relation was present for both PICH and 
IS. From previous reports, we know that the incidence of 
first-ever stroke is higher in Russia and Portugal com-
pared to England. Population characteristics, mainly the 
endemic level of vascular risk factors already related to 
weather changes  [38, 39] , as well as housing and environ-
mental features, may explain these contradictory find-
ings. Hypertension has a high prevalence in Portugal 
linked to the excess salt intake, i.e. almost twice as high 
as that recommended by the WHO  [40] as well as a high 
prevalence of vascular risk factors in general  [41] . There-
fore, extreme values in environmental temperature, ei-
ther during daytime or night-time would more likely 
trigger cardiovascular events. On the other hand, the sur-
rounding conditions for the effect of temperature to be 
felt cannot be disregarded. The Eurowinter Group, with 
data from Finland, Germany, the Netherlands, the UK, 
Italy and Greece  [21] , has shown that high indices of cold-
related mortality were associated with high mean winter 
temperatures, low living-room temperatures, limited 
bedroom heating, a low proportion of people wearing 
protective clothes and inactivity. In the region of the city 
under study, i.e. the old part of the city near the river 
bank, most of these conditions prevail and thus we may 
conclude that in Porto we had conditions for an almost 
‘experimental’ environmental study, excluding in general 
possible effect modifiers such as eating/conditioning sys-
tems.
 The major limitation of this study is the reduced num-
ber of events, especially when the analysis involves strat-
ification by IS subtypes or overall case fatality. However, 
the reduced study power for comparing incident strokes 
according to the OCSP or TOAST classification using the 
binomial model (that excludes days with no events), had 
no influence on our conclusion that the effects of cold 
days on outcome (fatal and non-fatal events) are different. 
The conclusions of most studies rely on subgroup analysis 
and although they concluded that there was an effect, 
some of them did not attempt to verify whether sub-
groups behave differently  [33] . Another important analy-
sis would be to investigate subgroups according to cir-
cumstances associated with the onset and time to maxi-
mum deficit, as has already been done for myocardial 
infarction  [42] . We have also assumed that meteorologi-
cal conditions are homogeneous in the study area and the 
risk to be similar across different environments and cir-
cumstances, which might not be true. The data specifica-
tion included the day when stroke occurred without spec-
ifying the hour of the day, and so the 24-hour exposure 
to meteorological parameters also refers to the preceding 
calendar day. This means that the value of T min (usually 
during night-time) might by more distant from the event 
onset than T max (usually during daytime). It would be 
rather difficult to know the ‘exact’ event time since pa-
tients might not remember the exact time and more im-
portantly this is impossible when symptoms are felt when 
awakening.
 Our results point out two major conclusions: stroke 
type and IS subtypes must be considered when studying 
the effects of weather on incidence, confirming and cor-
roborating the different aetiological mechanisms of 
stroke. Moreover, it is not only exposure (intensity) that 
matters, but also the hazard period involved. Since the 
trigger effect is associated with severity/outcome, emer-
gency services (either dial emergency number or hospital 
emergency departments) should be aware that specific 
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weather conditions are more likely to prompt calls for 
more severe strokes. Further studies with larger data sets 
involving time trends may be useful to show whether the 
effects remain after all recent developments in stroke pre-
vention and treatment.
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Abstract 
Background: Vestibular symptoms (VSs) are frequent complaints in patients attending 
ambulatory care and the emergency room. They may represent a peripheral vestibular 
disorder or a stroke/transient ischemic attack (TIA), yet many patients have VSs that 
cannot be clearly classified at presentation. This study aims to characterize and 
determine the long-term prognosis of these patients. 
Methods: In a prospective community-based study involving 104,700 individuals 
registered at 4 health centers of Northern Portugal, patients with a first-ever-in-lifetime 
focal neurologic symptom (FNS) were ascertained using comprehensive methods, 
including referrals from physicians working in the study area and data retrieved from 
emergency/discharge records. Physicians were encouraged to report/notify any patient 
who might have experienced an FNS, including those with vertigo or vertigo-like 
symptoms, imbalance, presyncope, or nonspecific dizziness. After neurologic 
assessment patients were classified as having a peripheral vestibular symptom (pVS), a 
stroke/TIA, or an unclassified vestibular symptom (uVS). They were followed up 7 years 
after the index event at the outpatient clinic; predictors of survival free from stroke or 
vascular events were determined using Cox proportional hazards models. 
Results: Of the 1163 patients with an FNS, 360 (31.0%) were included, 16.7% had a 
stroke/ TIA, 57.8% had pVS, and 25.6% had uVS. Most patients presented only isolated 
VSs (62.8%); 63% were women and mean age was 60.1 years (standard deviation=16); 
hypertension (47.8%), hypercholesterolemia (41.9%), and diabetes (19.2%) were the 
most prevalent vascular risk factors (VRFs). Cranial computed tomography (CT) scan 
was performed in 63.3%. Adjusting for age, sex, VRFs, and diagnosis (TIA, pVS and 
uVS), the long-term risk of stroke was higher when CT showed silent infarctions (hazard 
rate [HR]=3.96; 95% confidence interval [CI], 1.63-9.60) and the risk of vascular events 
(stroke, myocardial infarction, or vascular death) was higher in patients with 2 or more 
VRFs (HR=2.70; 95% CI, 1.25-5.86). Identical results were obtained when restricting the 
model to patients with pVS or uVS. 
Conclusions: First-ever-in-lifetime VSs are common in patients with FNS and may 
represent a good opportunity for preventing a serious vascular event, particularly in 
patients with vascular comorbidity (silent infarctions and VRFs). 
Key Words: Vestibular symptoms—long-term prognosis—brain imaging—vascular risk 
factors—community-based study. 
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Background 
Vestibular symptoms (VSs), including dizziness, vertigo, or imbalance, are common in 
health care settings and could be the main complaint of patients with a stroke/TIA, 
predominantly in the vertebrobasilar artery territory.1-3
In clinical practice, the approach to the ‘‘dizzy patient’’ is based on the quality of the 
symptom, distinguishing those with vertigo (spinning or motion, concerning a vestibular 
disorder), presyncope (impending faint, concerning a cardiac disorder), imbalance 
(unsteadiness, concerning a central nervous system disorder), and nonspecific dizziness 
(any other dizziness).4 In most of the world medical centers, brain computed tomography 
(CT) scan is still the most available imaging tool used to investigate patients with acute 
VSs when a central nervous system disorder is thought. Despite the availability, brain CT 
scan has low accuracy in the identification of acute stroke in the posterior fossa.5 Even 
diffusion weighted imaging - magnetic resonance has a high false-negative rate in acute 
vertebrobasilar stroke (around 20%), more often when lesions are located in the brain 
stem.6-7 Therefore, diagnosis is manly based on clinical grounds and many recent 
publications have concerned an effort to improve bedside diagnosis.8-11 Even so, the 
distinction between possible etiologies for VS is often difficult, especially when more 
complex presentations involve other comorbidities that may impair a definitive diagnosis. 
Prospective community registries are adequate to describe the prognosis of these 
patients, avoiding the selection bias present in hospital cohorts. This study addresses 2 
relevant issues. First, to estimate how many ischemic events are expected in patients 
with first-ever-in-life VS and their relative importance in stroke/TIA incidence; second, to 
understand the seriousness of unclassified vestibular symptoms (uVSs) by looking at the 
7-year outcomes of these patients, compared with those presenting with ischemic or 
peripheral etiology. 
Methods 
The ACINrpc (prospective community register of neurologic attacks) included all first-
ever-in-life stroke or transient focal neurologic symptoms (FNSs) which could be 
attributed to a dysfunction of the central nervous system, in individuals registered at 4 
health centers (HCs) of Northern Portugal, 86,023 residents in the city of Porto and 
18,677 in a rural municipality, between the October 1, 1998, and the September 30, 
2000. For case ascertainment, ‘‘hot and cold pursuit’’ methods were used.12 These 
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included referrals from general practitioners and other physicians working at HC/hospitals 
within the study area, mainly at the emergency room, as well as data retrieved from 
admission/discharge or outpatient clinical records. Contacts were also established with 
nursing homes and senior residences; death certificates respecting these populations 
were consulted. More detailed aspects are described elsewhere.13-14 General 
practitioners were encouraged to report/notify any patient presumed to have experienced 
an FNS, including those with vertigo or vertigo-like symptoms, imbalance, presyncope, or 
nonspecific dizziness. For reporting patients to the study center, a predefined form was 
used including demographic/social information, details of symptoms onset, and up to 4 
major complaining symptoms. After neurologic assessment we excluded those who 
presented symptoms after head trauma, who contemporaneously to the FNS had ear or 
central nervous system infection, and those who presented with a presyncope associated 
with a medical disorder such as hypoglycemia, severe anemia, hypotension, drug 
intoxication, or acute/decompensated cardiac disorder. Patients with previous similar 
FNS or stroke were also excluded.  
Patients were observed by a research team neurologist as soon as possible after the 
acute event and followed up at 3 months, 1 year, and 7 years. The investigation and 
treatment of each patient was under the responsibility of the assistant physician 
(HC/hospital). In case of a central nervous system disease, patients were regularly 
followed as outpatient by a research team neurologist. The 7-year follow-up was done 
preferentially at the neurology outpatient clinic; when that was not possible, a telephone 
contact and/or revision of hospitals’/HC’ clinical records were conducted. If no information 
was available, the patient was considered lost to follow-up. Informed consent was 
obtained from each participant or from the next of kin, when appropriate, before any 
clinical assessment. Patients who expressed their unwillingness to participate were 
excluded (refusals). 
Definitions 
For all patients included whose 4 major complaints included VS, the presenting 
symptoms were grouped as follows: (1) isolated VS (with or without nausea/vomiting); (2) 
VS plus other FNSs; (3) VS plus tinnitus/hypoacusis; (4) VS plus generalized non-FNSs 
(generalized weakness, faintness or confusion); and (5) VS plus cephalalgia. According 
to diagnosis/etiology based on clinical criteria, patients were classified with: (1) 
Stroke/TIA; (2) Peripheral vestibular symptom (pVS), including benign paroxysmal 
positional vertigo or labyrinthitis; and, (3) unclassified vestibular symptom (uVS) when 
none of the previous or any other determined diagnosis was established. Stroke was 
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defined according to the World Health Organization criteria.15 In this cohort, stroke was 
diagnosed in patients presenting an acute vestibular syndrome associated with ‘‘other’’ 
central nervous signs, with or without acute symptomatic lesion on CT or magnetic 
resonance imaging (MRI), and ischemic stroke subtype was defined according to the 
Oxfordshire Community Stroke Project classification.16 TIA was defined according to 
standard criteria,14 and in this cohort, it was diagnosed in patients with monophasic 
episodes of VSs associated with central signs, lasting less than 24 hours. In our cohort, 
patients diagnosed with a peripheral vestibular disorder presented paroxystic vertigo 
induced by head movement, with typical nystagmus, associated with other otologic 
manifestations (hypoacusis or tinnitus), in the absence of central nervous signs. Besides 
isolated VSs other nonfocal symptoms/signs such as blurred vision, bilateral weakness, 
imbalance without objective ataxia, or decreased consciousness might be present. 
Laboratory data included a cranial CT scan and triplex scan of carotid and vertebral 
arteries at entry (either requested by the assistant physician or if considered necessary 
by the study neurologist); CT brain lesions were read by a neuroradiologist blind to 
clinical symptoms/signs. Based on the description of the CT, the neurologist assigned 
any acute lesion compatible with neurologic symptoms and signs as symptomatic; other 
ischemic lesions (infarctions or lacunas) were considered nonsymptomatic. Triplex scan 
was considered abnormal in the presence of greater than or equal to 50% stenosis or 
occlusion of an artery. 
For the presence of previous vascular risk factors (VRFs), the following definitions were 
considered: hypertension, previous diagnosis and/or treatment of high blood pressure 
(BP), systolic BP .160 mm Hg and/or diastolic BP .95 mm Hg in at least 2 different 
measures; diabetes mellitus, previous diagnosis and/or under treatment with oral 
antidiabetic/insulin, fasten glycemia.126 mg/dL, postprandial glycemia $200 mg/dL, 
and/or glucose tolerance test with values of glycemia $200 mg/dL at second hour; 
hypercholesterolemia, previous diagnosis and/or treatment, serum total cholesterol level 
after 12 hours of fasting $240 mg/dL; current smoker, smoker at event date or in the last 
12 months; atrial fibrillation, evidence from the electrocardiogram (EKG) or registration in 
patient’s record; acute myocardial infarction (MI), confirmed by an increase in serum 
cardiac enzymes, EKG abnormalities or diagnosis confirmed by doctor at any time and 
angor, history of chest pain with or without superior limb pain related to physical exercise 
or emotion and release by rest. 
Throughout the follow-up period, the following major vascular events were recorded: 
stroke, MI (confirmed by EKG, tissular necrosis markers, or necropsy), and death of 
vascular etiology other than MI or stroke (suspected but not confirmed MI or heart failure, 
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thoracic or abdominal aortic aneurysm rupture, or sudden death of presumed vascular 
origin). 
Data Analysis 
The description of patients included according to etiology (ischemic, peripheral, or 
unclassified) is presented and a logistic regression model was used to estimate the 
independent predictors of a stroke/TIA at onset of symptoms, considering the 
sociodemographic profile and relevant VRF in the univariate analysis (P < .3). After 
checking the assumption of proportional hazards with the Schoenfeld test, Cox models 
were used to estimate survival free from stroke or a vascular event (stroke, MI, or 
vascular death) in patients with transient symptoms (excluding those with stroke) 
according to etiology (ischemic, peripheral, and unclassified), VRF, and laboratory 
findings, adjusted for age and gender. This analysis was repeated excluding patients with 
TIA. Patients were censored if death or death from a nonvascular cause occurred before 
the respective end point. 
Results 
During the registration period, 1922 patients were reported as having FNSs. In a first step 
759 were excluded, either by logistic reasons (n = 122) or after neurologic assessment, 
because their symptoms were nonfocal (n = 274), recurrent episodes (n = 198), including 
60 who had a previous stroke, or the symptoms were because of infectious/toxic 
diseases, non-neurologic, or neurologic noncentral diseases (Fig 1). Among the 1163 
included, 363 (31.2%) presented a VS—29 (8.0%) had a stroke (a primary intracerebral 
hemorrhage, 2 partial anterior circulation infarcts, 3 lacunar infarcts, and 23 posterior 
circulation infarcts), 31 (8.5%) had a TIA, 3 (.8%) other diagnosis (drop attack, functional 
disorder, and hydrocephalus), 208 (57.3%) had a pVS, and 92 (25.3%) had an uVS. 
Considering all first-ever incident cerebrovascular events in this population (579 strokes 
and 141 TIA), 5% of all patients with stroke and 22% of all patients with TIA 
presented/complained of VS, either isolated or concomitantly with other symptoms. 
Most patients were referred directly to the study center (60.0%), a higher proportion 
among those with stroke/TIA (75.0% vs. 57.0%; Table 1). Hospital emergency 
department (ED) and 24 hours HC service were the most sought (94.7%) and 60.6% of 
patients were observed in the first 24 hours. The mean age at event onset was 60.1 
years (range, 11-93), with a higher proportion of patients with stroke/TIA 65 years of age 
or older (60.0% vs. 41.0%); 62.8% were women. Hypertension was the most prevalent 
Tendências na Incidência e Prognóstico do AVC 
- 62 - 
VRF (47.8%) followed by hypercholesterolemia (41.9%), diabetes (19.2%), angina/MI 
(7.8%), and atrial fibrillation (4.2%); 14.7% were current smokers. The logistic regression 
model indicated that age greater than 65 years (odds ratio [OR] 5 1.91; 95% CI, 1.04-
3.54), male sex (OR 5 2.36; 95% CI, 1.28-4.35), diabetes (OR 5 2.70; 95% CI, 1.40-
5.19), and atrial fibrillation (OR 5 6.30; 95% CI, 1.99-19.9) increased the likelihood of VS 
of ischemic etiology. This etiology was more frequent in patients that had VS plus FNS 
(80.9%) or VS plus with other nonfocal neurologic symptoms (22.2% and 22.9%), and 
more rare in patients with isolated VS (3.5%) or VS plus tinnitus/hypoacusis (2.9%). 
Assessed for eligibility
(n=1922)
Exclusions (n=759)
Logistic reasons 
- Out of study period (n=12)
- Out of study population (n=110)
After neurological assessment
- Without focal symptoms/signs (n=274)
- Recurrent episode (n=198)
- Other diagnosis (n=148)
- Refusals (n=17)
Total included
(n=1163)
Long-term follow-up
(1) (2) (3) (4) All
- Lost 2 0 2 3 7
- Died 6 9 20 21 56
- Alive
- Face to face 14 17 59 148 248
- By phone 0 4 9 20 33
- Clinical records 7 1 2 6 16
With vestibular symptoms
(n=363)
(1) Stroke
(n=29)
(2) TIA
(n=31)
(4) Peripheral vertigo
(n=208)
(3) Unclassified vertigo
(n=92)
Others causes
(n=3)
Figure 1. Flowchart of inclusion of patients and details of 7-year follow-up. 
Cranial CT/MRI was performed in 228 patients (63.3%) of whom 82 (36.0%) in the first 24 
hours; ischemic lesions were detected in 28.9%of all CTs. Only 12 of the 29 patients with 
stroke showed newrelevant lesions; among the 31 patients with TIA, 28 had cranial CT 
and in 8 (28.6%) it showed ischemic nonsymptomatic lesions, proportion not significantly 
different from 21.6 (37 of 171) in patients with other VS. The triplex scan showed signs of 
stenosis in 61 patients (46.2%) of the 132 (36.7%) investigated. 
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Table 1. Ascertainment of patients, characteristics, and diagnostic procedures 
  Other vestibular symptom  Stroke/TIA 
vs. others  Stroke/TIA Unclassified Peripheral All All 
Characteristics (n=60) (n=92) (n=208) (n=300) (n=360) P value 
Identification, n (%)   
 1st source: Direct  45 (75.0) 56 (60.9) 115 (55.3) 171 (57.0) 216 (60.0) .009 
  Hospital 26 (43.3) 39 (42.4) 83 (39.9) 122 (40.7) 148 (41.1) .08 
  Health Centre 19 (31.7) 17 (18.5) 32 (15.4) 49 (16.3) 68 (18.9)  
 Assessment   
  Emergency room 59 (98.3) 84 (91.3) 198 (95.2) 282 (94.0) 341 (94.7) .2 
  Delay from onset <24h 36 (60.0) 50 (54.3) 132 (63.5) 182 (60.7) 218 (60.6) .9 
Patients characteristics, n (%)   
 Age, mean (SD) 67.9 (11.9) 61.8 (17.9) 57.1 (15.9) 58.5 (16.7) 60.1 (16.4)  
  Range 38-92 15-93 11-84 11-93 11-93  
  >65 years 36 (60.0) 45 (48.9) 78 (37.5) 123 (41.0) 159 (44.2) .007 
 Women 31 (51.7) 59 (64.1) 136 (65.4) 195 (65.0) 226 (62.8) .051 
 Hypertension 34 (56.7) 45 (48.9) 93 (44.7) 138 (46.0) 172 (47.8) .1 
 Hypercholesterolemia 27 (45.0) 33 (35.9) 91 (43.8) 124 (41.3) 151 (41.9) .6 
 Diabetes 21 (35.0) 17 (18.5) 31 (14.9) 48 (16.0) 69 (19.2) <.001 
 Myocardial infarction/Angina 7 (11.7) 10 (10.9) 11 (5.3) 21 (7.0) 28 (7.8) .2 
 Atrial fibrillation 8 (13.3) 3 (3.3) 4 (1.9) 7 (2.3) 15 (4.2) <.001 
 Current smoker 11 (18.3) 16 (17.4) 26 (12.5) 42 (14.0) 53 (14.7) .4 
 Number of risk factors*, n (%)  .001 
  0 13 (21.7) 41 (44.6) 101 (48.6) 142 (47.3) 155 (43.1)  
  1 29 (48.3) 32 (34.8) 79 (38.0) 111 (37.0) 140 (38.9)  
  2 13 (21.7) 15 (16.3) 24 (11.5) 39 (13.0) 52 (14.4)  
  3+ 5 (8.3) 4 (4.3) 4 (1.9) 8 (2.7) 13 (3.6)  
Presenting symptoms, n (%)  <.001 
 Vestibular symptom alone 8 (13.3) 59 (64.1) 159 (76.4) 218 (72.7) 226 (62.8)  
  + Focal 38 (63.3) 6 (6.5) 3 (1.4) 9 (3.0) 47 (13.1)  
  + Tinnitus/ Hypoacusis 1 (1.7) 8 (8.7) 25 (12.0) 33 (11.0) 34 (9.4)  
  + Faintness/ Confusion 6 (10.0) 13 (14.1) 8 (3.8) 21 (7.0) 27 (7.5)  
  + Cephalalgias 7 (11.7) 6 (6.5) 13 (6.3) 19 (6.3) 26 (7.2)  
CT-scan/MRI,† n (%) 57 (95.0) 52 (56.5) 119 (57.2) 171 (57.0) 228 (63.3) <.001 
 Before 24h 36 (63.2) 15 (28.8) 31 (26.1) 46 (26.9) 82 (36.0)  
  With ischemic lesions 20 (55.6) 7 (46.7) 9 (29.0) 16 (36.8) 36 (43.9) .06 
 After 24h 21 (36.8) 37 (71.1) 88 (73.9) 125 (73.1) 146 (64.0)  
  With ischemic lesions 9 (42.9) 10 (27.0) 11 (12.5) 21 (16.8) 30 (20.5) .006 
Triplex scan, n (%) 24 (40.0) 29 (31.5) 79 (38.0) 108 (36.0) 132 (36.7) .6 
 Abnormal (with stenosis) 13 (54.2) 14 (48.3) 34 (43.0) 48 (44.4) 61 (46.2) .4 
Medication (during 1st year follow-up), n (%)   
 Antiplatelet therapy  36 (60.0) 33 (35.9) 43 (20.7) 76 (25.3) 112 (31.1) <.001 
 Antihypertensive therapy‡ 33 (97.1) 39 (86.7) 85 (91.4) 124 (89.9) 157 (91.3) .2 
 Lypid-lowering therapy‡ 11 (40.7) 8 (24.3) 24 (26.4) 32 (25.4) 43 (28.5) .1 
 Hypoglycaemic therapy‡ 18 (85.7) 14 (82.4) 24 (77.2) 38 (79.2) 56 (81.2) .5 
 Multitherapy in patients with >1RF 15 (83.3) 13 (68.4) 20 (71.4) 33 (70.2) 48 (73.8) .3 
Abbreviations: MRI, magnetic resonance imaging; SD, standard deviation; TIA, transient ischemic attack; VS, vestibular 
symptom; RF, risk factor. 
*includes hypertension, diabetes, angina/myocardial infarction and atrial fibrillation. 
†only 7 patients with MRI (2 with unclassified VS and 5 with peripheral VS). 
‡calculated in patients with hypertension, hypercholesterolemia and diabetes, respectively. 
Tendências na Incidência e Prognóstico do AVC 
- 64 - 
During the first year follow-up 195 patients (95.1%) with VRF were under preventive 
vascular therapy and 41 (26.5%) of those with no previous VRF began therapy after the 
episode. Antiplatelet therapy was more prescribed in patients with stroke/TIA and other 
therapeutic agents equally likely prescribed in all patients with the specific VRF; lipid-
lowering therapy was seldom prescribed (Table 1). 
At the 7-year follow-up, 56 patients (15.6%) had died and 7 (1.9%) were lost to follow-up 
(Fig 1). Most patients alive at the end of follow-up were examined at the outpatient clinic 
by a research team neurologist (83.5%) and 33 (11.1%) were contacted by phone to 
inform about details of vascular events that had happened meanwhile. For all patients, 
clinical records were checked for relevant information. Patients with stroke/TIA had 18 
(30%) vascular events: 8 recurrent strokes, 7 first-ever strokes (after a TIA), and 3 other 
vascular events (2 MI and 1 vascular death). Patients with uVS had 17 (18.5%) vascular 
events, 7 strokes, 6 MI, and 4 vascular deaths. In the pVS group, there were 23 (11.1%) 
vascular events, 15 strokes, 3 MI, and 5 vascular deaths. In the univariate analyses, the 
number of VRF, the presence of silent infarctions, and VS due to TIA shortened survival 
free from stroke or a vascular event (Table 2 and Fig 2). In the multivariate model 
including these variables, only in the presence of ischemic lesions on CT scan there was 
an almost  4-fold risk of stroke in the long-term follow-up (hazard rate [HR] 5 3.96; 95% 
CI, 1.63-9.60), whereas the longterm risk of a vascular event increased in patients with 2 
or more VRFs (HR 5 2.70; 95% CI, 1.25-5.86). After excluding patients with TIA, the 
multivariate models yielded identical results (Table 3); patients with at least 2 VRFs were 
at a higher risk of stroke (HR 5 5.75; 95% CI, 1.71-19.4) or of a vascular event (HR 5 
5.15; 95% CI, 2.26- 11.7), whereas the presence of any ischemic lesion on CT scan 
increased the risk of stroke (HR 5 5.75; 95% CI, 1.71-19.4). 
Discussion 
This is the first prospective community-based study to analyze the diagnosis of patients 
presenting with firstever-in-lifetime VS, and according to this presenting symptom, trying 
to understand their seriousness in a prolonged long-term follow-up. In most patients, the 
symptoms at presentation had peripheral etiology (57.3%), but still in 16.5% of them it 
was the complaining symptom of a first-ever-in-the-lifetime stroke/TIA, indicative in this 
population of 5% of first-ever strokes and 22% of first-ever TIA. Despite being observed 
and followed up by neurologists close to onset and at 3 months, in 25.3% of patients the 
VS remained unclassified. For this relatively high proportion of patients, some discharged 
with a ‘‘symptomatic diagnosis’’ and others with alternative possible diagnosis (as 
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migraine or functional disorder) we may conclude that the presence of silent infarctions 
on CT and VRFs are the more important predictors of a serious vascular event, such as 
stroke, MI, or vascular death.  
Table 2. Cox proportional hazard rates (HR) for stroke and vascular events in the seven-year 
follow-up in patients with transient VS (n=331) 
  Stroke Vascular events 
Patients characteristics and 
diagnostic procedures 
No. 
events‡
Univariate Multivariate No. 
events‡
Univariate Multivariate 
HR 95% CI HR 95% CI HR 95% CI HR 95% CI 
Socio-demographic          
 Men vs. Women 12/18 1.20 0.58-2.49 1.17 0.55-2.50 22/29 1.36 0.78-2.36 1.55 0.87-2.77
 Age (years)* 17/13 1.05 1.02-1.08 1.03 0.99-1.07 35/16 1.06 1.04-1.09 1.06 1.03-1.08
Risk factors (Yes vs. No)          
 Hypertension 20/10 2.39 1.12-5.10   33/18 2.24 1.26-3.97   
 Hypercholesterolemia 12/18 0.92 0.44-1.91   24/27 1.25 0.72-2.16   
 Diabetes 9/21 2.09 0.96-4.57   15/36 2.10 1.15-3.83   
 Angina/Myocardial infarction 6/24 3.36 1.37-8.22   10/41 4.05 1.60-10.2   
 Atrial fibrillation 4/26 5.19 1.81-14.9   5/46 3.35 1.68-6.69   
 Current smoker 3/27 0.73 0.22-2.40   6/45 0.86 0.37-2.02   
No. risk factors (vs. 0)†          
 1 14/6 2.94 1.13-7.64 1.89 0.71-5.05 20/12 2.12 1.03-4.33 1.42 0.69-2.93
 2+ 10/6 4.85 1.76-13.4 2.43 0.80-7.35 19/12 4.91 2.38-10.1 2.70 1.25-5.86
CT-scan (vs. without ischemic 
lesions) 
        
 Not done 8/9 1.07 0.41-2.77 1.08 0.40-2.90 16/19 1.03 0.53-2.00 0.96 0.48-1.91
 With ischemic lesions 13/9 5.74 2.45-13.4 3.96 1.63-9.60 16/19 3.40 1.75-6.61 1.95 0.98-3.88
Triplex scan (vs. without stenosis)          
 Not done 19/4 1.64 0.56-4.83   32/8 1.39 0.64-3.02   
 With stenosis 7/4 2.35 0.69-8.04   11/8 1.85 0.74-4.59   
Diagnosis (vs. peripheral VS)          
 Transient ischemic attack 7/15 3.74 1.52-9.17 1.79 0.64-5.06 10/23 3.60 1.71-7.57 1.49 0.65-3.43
 Unclassified VS 8/15 1.31 0.56-3.10 0.87 0.36-2.11 18/23 1.99 1.07-3.68 1.36 0.72-2.57
Abbreviations: CI, confidence interval; CT, computed tomography; HR, hazard rates; VS, vestibular symptom. 
*Number of events according to age in 2 groups:  65, <65 years. 
†According to univariate analysis includes hypertension, diabetes, angina/myocardial infarction, and atrial fibrillation. 
‡Number of events of each category against reference category. 
The relatively high proportion of unclassified patients in this study reflects the known 
difficulty of managing VS patients, especially when they present a first-ever episode. 
Even so, we have achieved a similar proportion of definitive diagnosis as reported in 
other studies retrospectively based on ED visits.17 The high incidence of stroke/TIA 
among patients with VS maybe justified by the fact that our study is community-based 
and mainly because we excluded many patients with only non- FNSs such as presyncope 
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or other toxic/infectious etiologies. Moreover, by including only the first-ever-in-life 
episode, many patients with usually benign and highly prevalent chronic or recurrent 
etiologies, such as paroxysmal positional vertigo or Meniere disease, were excluded. This 
was a more restrictive approach because we were mainly interested in symptoms that 
could be attributed to a vascular cause. More and less restrictive approaches may justify 
the wide range of central causes of vertigo/dizziness found in other studies, such as .5% 
using a National Health Insurance database,18 and proportions between 3.2% and 
9.2%3,17,19-21 based on patients seen at EDs or 42% in patients seen at na emergency 
neurologic consultation.22  
(A) (C) 
(B) (D) 
Figure 2. Kaplan–Meier survival free from stroke and free from a vascular event according to the 
number of vascular risk factors (A) and (C) and computed tomography scan results (B) 
and (D). 
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Table 3. Cox proportional hazard rates (HR) for stroke and vascular events in the seven-year 
follow-up for patients with peripheral and unclassified VS (n=300) 
Patients characteristics and diagnostic 
procedures 
No. 
events‡
Stroke No. 
events‡
Vascular events 
HR 95% CI HR 95% CI 
Socio-demographic      
 Men vs. Women 9/14 1.21 0.50-2.92 18/23 1.68 0.88-3.20 
 Age (years)* 13/10 1.03 0.99-1.07 28/13 1.06 1.03-1.09 
No. risk factors (vs. 0)†      
 1 10/4 2.10 0.64-6.89 15/9 1.49 0.64-3.45 
 2+ 9/4 5.75 1.71-19.4 17/9 5.15 2.26-11.7 
CT-scan (vs. without ischemic lesions)      
 Not done 8/5 1.35 0.43-4.15 14/14 0.82 0.39-1.73 
 With ischemic lesions 10/5 5.75 1.86-17.7 13/14 2.20 1.00-4.83 
Diagnosis       
 Unclassified  vs. peripheral VS 8/15 0.76 0.31-1.87 18/23 1.32 0.70-2.50 
Abbreviations: CI, confidence interval; CT, computed tomography; HR, hazard rates; VS, vestibular 
symptom. 
*Number of events according to age in 2 groups:  65, <65 years. 
†According to univariate analysis includes hypertension, diabetes, angina/myocardial infarction and 
atrial fibrillation. 
‡Number of events of each category against reference category. 
Considering that most patients were notified by physicians at ED, the proportion found is 
relatively high, reaching 3.7% (8 of 228) in patients whose complaint was isolated vertigo, 
again much higher than reported in patients admitted to hospital ED (.7%).3 As it would 
be expected the diagnosis of stroke/TIA was more frequent among patients complaining 
or presenting any focal abnormality on examination (80.9%), but other presentations in 
which vertigo was accompanied by headache, faintness/confusion were also common in 
patients with stroke/TIA. Moreover, the likelihood of vertigo with central cause was higher 
in men and increased with age and the number of risk factors, namely atrial fibrillation 
and diabetes. These results corroborated previous findings in ED patients with a triage 
complaint of vertigo20 and in studies comparing patients with and without vertigo.3,18
As it might be expected, patients with TIA had a higher long-term risk of stroke or other 
vascular events than patients with a peripheral etiology, although after adjusting for age, 
gender, VRFs, and the presence of nonsymptomatic (silent) ischemic lesions on CT, the 
diagnosis/etiology lost importance. For patients without definite diagnosis, the long-term 
risk of vascular events is somewhere between those with known etiologies. Probably the 
recognition and description of symptoms by these patients was not so accurate to allow a 
better interpretation by the physician. After excluding patients with a TIA from the analysis 
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of long-term prognosis, the high risk of upcoming vascular events in patients with 2 or 
more VRFs compared with those with no risk factors suffers a remarkable increase from 
2.7 to 5.2, indicating that in this reduced group VRFs are even more important. It is 
possible that a referral bias exists because patients with VRFs maybe more prone to 
attend medical care and thus to be notified by their physicians. Identical findings were 
reported in patients hospitalized with a principal diagnosis of vertigo (excluding central 
vertigo).23 Another interesting finding is the fact that age (.65 years) is not a prognostic 
factor when the outcome is stroke, contrary to a vascular event. This maybe explained by 
the fact that patients presenting VS from central cause are a younger group compared 
with what is found in the general population,13-14 and their risk profile, excluding diabetes 
and atrial fibrillation, is similar to that of patients with pVS or uVS. This may also explain 
the diagnosis difficulties and the ‘‘useless’’ of the CT scan for diagnostic purposes in 
patients with vertigo as remarked in other studies.21 This inadequacy of CT scan might be 
even more pronounced because in some patients (36%) it was performed in the first 24 
hours after the first-ever episode of VS, and it was not repeated few days later, making it 
difficult to identify eventual symptomatic lesions and a consequent change in diagnosis.24
On the other hand and independently from diagnosis, CT scan results, namely, the 
presence of nonsymptomatic ischemic lesions of any type/location (mostly lacunas) 
increases significantly the long-term risk of stroke, both including (HR 5 3.96) or 
excluding patients with TIA (HR 5 5.75). Again, we cannot rule out a possible bias 
because CT/MRI might had been more likely performed in patients for whom an ischemic 
etiology was admitted. Nevertheless the risk of stroke/vascular event in patients without 
CT/MRI was similar to that of patients showing no ischemic lesions. 
In spite of the low short-term risk of stroke of patients with an acute VS when compared 
with other transient focal symptoms/signs,25 VRF and the presence of silent ischemic 
lesions deserve better secondary prevention for avoiding vascular events in the long run. 
Our results illustrate more closely the spectrum of a first-ever VS at community level and 
their prognosis than other retrospective studies based only on ED visits, relying mostly on 
	
	

 codes and so disregarding subtle neurologic findings 
that might indicate a central nervous system dysfunction.20,23,26 Even so, we may have 
missed episodes that do not come to medical attention, although less likely first episodes, 
because in the public perception whenever these symptoms are present the person 
seeks medical care27 providing a good opportunity for risk factors surveillance. We 
recognize 2 major limitations in this study. The first is the lack of useful imaging data, 
namely, MRI in the acute setting or a later repeated CT scan that could have helped in 
the identification of TIA/stroke and eventually diminish the number of patients with 
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undetermined etiology. The second is the lack of systematic data about medication used 
before and after the acute event. Even so, during the first year follow-up, a considerable 
number of patients were not under an adequate therapy according to the risk factors 
presented, particularly antiplatelet and lipid-lowering therapy. Moreover, these secondary 
preventive measures were more likely undertaken in patients with a TIA rather than in 
those with uVS, which might partially explain why the diagnosis was not an important 
prognostic factor. 
Conclusions 
More than 8% of patients with a first-ever stroke/TIA present to the assistant physician 
with a first-ever complaint of VS. About a quarter of all patients presenting with VS remain 
with no definitive diagnosis. However, independently of diagnosis, the prognosis is mostly 
dependent on the number of VRF and on the presence of old, nonsymptomatic ischemic 
lesions on the acute CT scan. To prevent future vascular events, we purpose that those 
patients with VRF and/or old asymptomatic ischemic lesions should have a vascular 
workup similar to those diagnosed with stroke/TIA and a strict control of their VRF. 
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Abstract 
Background 
The recognition of the burden of stroke in Portugal led to the implementation of 
preventive and therapeutic measures and, despite of the population aging, mortality rates 
have been declining. Monitoring changes in incidence/outcome highlights the efficacy of 
these measures. 
Objective 
Two prospective community registries of focal neurological attacks were used to estimate 
changes in stroke incidence and to determine factors associated with changes in stroke 
outcome. 
Methods 
Identical definitions and sources of information were used to ascertain all first-ever-in-a-
lifetime strokes occurring in the metropolitan area of Porto in the periods 1998-2000 and 
2009-11. In the second study a record-linkage methodology based on the National Health 
Number was implemented.  
Results 
Eleven years apart stroke incidence decreased 25% (incidence rate ratio=0.75, 95% CI 
0.67-0.84), with a 27% reduction in disabling strokes and 21% in non-disabling strokes. A 
concomitant 40% (95% CI 23-53%) reduction in case-fatality was observed after 
adjustment. These reductions were more marked in women than in men, in particular an 
incidence reduction in primary intracerebral hemorrhage of 62% compared with 21% in 
men. After adjustment for patient and stroke characteristics, the improvement in 28-day 
severity in the second study resulted from differences in the oldest patients and inpatient 
care. 
Conclusions 
There was a “gender decline” in the incidence of stroke, hemorrhagic stroke and disabling 
stroke in the sense that it was evidenced in women rather than men. The implementation 
of stroke units and changes in secondary prevention in the elderly underlie the better 
stroke outcome in the second period. 
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One decade ago Portugal had one of the highest stroke incidence rates among Western 
European countries, 305 per 100,000 in rural and 269 per 100,000 in urban populations, 
and a low case-fatality at 28 days, 14.6% in rural and 16.9% in urban areas.1 This high 
incidence could explain why stroke was the leading cause of death in Portugal. However, 
mortality from stroke declined from 154.2 to 91.6 per 100,000 between 1999 and 2005 
and from 164.2 to 93.1 in the Northern Region of Portugal,2-3and these changes may be 
associated with a decline in incidence and/or changes in survivorship. Conclusions from 
the WHO MONICA project on populations aged 35 to 64 years indicated that changes in 
stroke mortality were mainly attributable to changes in case fatality rather than in event 
rates,4 but the study fell short from demonstrating that they resulted from disease severity 
and management. Nevertheless disability-adjusted life-years lost from stroke in Portugal 
had a 39.4% reduction in the 1990-2005 period,5 indicating that changes in stroke 
severity might be implied.  
Soon after the first study was carried out, several health measures were advanced by the 
National Health Authorities, resulting from recognizing that stroke was the leading cause 
of death and hospital inpatient care calling to integrated primary, secondary and tertiary 
prevention actions.6 Among others, it was purposed to intensify population-based 
campaigns about the disease and risk factors7 and to identify VRF carriers using a 
periodical medical examination; the organization of stroke units and implementation of 
Stroke Code pathways8 were the measures directed to patients. 
Using the updated methodology for ‘ideal’ population-based studies,9 a second incidence 
study was undertaken in the northern region of Portugal. In this article we focused in 
urban populations living in the region of Porto, and we are mainly interested in knowing 
whether the reduction in mortality stems from a decrease in incidence rates, particularly a 
decrease in short-term stroke severity and measures implemented meanwhile. 
Subjects and Methods 
The ACIN2 (prospective community registry of Neurological Attacks) is the second 
population-based study in the North of Portugal for studying the incidence and outcome 
of stroke and transient focal neurologic attacks (TNA) which could be attributed to a 
dysfunction of the central nervous system. We used the criteria for epidemiological 
population-based stroke research proposed by Sudlow and Warlow10 and updated by 
Feigin and Carter9 for achieving complete case ascertainment. 
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Study Population 
Following the reorganization of the Portuguese National Health Service (NHS) in 2008, 
the metropolitan area of Porto (Figure 1) was divided in 9 major health divisions, two of 
them, the Western and Eastern Porto ACES (association of health centers) for persons 
living in the city of Porto. The study population comprised all individuals registered in the 
Western Porto ACES (WPACES), involving approximately 57% of the city population 
residing in 12 administrative regions. This health unit aggregates five health centers (HC) 
and 105 family doctors, including the three HC involved in the study undertaken in 1998-
2000, and the Centro Hospitalar do Porto, which includes the Hospital Santo António 
(HSA) that receives all patients from the WPACES who are referred for 
emergency/specialized care. The national health number (NHN) database from the 
WPACES was used to define the study population and served as reference to collect 
medical information. The NHN provides a unique patient identifier for every resident in 
Portugal after registration at a particular health unit/family doctor, for accessing the NHS 
network.  
H
H
H
H

N
H  Hospital
H Municipality
Figure 1. Map of the metropolitan area of Porto, showing areas included in both studies (dark 
shaded) and added in the second study (light shaded), and main hospitals involved 
Case ascertainment and follow-up 
To make studies comparable we used identical sources of information. (1) All family 
doctors were informed about the project and were asked to report, as soon as possible 
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after the event, any patient suspected of a stroke or TNA either by using the project 
website (www.acin2.com) or by other means (mail, fax, phone, electronic hospital 
outpatient clinic booking). This dedicated website was created on purpose for the ACIN2 
and was used by all physicians at the HSA for reporting patients admitted at Emergency 
Department (ED), hospital ward or examined at the ultrasound/radiology laboratories. 
This topic was addressed every day by the neurology team at the emergency room and 
at weekly meetings of the neurology department. This webpage, identified by the patient 
NHN, contained the essential information for each event/patient: details of place, time 
and clinical characteristics, diagnostic procedures, and proposed diagnosis. (2) While in 
the first study hospital discharge registers, ED records and a sample of imaging 
department records were reviewed, in the present study a record-linkage methodology 
based on the NHN was implemented. For this purpose, several computer-generated lists 
were provided by the entities involved in the study: ED admissions, inpatient discharges 
and brain/cervical arteries imaging procedures. (3) In the first study death certificates 
could be scrutinized, but the new legislation issued in Portugal forbids access to this 
“individual” information for research purposes; to overcome this issue we screened the 
HSA and the National Network for integrated long-term care death lists. Autopsies 
performed at HSA pathology department or at the Medical Forensic Institute in Porto 
(covering the Northern Region) whose death cause was stroke were reviewed in both 
studies. (4) Regular contacts with private hospitals and nursing homes were made in both 
studies to capture patients not attending the NHS. 
In the present study we used two additional case-ascertainment methods recently 
implemented in the NHS. The pre-hospital stroke code activation lists and the computer-
generated list of all primary care patients (HCs) with a diagnostic code of stroke/TIA. The 
reorganization of the NHS in the city of Porto centralized the emergency care out-of-
hospital in a single dedicated unit (Service for Urgent Situations), open daily from 8h-24h. 
This unit receives approximately 4,300 patients per month and the clinical information is 
hand-written. To scrutinize all records would be an exceedingly time-consuming task and 
so we selected a two month sample to estimate an eventual loss of cases. Prospective 
methods included direct “individual” referrals and daily check of ED admissions at HSA; 
at other hospitals in the region of Porto (Figure 1) this was done on a monthly basis. 
Retrospective methods included a monthly, quarterly or yearly based review of hospital 
diagnostic coding data (International Classification of Disease, Ninth revision codes 430 
to 438, 342 and 781) and the overall Northern Region pre-hospital stroke code activation 
records, for identifying cross-boundary flow of patients. At the end of the study period the 
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computerized register of ED visits of the remaining 21 hospitals in the Northern Region 
were checked.  
Between October 1, 2009 and September 30, 2011, all possible strokes occurred in 
patients registered at Western Porto unit were recorded. Surveillance of all sources of 
information continued for a further three months to ensure full registration. Patients were 
examined by a neurologist as soon as possible after the event at ED, during their hospital 
stay or at a special study outpatient clinic and, followed up at three months. As in the first 
study, the principal investigator (M.C.) reviewed the medical history of each patient to 
ascertain the first-ever-in-a-lifetime stroke (FELS) and its pathological type. If a patient 
died soon after the event, we attempted to obtain additional information from an 
eyewitness and clinical records. For patients unable to communicate we interviewed 
close relatives or other suitable informants.  
The objectives and field work planning were presented to the Northern Region Health 
Authorities for granting permission to perform the study. The study was approved by the 
Porto Hospital Center Ethics Committee. Informed consent was obtained from the 
prospectively included patients or from next of kin, when appropriate, before any clinical 
assessment. The Portuguese Data Protection Authority approved all procedures 
implemented. 
Definitions 
As in the first study,1 stroke was defined according to the World Health Organization as 
‘rapidly developing clinical signs of focal (or global) disturbance of cerebral function, with 
symptoms lasting 24 h or longer or leading to death, with no apparent cause other than of 
vascular origin’.11 Pathological types were classified according to Sudlow and Warlow as 
ischemic stroke, primary intracerebral hemorrhage (PICH) and subarachnoid hemorrhage 
(SAH).12 Patients without brain CT scan performed within 30 days, no brain MRI, no post-
mortem confirmation, and no lumbar puncture or angiography in case of suspected SAH, 
were classified as stroke of undetermined type.  
Information on vascular risk factors (VRF) was collected using the same methodology 
throughout the two study periods. The criteria used for hypertension was a history of 
known hypertension or antihypertensive treatment; for diabetes, a previous 
diagnosis/treatment of diabetes mellitus with oral anti-diabetic/insulin or fasting 
glycaemia>126mg/dl, postprandial glycaemia200mg/dl and/or glucose tolerance test 
with values of glycaemia200mg/dl at the 2nd hour; for hypercholesterolemia, a previous 
diagnosis/treatment of hypercholesterolemia; for atrial fibrillation, evidence from the 
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electrocardiogram or documented in patient’s record; patients were classified as current 
smoker if they smoked at the event date or at any time during the preceding 12 months. 
The pre-stroke and post-stroke (approximately 1 month after the event) modified Rankin 
Scale (mRS) scores were recorded for every patient and were used for classifying 
disability resulting from stroke as follows: a minor (non-disabling) stroke if the post-stroke 
score was less than 2 or the mRS score did not change after the event; otherwise they 
were considered non-minor (disabling).  
Statistical methods 
Following identical criteria of the first study, incidence rates were calculated using the 
population registered in the WPACES at the middle of the study period (September 30, 
2010) and the confidence intervals (CI) were calculated based on the Poisson 
distribution. These rates were standardized to the European population.13 Specific 
incidence rates and ratios (IRR) and the respective 95%CI were calculated for 
pathological stroke type and severity using as standard the Portuguese population of the 
2011 Census.  
Poisson regression models were used to analyze the relationship between study period, 
gender, age group (<55, 55-64, 65-74, 75-84 and ≥85 years), and stroke risk. The 
outcome was the number of strokes within each age/gender/period strata, with the 
population counts from the 2011 Portuguese Census for each strata serving as the offset. 
We examined all models with the various combinations of effects: main effects for age, 
gender and, period and effect modification terms: age-gender, age-period, and gender-
period using the deviance that follows approximately a chi-squared distribution with 
degrees of freedom equal to the number of cells minus the number of parameters. The 
preferred model was that with fewer parameters that fitted the data (p>0.05), unless a 
model with an extra effect provided a significantly improved fit (p<0.05) over the simplest 
model evaluated by the difference in chi-square values for the two models with the 
difference in degrees of freedom. Models were tested for all strokes combined and a 
sensitivity analysis was performed for minor and non-minor stroke separately. Proportions 
and median values of baseline characteristics were compared in the two periods using 
the chi-square test and the median test following also a chi-square distribution. Setwise 
regression models were used to ascertain a period effect in short-term disability (28-day 
mRS score). The first model included the set of baseline and stroke characteristics and 
the effect of period, followed by all two-way interaction effects with period entered in the 
equation using a stepwise procedure; in the following model the set of management 
variables was added and again in a stepwise manner their interaction effects with period 
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(final model). A robust Poisson model14 was used to estimate the prevalence ratio of pre-
stroke risk factors and the ratio of case-fatality rates by stroke type adjusted for age and 
sex, using the values of the first period as reference.  
Results 
The population of the second study comprised 189968 individuals registered at WPACES 
on September 2010, from whom 1020 were notified as stroke patients. Diagnosis was 
confirmed in 942 (92.4%) and 78 were excluded (31 with incorrect diagnosis, 36 out of 
study population and 11 for other reasons). A FELS occurred in 721 patients, 674 from 
the above and 47 (6.5%) first notified as TNA (compared to 3.2% in the first study). From 
prospective methods we identified 643 (89.2%) patients, from discharge lists 41 (5.7%), 
from HCs list and imaging department records more 28 (3.9%) cases and the remaining 9 
(1.2%) by checking ED lists of hospitals outside metropolitan area; in the first study 
69.5% patients were found by prospective methods and 19.3% by manual searching of 
ED lists at HSA and emergency transportation calls (equivalent in the present study to 
patients identified by prospective methods), 4.8% in discharge lists, 0.6% from imaging 
records and 5.6% by death certificates. 
Incidence 
Eleven years apart the incidence of FELS decreased from 269 to 190 per 100,000 and 
from 173 to 125 after standardized to the European population (Table 1). The overall 
reduction was 25%, 16% in men and 33% in women (Table 2). PICH incidence rate 
reduced 44% and that of ischemic stroke 16%; this reduction was higher for women 
compared to men. The incidence rate of fatal stroke declined 54%, 28% in men and 66% 
in women. The incidence in strokes that resulted in none or slight disability (mRS 0-1) 
declined 29%. Figures 2(A) to (D) display the age-sex specific incidence for all strokes 
and the age-specific incidence for minor and non-minor stroke in the two study periods. 
The Poisson models that fitted data for all strokes and both minor and non-minor strokes 
includes the interaction between gender and age (Supplemental table), indicating a 
higher incidence in men compared to women in the youngest and no difference in the 
oldest. While in minor strokes there is a constant effect of period for all age-gender strata, 
IRR=0.79 (95%CI, 0.65-0.96), for all strokes and non-minor strokes the effect of period 
depends on gender; the overall decrease in all strokes for the 2nd period, IRR=0.75 
(95%CI, 0.67-0.84), was significant in women, IRR=0.67 (95%CI, 0.57-0.79) and not in 
men, IRR=0.85 (95%CI, 0.72-1.02) (Table 3); for non-minor strokes the overall IRR=0.73 
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(95%CI, 0.63-0.84), IRR=0.62 (95%CI, 0.51-0.75) for women and, IRR=0.89 (95%CI, 
0.71-1.12) for men.  
Table 1. Annual incidence rates of first-ever stroke per 100,000 in Porto, Portugal over eleven 
years, by gender and age 
 Men Women Total 
Age, years at Risk n rate 95% CI at Risk n rate 95% CI at Risk n rate 95% CI 
1998-2000 
 <35 16178 2 6 1-22 18175 3 8 2-24 34353 5 7 2-17
 35-44 5276 10 95 45-174 7127 12 84 43-147 12403 22 89 56-134
 45-54 5168 17 164 96-263 6582 21 160 99-244 11750 38 162 114-222
 55-64 4202 34 405 280-565 5590 32 286 196-404 9792 66 337 261-429
 65-74 3916 57 728 551-943 5856 76 649 511-812 9772 133 681 565-796
 75-84 1991 42 1055 760-1426 3915 87 1111 890-1370 5906 129 1092 904-1281
85 519 13 1252 667-2142 1528 56 1832 1384-2380 2047 69 1685 1311-2133
 Total 37250 175 235 200-270 48773 287 294 260-328 86023 462 269 244-293
ASRE 179 148-209 167 141-193 173 153-192
2009-2011 
 <35 37690 8 11 5-21 37774 2 3 0-10 75464 10 7 3-12
 35-44 14530 18 62 37-98 15702 12 38 20-067 30232 30 50 33-71
 45-54 12690 42 165 119-224 14624 21 72 44-110 27314 63 115 89-148
 55-64 10482 70 334 260-422 12976 45 173 126-232 23458 115 245 200-290
 65-74 7052 73 518 406-651 9506 70 368 287-465 16558 143 432 361-503
 75-84 4264 80 938 744-1168 7790 136 873 726-1020 12054 216 896 776-1015
85 1296 36 1389 973-1923 3592 108 1503 1220-1787 4888 144 1473 1232-1714
 Total 88004 327 186 166-206 101964 394 193 174-212 189968 721 190 176-204
ASRE 151 133-169 102 89-116 125 113-136
ASRE indicates age-standardized rate for the European population 
Patient characteristics and assessment 
In both cohorts, the included patients were more often women, with a lower proportion in 
the second cohort (p<0.02). Median age in the second cohort was 2 years higher than in 
the first cohort (p<0.04), and 4 years higher in women (p<0.005) (Table 4). The 
proportion of patients independent before stroke decreased in the second study but the 
PR=1.02 (95%CI, 0.95-1.09) after adjustment. In general, the prevalence of VRF 
increased in the 2009-2011 period; after adjustment the prevalence ratio for hypertension 
was 1.20 (95%CI, 1.08-1.33), 1.45 (95%CI, 1.09-1.93) for atrial fibrillation, 1.29 (95%CI, 
1.06-1.56) for hypercholesterolemia, and 2.12 (95%CI, 1.80-2.49) for former smokers; the 
prevalence of diabetes and myocardial infarction/angina remained stable. The pattern of 
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stroke has changed with a reduction in the proportion of hemorrhagic stroke from 20.6% 
to 15.3%. 
Table 2. Annual incidence rates of first-ever stroke per 100,000 in Porto, in the two study periods 
stratified by pathological type and disability in men and women 
 1998-2000 2009-2011 
 rate 95% CI rate 95% CI IRR* 95% CI 
All first stroke 260 236-285 195 181-209 0.75 0.67-0.84
 Men 239 204-274 202 181-223 0.84 0.71-1.01
 Women 281 248-314 188 169-207 0.67 0.57-0.83
Pathological type 
 Ischemic stroke 196 176-217 164 151-177 0.84 0.73-0.95
  Men 181 151-212 164 145-183 0.91 0.74-1.11
  Women 211 182-240 165 147-182 0.78 0.66-0.93
 Primary intracerebral haemorrhage 44 35-55 25 20-30 0.56 0.41-0.76
  Men 41 28-59 31 24-41 0.79 0.51-1.23
  Women 47 35-63 18 13-25 0.38 0.25-0.59
 Subarachnoid haemorrhage 9 5-15 6 3-8 0.59 0.31-1.14
  Men 7 2-16 6 3-10 0.85 0.29-2.48
  Women 12 6-20 5 3-10 0.48 0.21-1.10
Rankin score at 28 days 
 mRS 0-1 72 59-85 51 44-58 0.71 0.57-0.89
  Men 86 66-110 59 47-70 0.69 0.50-0.94
  Women 59 45-77 44 35-54 0.74 0.53-1.02
 mRS 2-3 66 54-78 77 68-86 1.16 0.94-1.44
  Men 58 42-78 84 70-97 1.40 1.00-1.97
  Women 73 57-92 71 60-83 0.99 0.75-1.31
 mRS 4-5 80 67-94 47 40-53 0.58 0.46-0.73
  Men 61 44-81 37 28-46 0.60 0.41-0.88
  Women 97 79-119 55 45-66 0.57 0.43-0.75
 mRS 6 44 34-55 20 16-25 0.46 0.34-0.64
  Men 33 22-50 23 17-32 0.72 0.44-1.20
  Women 53 39-69 18 12-24 0.34 0.22-1.52
Minor stroke (non-disabling)† 92 78-106 72 64-81 0.79 0.65-0.96
 Men 98 77-123 77 64-90 0.78 0.59-1.04
 Women 86 69-107 68 57-79 0.80 0.61-1.04
Non-minor stroke (disabling) 169 149-188 122 111-134 0.73 0.63-0.84
 Men 140 113-166 125 109-142 0.89 0.71-1.13
 Women 195 167-222 120 106-136 0.62 0.51-0.75
*IRR indicates incidence rate ratio (2009-2011 versus 1998-2000), standardized to the 2011 Census 
population of Portugal; †excluding 2 patients in 1998-2000 
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Figure 2. Age specific annual incidence rates of first-ever stroke in (A) men, (B) women, (C) minor 
stroke and (D) non-minor stroke in the two study periods. Errors bars are 95% 
confidence intervals  
Overall, 19 patients in the first period and 8 in the second did not attend ED services; the 
proportion of patients assessed in the first 24h after stroke onset was similar in both 
cohorts, while brain imaging (CT/MRI) performed in the first 24h hours in these patients 
increased from 84.5% to 91.9% (p<0.001). In-patient admissions increased from 57.8% to 
64.2% (p<0.03), including 18 patients in the first study and 42 in the second study who 
had a stroke while in hospital for another reason. 
The degree of handicap has decreased in the second period, mainly shifting from severe 
(mRS>4) to moderate disability (1<mRS<5) (Figure 3(A)). Stroke case-fatality in the first 
28 days decreased 37.9%, from 16.9% to 10.5%, and after adjustment 40% (95%CI, 23-
53%). Overall there was a significant mRS decrease in the second period after adjusting 
for patient and stroke characteristics, that lost importance when the interaction of period 
with age was included in the model, indicating that the better outcome was achieved in 
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patients over 74 years compared to others (Table 5); moreover the overall higher level of 
disability of inpatients decreased in the second period. Figure 3(B) and (C) resumes 
these effects. Given there was non random missing data in pre-stroke disability in the first 
period (38 patients excluded from the previous analyses), we repeated the models using 
several inputting methods and the relative importance of these factors was not altered. 
Table 3. Incidence rate ratios (2nd vs. 1st period) by gender and incidence rate ratios (men vs. 
women) by age in the two study periods for all stroke and non-minor stroke; period 
incidence rate ratio (2nd vs. 1st) and incidence rate ratios (men vs. women) by age for 
minor stroke 
All strokes 
(PG + GA) 
Non minor stroke 
(PG + GA) 
Minor stroke 
(P + GA) 
Gender 
 IRR 
2
nd
 vs. 1
st 95% CI P 
IRR 
2
nd
 vs. 1
st 95% CI P 
IRR 
2
nd
 vs. 1
st 95% CI P 
 Men  0.85 0.72-1.02 0.076  0.89 0.71-1.12 0.327     
 Women  0.67 0.57-0.79 <0.001  0.62 0.51-0.75 <0.001     
 All          0.79 0.65-0.96 0.017
Study period 
Age-
group 
IRR* 
M vs. W
95% CI P 
IRR* 
M vs. W
95% CI P 
IRR 
M vs. W
95% CI P 
 1st period < 55 1.32 0.94-1.86 0.112  1.74 1.06-2.88 0.030     
 55-64 1.48 1.07-2.05 0.018  1.27 0.83-1.94 0.279     
 65-74 1.10 0.83-1.44 0.520  0.76 0.54-1.09 0.134     
 75-84 0.88 0.68-1.14 0.328  0.86 0.63-1.18 0.363     
 85+ 0.72 0.51-1.02 0.068  0.69 0.46-1.02 0.065     
 2nd period < 55 1.69 1.22-2.32 0.001  2.53 1.57-4.08 <0.001     
 55-64 1.89 1.39-2.56 <0.001  1.84 1.23-2.74 0.003     
 65-74 1.40 1.09-1.80 0.009  1.11 0.80-1.53 0.536     
 75-84 1.12 0.90-1.41 0.314  1.25 0.95-1.66 0.111     
 85+ 0.92 0.66-1.28 0.623  1.00 0.69-1.44 0.993     
 All < 55         1.09 0.72-1.68 0.676
 55-64         1.87 1.20-2.92 0.006
 65-74         2.04 1.39-3.01 <0.001
 75-84         0.92 0.64-1.33 0.656
 85+         0.62 0.28-1.37 0.242
Incidence rate ratio standardized to the 2011 Census population of Portugal 
*The IRR for the second period are obtained from the values of the first multiplied by the ratio of the period 
IRR in men and women (0.85/0.67 for all stroke and 0.89/0.62 for non-minor stroke) 
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Table 4. Patient’s characteristics, assessment and management in the two study periods 
1998-2001 
(n=462) 
2009- 2011 
(n=721) 
n % n % P value
Baseline  
 Women  287 62.1 394 54.6 0.011 
 Median age (IQR), y  72 (63-81) 74 (61-83)  0.037 
  Men  69 (60-76) 69 (58-78)  0.742 
  Women  74 (65-83) 78 (68-85)  0.005 
 Prestroke disability (mRS >1)*  115 27.1 238 33.0  0.037 
 Hypertension  288 62.3 531 73.6  <0.001 
 Diabetes  125 27.1 192 26.6  0.872 
 Atrial fibrillation  64 13.9 154 21.4  0.001 
 Myocardial infarction/Angina  49 10.6 96 13.3  0.166 
 Hypercholesterolemia  175 37.9 336 46.6  0.003 
 Smoking habits   <0.001 
  Current smoker  78 16.9 117 16.2   
  Former smoker  36 7.8 134 18.6   
 No vascular risk factors†   <0.001 
  0  117 25.3 129 17.9   
  1  200 43.3 276 38.3   
  2  114 24.7 238 33.0   
  3 or more  31 6.7 77 10.8   
Stroke characteristics    
 Signs    
  Coma  32 6.9 30 4.2  0.037 
  Motor deficit  324 70.1 528 73.2  0.246 
  Verbal deficit  116 25.1 171 23.7  0.586 
 Pathological type‡   <0.001 
  Ischemic stroke  348 75.3 610 84.6   
  Primary intracerebral haemorrhage  78 16.9 88 12.2   
  Subarachnoid haemorrhage  17 3.7 22 3.1   
 Disabling stroke§  301 65.4 454 63.0  0.389 
Assessment and management    
 Delay onset to 1st assessment   0.511 
  < 3h  186 40.3 305 42.3   
  3-24h  182 39.4 260 36.1   
  > 24h  94 20.3 156 21.6   
 Delay onset to CT/MRI<24h  311 67.3 519 72.0  0.087 
 Inpatient admission  267 57.8 463 64.2  0.027 
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Figure 3. Distribution of modified Rankin Scale scores at 28-days, stratified by study period in (A) 
all patients, and according to (B) age and (C) inpatient care 
Discussion 
We have shown that from 1998 to 2011 the incidence of stroke in the metropolitan area of 
Porto decreased, with a higher decline in disabling strokes than in non-disabling strokes, 
particularly in strokes that resulted in a 28-day severe disability or death (mRS>3). 
Women compared to men contributed more for the decline in the incidence rates; in 
particular an incidence reduction of 62% compared with 21% in men in PICH that might 
be linked to a 66% reduction in fatal stroke compared to 28% in men. After adjustment for 
patient and stroke characteristics, the improvement in 28-day severity from 1998 to 2011 
resulted from differences across study periods in the oldest patients and inpatient care, 
suggesting that these were the most important factors accounting for the better stroke 
outcome. The higher decrease in the incidence of disabling stroke in the second study 
resulted in a 40% reduction in case-fatality, results that might explain in part the 18.8% 
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reduction in mortality rate from 71.8 to 58.3 per 100,000 between 2006 and 2012 in 
Porto.15-16
Table 5. Coefficients of the linear regression models of the modified Rankin Scale scores on 
patients and stroke characteristics and management 
 Model 1 Model 2 Model 3 Model 4 
 b P b P b P b P 
Baseline        
 Age <65 y vs. others - 0.23 0.061  - 0.24 0.048  - 0.29 0.015  - 0.28 0.016
 Age >74 y vs. others 0.30 0.010  0.57 <0.001  0.56 <0.001  0.55 <0.001
 Men vs. Women - 0.05 0.606  - 0.06 0.518  - 0.07 0.431  - 0.04 0.607
 Disable (mRS>1) vs. others 1.26 <0.001  1.25 <0.001  1.17 <0.001  1.19 <0.001
 No vascular risk factors  0.24 <0.001  0.25 <0.001  0.19 <0.001  0.19 <0.001
Stroke signs (yes vs. no)       
 Coma 2.66 <0.001  2.65 <0.001  2.44 <0.001  2.43 <0.001
 Motor deficit 0.55 <0.001  0.55 <0.001  0.53 <0.001  0.55 <0.001
 Verbal deficit 0.75 <0.001  0.74 <0.001  0.54 <0.001  0.53 <0.001
Stroke type       
 Not ischemic vs. ischemic 0.90 <0.001  0.91 <0.001  0.63 <0.001  0.61 <0.001
Period (2nd vs. 1st) - 0.30 <0.001  - 0.10 0.402  - 0.21 0.076  0.15 0.349
 Period * Age >74 y    - 0.44 0.016  - 0.37 0.037  - 0.36 0.039
Management       
 CT/MRI <24 h vs. others     - 0.06 0.501  - 0.05 0.569
 Inpatient vs. others     0.99 <0.001  1.36 <0.001
  Period * Inpatient       - 0.60 0.001
We do not think that the risk of FELS decreased because of under ascertainment of 
cases in the second period. We included in both studies all sources of information 
available at the respective time period and so we can rule out the possibility of a 
differential ascertainment bias. Indeed the proportion of patients ascertained by 
prospective methods (direct referrals and ED admissions) was similar, 83.8% in the first 
and 89.2% in the second period, as well as from discharge lists (4.8% and 5.7%, 
respectively). Other sources of information were different; the inspection of death 
certificates performed in the first study is now forbidden by law and we used the hospitals 
list of deceased patients to overcome this problem. Nevertheless from the 5.6% (26 
patients) known by this mean in the first study, 16 would be identified at present in the 
computer-generated lists. As in the first study, few patients were referred from private 
hospitals, but that was to be expected because in Portugal the neurologists working (part-
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time) in private hospitals work also in public hospitals and so it is not a matter of 
private/public care but of the physician involved. Moreover, even if the patient is 
examined at a private hospital, especially in case of severe stroke, he would be sent to a 
public hospital for further investigation and inpatient care. On the other hand the 
population in the second study had a unique identifier in a computer generated data-list, 
while in the first we had counts of the population registered with no possibility of record-
linkage and so, if the residence and/or NHN identification was wrong/missing the linkage 
to the study population was not guaranteed; however in the first study there was an 
almost perfect geographic correspondence between the population registered and 
resident in the area. At present, in case of stroke, the emergency transport takes the 
patient to nearest hospital with a stroke unit while in the first study this was always the 
reference hospital. The computer-generated list of the population registered and the 
record linkage process implemented in the second study by means of the NHN is the 
ideal procedure to avoid wrong denominators, providing more accurate information on 
patient’s clinical history, access to more comprehensive data sources and, a more 
reliable differential diagnosis. In this respect the first study was more prone to information 
bias, since previous medical history relied on patient’s information and not always on 
clinical records. Nevertheless the possibility of bias may be diminished because the 
research team (R.M., M.C., M.C.S.) was the same and the same neurologist reviewed the 
information available for every patient; this was especially important since in the second 
study a considerable number of patients (152) were ascertained outside the reference 
hospital. 
The age-gender interaction in incidence rates described in both periods, either for minor 
or non-minor strokes, with a higher risk of stroke in men than women in the youngest that 
disappears in the eldest, was reported in other studies with slight variations on the age at 
the turning point17-18 The Framingham Heart study19 was the only one reporting that after 
85 years of age the pattern reversed, perhaps due to a high power for detecting the 
difference in the oldest. Several explanations were advanced for the attenuation of 
gender differences. Changes in the vascular risk profile in the decade after menopause, 
increasing the risk of stroke afterwards and/or a selective survival in men, since survivors 
to older ages may have different susceptibility to stroke than men who had a stroke when 
young.18
For non-disabling stroke this pattern holds irrespective of study period, and the IRR 
peaks in the 65-74 age-group, with men having a risk of stroke twice as high as women 
(Table 3). In this period of the life-span, retirement may have more adverse affects in 
men than women, and men may be more prone and alert to health problems than 
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women, since the homemaker role of women usually does not involve major differences 
in their life-style after retirement. On the other hand the gender-period interaction 
described for disabling strokes indicates that the risk of stroke in men compared to 
women has changed across the study periods, in men remained stable while in women 
decreased significantly.  
In general the results in the two periods are in accordance to other studies concluding 
that the FELS occurs in women later in life compared to men.20 The average age 
difference of 4-5 years reported was found in the first period, increasing to approximately 
9 years in the second (78 vs. 69 years). Despite the increase of the age gap between 
women and men in the second period, the reduction of stroke risk was more striking in 
women, meaning that they have postponed the first-ever stroke and they managed to 
reduce the risk of disabling stroke, in particular the risk of PICH and disability/death as 
consequence of stroke (mRS>3) compared to men. This could be due to the progressive 
disappearance of the gender-gap in educational level,21 and eventually to other social 
factors, including health awareness.7
Using standardized rates for the Segi world population22 in other studies that compared 
stroke incidence across different time periods,23-31 a decrease in incidence between 10% 
in Aucland23 and 25% in Joinville24 was estimated for a 10-year period; in Lund-Orup,25-26
Tartu23, 29 and Valley d’Aosta30-31 the decrease was more marked in women (26.1%, 20% 
and 22%, respectively) and in Oxfordshire23, 27 and Takashima28 in men (16.4% and 22%, 
respectively). Case-fatality changes were more heterogeneous, ranging from a relative 
change of 2% in Oxfordshire to 78% in Dijon.23 The decrease in stroke incidence was 
higher in Porto (27%), and the reduction of case-fatality (34%) followed that observed in 
Dijon, however in this study the methodology differed across study periods.32 The period 
1998 to 2011 in Portugal captures higher changes that would not be present if other 
periods were compared, and these changes may be linked to the implementation of 
population-based campaigns about stroke and vascular risk factors7 and 
identification/treatment of VRF carriers. Indeed the increase in the prevalence of VRF in 
the second period reinforces this idea, namely the evolution of the recommended cut-off 
points in several measures (blood pressure and total cholesterol) for initiating therapy. A 
recent study comparing the prevalence of hypertension in 2003 and 2012 in Portugal 
concluded that it remained stable, but there was a relevant increase in the proportion 
taking antihypertensive medication (39% to 75%),33 justifying the decreasing incidence of 
hemorrhagic stroke. Nevertheless, we cannot rule out the possibility of an artefact due to 
the more reliable methods for identifying VRF in the more recent registry. For other VRF, 
studies in our country showed that in the last years their prevalence remained stable or 
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increased,34-35 while the proportion of former smokers more than doubled and it was 
higher than reported in 2007 for the Portuguese population.36 Studies in other countries 
showed that looking at the 1980-2004 period27 there was a substantial reduction in the 
prevalence of VRF and in a more recent period (1990-2008) there was an increasing 
trend in blood pressure levels followed by an increased use of medication for treatment of 
VRF.37  
The better outcome in terms of disability/case-fatality across periods is a consequence of 
improvements towards oldest patients and inpatient care, after adjusting for patients 
profile and stroke signs and type. This evidences the impact of recent health measures 
directed to patients, as the organization of stroke units and Stroke Code pathways.8
Moreover, optimal secondary prevention interventions restricted to younger patients in 
the first period are at present adopted in the elderly, showing that they even benefit more 
than the youngest patients.38 Other studies reporting case-fatality changes, from the 
80s/90s until the first years of the 21st century,23-31 lower than in Porto, probably did not 
include recent advances in stroke prevention/care in that particular country. 
In conclusion we may add that the “gender decline” in the risk of a first-ever stroke, 
particularly of hemorrhagic and disabling stroke, may be linked to social-cultural changes 
in the Portuguese population whose age-gender distribution is mirrored by that of Porto. 
Advances in the quality of inpatient care and primary/secondary prevention in the elderly 
contributed decisively for the better short-term outcome across the last decade.  
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Supplemental data 
Supplemental table. Deviances and goodness of fit test for Poisson Log-linear Models fitted to 
the expected number of incident strokes according to the Census 2011 
population 
Degrees 
of 
freedom
All strokes  Non minor stroke  Minor stroke  
Model Deviance
Goodness 
of fit P 
 Deviance
Goodness 
of fit P 
Deviance
Goodness 
of fit P 
Null  19 1928.2 <0.001  1472.7 <0.001  533.8 <0.001  
One-factor Models            
 Period  18 1905.7 <0.001  1454.9 <0.001  528.3 <0.001  
 Gender  18 1928.1 <0.001  1470.8 <0.001  532.5 <0.001  
 Age  15 62.6 <0.001  47.5 <0.001  43.0 <0.001  
Two-factor Models            
 Period + Gender  17 1905.6 <0.001  1453.0 <0.001  526.9 <0.001  
  PG  16 1901.5 <0.001  1447.0 <0.001  526.9 <0.001  
 Period + Age  14 40.1 <0.001  29.7 0.008  37.5 0.001  
  PA  10 35.6 <0.001  28.0 0.002  29.4 0.001  
 Gender + Age  14 51.8 <0.001  43.7 <0.001  35.5 0.001  
  GA  10 35.7 <0.001  28.8 0.001  19.6 0.033  
Three-factor Models            
 P + G + A  13 29.3 0.006  25.9 0.018  29.9 0.005  
  PG + A  12 25.2 0.014  19.8 0.071 (1) 29.9 0.003  
  PA + G  9 24.8 0.003     22.4 0.008  
  GA + P  9 13.2 0.154 (1)    14.1 0.120 (1)
  PG + PA  8    17.3 0.027     
  PG + GA  8 9.1 0.337 (2) 4.9 0.767 (2) 14.1 0.080  
  PA + GA  5 8.7 0.123     6.5 0.261 (2)
  PG + PA + GA  4 2.6 0.633 (3) 1.3 0.856 (3) 6.1 0.191 (3)
All strokes: (1) The simplest model that provided an adequate fit to the data is (GA + P); (2) this 
hierarchic model (PG + GA) improved significantly the fit of the previous model (chi-square=4.1, 
df=1, p<0.05) and the model (3) (PG + PA + GA) did not improve the fit (chi-square=10.6, df=5, 
p>0.05) - Final model PG + GA.  
Non minor stroke: (1) The simplest model that provided an adequate fit to the data is (PG + A); (2) 
this hierarchic model (PG + GA) improved significantly the fit (chi-square=14.9, df=4, p<0.005) and 
the more complex model (3) (PG + PA + GA) also improved significantly the fit (chi-square=18.5, 
df=8, p<0.02) - Final model PG + GA (the simplest that improved the fit).  
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Conclusions: Both models are of partial independence, i.e., the interaction between Gender and 
Age (higher incidence rates for youngest men compared to women and no differences in the 
oldest age-groups) is similar in both study periods and the decline in incidence from 1998 to 2011 
was higher in women compared to men, irrespective of age-group (Table 3). 
Minor stroke: (1) The simplest model that provided an adequate fit to the data is (GA + P); (2) this 
hierarchic model (PA + GA) did not improve significantly the fit of the previous model (chi-
square=7.6, df=4, p>0.1) as well as model (3) (PG + PA + GA), (chi-square=8.0, df=5, p>0.1) - 
Final model GA + P. 
Conclusions: The interaction between Gender and Age (higher incidence rates for men compared 
to women for those aged 55 to 74 years and no differences in the other age-groups) is similar in 
both study periods and there was an overall decline in incidence from 1998 to 2011 (Table 3).  
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CONCLUSÕES
Nos capítulos anteriores (2-6) são apresentados cinco artigos que, naturalmente, 
apresentam uma discussão própria, onde se comparam os resultados encontrados com 
os descritos na literatura, discutem-se os pontos fortes e as limitações da investigação 
bem como as possíveis implicações em termos de saúde pública. Neste capítulo serão 
abordadas as principais conclusões resultantes desses artigos. 
A comparação das taxas de incidência de AVC em diferentes regiões e países permite 
aumentar o conhecimento dos vários mecanismos etiológicos e dos meios de prevenção. 
Para possibilitar a comparação é necessário que os diferentes estudos utilizem as 
mesmas definições, a mesma metodologia e que apresentem essa informação de forma 
semelhante. Com o segundo projecto ACINrpc pretendeu-se registar todos os primeiros 
acidentes neurológicos na vida ocorridos no período compreendido entre 1 Outubro de 
2009 e 30 de Setembro de 2011. Tal como no primeiro projecto, a metodologia adoptada 
seguiu de perto os critérios ideais definidos para a realização de estudos de incidência. 
Para além disso a metodologia foi adaptada à evolução na quantidade e armazenamento 
de informação clínica em bases de dados informatizadas. 
No segundo projecto, a utilização de meios informáticos para efectuar a revisão das 
diferentes fontes de informação, garantiu uma maior fiabilidade na identificação dos 
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eventos ocorridos na população, ao contrário do primeiro, onde a revisão das fontes de 
informação decorreu manualmente, quase que exclusivamente, com recurso a fontes de 
informação em suporte físico (processos clínicos de doentes, boletins do serviço de 
urgência escritos, etc). Para além disso, a qualidade da informação clínica informatizada 
permitiu aferir, com maior clareza, se os eventos identificados correspondiam ao primeiro 
evento na vida, bem como confirmar muitos dos aspectos relacionados com os 
antecedentes clínicos do doente, principalmente a presença de factores de risco 
vascular. Por outro lado, ambos os projectos ACINrpc permitiram demonstrar a 
importância da inclusão e seguimento dos episódios neurológicos transitórios nos 
estudos de incidência de AVC. 
O primeiro estudo permitiu concluir que o padrão etário na incidência de AVC marca a 
diferença entre populações rurais e urbanas, com um maior risco para os mais novos no 
meio urbano e para os mais velhos no meio rural. No entanto, a ruralidade não está 
associada com o prognóstico a longo prazo, o que pode ser explicado pela menor 
prevalência dos factores risco associados ao AVC no meio rural e pelo facto de não 
haver diferenças no tratamento e gestão dos doentes. Com o seguimento a longo prazo, 
foi também possível concluir que o nível de incapacidade aos três meses é um bom 
indicador do prognóstico a longo prazo dos doentes com AVC Isquémico, quer em 
termos de sobrevivência quer em termos de incapacidade. Este conhecimento, para 
além de permitir informar melhor os doentes com AVC e os seus familiares, tem 
implicações no planeamento dos serviços de saúde, nomeadamente na avaliação 
custo/beneficio dos tratamentos na fase aguda e na organização de unidades de 
reabilitação dirigidas para o doente com AVC. 
O conhecimento dos factores que aumentam o risco de sofrer um AVC é amplo, ao 
contrário dos factores que o podem desencadear (despoletar). Com o estudo realizado 
no Porto, foi possível concluir que existe uma associação entre a temperatura ambiental 
e a ocorrência de AVC e sua gravidade. Ressalta também da análise a importância do 
tipo patológico de AVC, bem como o subtipo de AVC Isquémico, na interpretação destas 
associações, pois os mecanismos etiológicos subjacentes são diferentes. Para além 
disso, não é só a intensidade da exposição que interessa mas também a duração da 
mesma. Os serviços de emergência devem ter presente que determinadas condições 
meteorológicas podem contribuir quer para um aumento do número de episódios quer 
para uma maior gravidade dos mesmos. 
Com o estudo realizado na cidade do Porto, podemos concluir que o declínio da 
mortalidade por AVC pode ser explicado, em parte, pela diminuição na incidência e pela 
melhoria na incapacidade pós-AVC decorrente das gestão dos doentes mais velhos e 
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tratamento durante o internamento. Para esta diminuição da incidência contribuiu 
predominantemente a diminuição do risco nas mulheres, em particular, do risco do AVC 
incapacitante e de AVC hemorrágico. Como referido noutros estudos, parece estar 
subjacente a este facto as mudanças socioculturais ocorridas entretanto na população 
portuguesa. Os avanços na qualidade dos cuidados no internamento (unidades de AVC) 
e a prevenção primária/secundária nos mais velhos contribuíram para uma melhoria no 
prognóstico destes doentes nos últimos anos. 
Perspectivas de investigação futura 
Os registos organizados no âmbito dos projectos ACINrpc constituem uma valiosa base 
de informação quer para a investigação actual quer para investigações futuras no âmbito 
do AVC ou dos acidentes neurológicos. Num futuro próximo, com o objectivo de 
comparar a evolução das taxas de incidência entre o meio urbano e o rural, será 
estudada a evolução das taxas de incidência no meio rural, recorrendo a uma 
metodologia de análise análoga à utilizada para medir o declínio da incidência no meio 
urbano. De igual modo, e dada a importância do AIT, será estudada a evolução da 
incidência destes eventos, comparando o meio urbano com o meio rural.  
Com o propósito de verificar se as associações com os parâmetros meteorológicos se 
mantém, após todos os desenvolvimentos recentes na prevenção e tratamento do AVC, 
será possível replicar o estudo realizado, utilizando para o efeito a informação recolhida 
durante os dois períodos (1998-2000 e 2009-2011). Em função da maior dimensão 
amostral, o estudo poderá ser alargado no sentido de compreender como é que estas 
associações variam com as diferentes etiologias do AVC isquémico. 
Antes da utilização da trombólise no tratamento do AVC na fase aguda, colocava-se 
pouco ênfase na rapidez e precisão de um diagnóstico de AVC. Mas para a trombólise 
ser eficaz é necessário que o doente procure e chegue atempadamente à instituição de 
saúde após o início dos sintomas. Com a informação do segundo estudo ACINrpc será 
possível estudar o prognóstico dos doentes com AVC em função do percurso que este 
realiza nas instituições de saúde. Em particular, será possível estender a caracterização 
dos doentes que utilizaram a Via Verde do AVC aos dois anos do estudo. 
A médio prazo, com o seguimento dos doentes do segundo estudo, será possível 
comparar o prognóstico a longo prazo dos dois coortes de doentes, para analisar até que 
ponto as melhorias observadas no curto prazo se repercutem no longo prazo.  
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ANEXO I
AVALIAÇÃO DA VIA VERDE DO ACIDENTE VASCULAR
CEREBRAL NO NORTE DE PORTUGAL:
CARACTERIZAÇÃO E PROGNÓSTICO DOS
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RESUMO
Introdução: Em 2002 Portugal detinha uma das mais altas taxas de mortalidade por doenças cerebrovasculares entre os países eu-
ropeus. Várias estratégias foram adoptadas para melhorar a prevenção da doença e o seu tratamento na fase aguda, entre as quais a 
criação da Via Verde do Acidente Vascular Cerebral. O objectivo deste trabalho é descrever a utilização e resultados desta estratégia 
no contexto de um registo prospectivo comunitário na Região Norte de Portugal.
Material e Métodos: Foram registados todos os AVCs ocorridos entre 1 de Outubro de 2009 e 30 de Setembro de 2010 nos utentes 
inscritos no agrupamento de centros de saúde do Porto Ocidental e nos de Mirandela e Vila Pouca de Aguiar. Para a detecção de 
casos utilizaram-se múltiplas fontes de informação: notificação via WEB, e-mail, Alerta P1 e pesquisas sistemáticas em registos dis-
ponibilizados pelas entidades envolvidas - urgências hospitalares, listas de altas, procedimentos de diagnóstico, óbitos, Via Verde do 
Acidente Vascular Cerebral e serviço de atendimento de situações urgentes. 
Resultados: Ocorreram 600 AVCs em 241 000 habitantes (taxa de incidência de 250 / 100 000), dos quais 434 foram primeiros na 
vida (180 / 100 000). Foram registados 72 acessos à Via Verde do Acidente Vascular Cerebral, dos quais 66,7% foram diagnosticados 
como AVC. Considerando os quatro critérios de activação (idade ≤ 80 anos, independência funcional, sinais/sintomas do AVC e tempo 
após episódio ≤ 3 horas), só 15,9% dos doentes a poderiam utilizar e, dos utilizadores, apenas 56,3% satisfaziam esses critérios. Dos 
doentes com critérios de activação, foram internados 96,3% pela VV pré-hospitalar, 83,3% pela VV intra/inter-hospitalar e 64,0% dos 
restantes; a fibrinólise foi realizada em 77,3%, 36,4% e 17,4% dos doentes com enfarte cerebral, respectivamente. O Rankin pós-
AVC é mais grave nos utilizadores da VV pré-hospitalar (70,3% vs. 35,3%), mas estes apresentam mais assiduamente os três sinais/
sintomas de AVC (44,4% vs. 16,2%). Ajustando para a idade, sexo e número de sinais, o risco de incapacidade grave pós-AVC não é 
significativamente diferente no acesso pela VV pré-hospitalar (RP = 2,9; IC 95%: 0,8 - 10,2), bem como a taxa de letalidade. 
Conclusões: Os critérios para activação da Via Verde do Acidente Vascular Cerebral são muito restritivos. Embora esta seja mais 
vezes accionada em situações clínicas graves, a proporção de doentes que realizou fibrinólise é relativamente alta em comparação 
com outros estudos.
Palavras-chave:  Acidente Vascular Cerebral; Portugal.
ABSTRACT
Introduction: By 2002 Portugal had one of the highest mortality rates due to cerebrovascular diseases among the European Countries. 
Meanwhile, several strategies have been adopted to improve prevention and treatment in the acute phase, amongst which the Stroke 
Code. The purpose of this study is to describe how this measure has been used and its outcome as part of a prospective community 
based study of stroke/TIA incidence in Northern Portugal.
Materials and Methods: Between 1st October 2009 and 30th September 2010 all strokes occurred in patients registered at Western 
Porto, Mirandela and Vila Pouca de Aguiar health centres have been recorded. For cases ascertainment multiple sources of informa-
tion were used, including the WEB, letter, e-mail and Alert P1, as well as systematic searches on databases provided by the entities 
involved in this study: hospital emergency, discharge records, diagnosis procedures, death certificates, Stroke Code admissions and 
health centre emergency records. 
Results: Six hundred strokes were recorded in a population of 241 000 (incidence rate of 250 / 100 000 person-years) and 434 were 
first-ever-in-the-lifetime (180 / 100 000). There were 72 Stroke Code calls and in 66.7% of them a stroke was confirmed. Consider-
ing the criteria for Stroke Code call (age ≤ 80 years, functional independency, the stroke signs/symptoms, and time after episode ≤ 3 
hours), only 15.9% patients “could” have access to it. Of those who used the Stroke Code, only 56.3% fulfilled the criteria. Consider-
ing all patients fulfilling Stroke Code criteria, 96.3% that used prehospital Stroke Code were inpatients, as well as 83.3% that used 
intra/interhospital Stroke Code and 64.0% of the remainder; this trend is also present in patients with ischaemic stroke submitted to 
fibrinolysis, 77.3%, 36.4% and 17.4%, respectively. A high post-stroke Rankin was more frequent among Stroke Code users (70.3% 
vs. 35.3%), but they exhibit more often the three stroke signs/symptoms (44.0% vs. 16.2%). After adjusting for age, sex and number 
of signs, the risk of a more severe post-stroke Rankin is not significantly different among patients using the prehospital Stroke Code 
(OR = 2.9, 95% CI: 0.8 - 10.2).
Conclusions: The criteria for accessing the Stroke Code are currently restrictive. Though the Stroke Code is accessed in case of more 
severe patient’s conditions, the proportion of patients treated with fibrinolysis is relatively high in comparison with other studies.
Keywords: Stroke; Portugal; Emergency Medical Services.
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INTRODUÇÃO
 O primeiro registo prospectivo de acidentes neurológi-
cos na comunidade (ACINrpc) realizado uma década atrás1 
obedeceu aos critérios metodológicos ideais para o cálcu-
lo da incidência do primeiro Acidente Vascular Cerebral na 
vida e respectiva taxa de letalidade,2 permitindo concluir 
que em Portugal, particularmente na Região Norte, a taxa 
de incidência era uma das mais altas dos países europeus, 
305 e 269 por 100 000 pessoas-ano (202 e 173 padroni-
zadas para a população europeia), respectivamente em 
áreas rurais e urbanas. A taxa de letalidade aos 28 dias 
(16,1%) foi semelhante à dos outros países, embora nas 
estatísticas oficiais da Direcção Geral de Saúde a taxa de 
mortalidade padronizada fosse de 154 / 100 000, uma das 
mais altas dos países da Europa Ocidental.3
 Utilizando dados da Organização Mundial de Saúde 
(OMS) referentes a 2002, Portugal detinha ainda uma das 
taxas de mortalidade mais altas entre os países pertencen-
tes ao grupo A (taxas de mortalidade infantil e em adultos 
muito baixas) estimando-se que a taxa anual de variação 
para o período de 1990 - 2006 seria das mais baixas.4 No 
mesmo período Portugal tem um valor alto extremo na taxa 
de mortalidade e o mais alto nos anos de vida ajustados à 
incapacidade (DALYs) por doença cerebrovascular entre os 
países de mais alto rendimento.5 Desde então foram imple-
mentados avanços consideráveis ao nível da intervenção 
no AVC com o objectivo de alterar o seu peso na comunida- 
de, reflectido não só na incidência, mas também em indi-
cadores de mortalidade e anos de vida com incapacidade. 
 A tendência decrescente nas taxas de mortalidade em 
Portugal continental e Região Norte6 em particular, que em 
2006 eram respectivamente 80,7 e 81,4 por 100 000, pode 
resultar da diminuição da incidência e/ou da intervenção 
terapêutica com repercussões na taxa de letalidade. A efi-
cácia desta intervenção depende da organização e aces-
sibilidade dos serviços de saúde, mas também do alerta 
da população para os sinais/sintomas do Acidente Vascular 
Cerebral (AVC), para que seja cumprida a janela terapêuti-
ca das três horas.7 Uma das estratégias adoptadas nas fa-
ses pré, intra e inter-hospitalar foi o programa Via Verde do 
AVC (VVAVC).7 O objectivo principal foi o diagnóstico pre-
ciso e atempado para um tratamento adequado e teve por 
base a organização da emergência pré e intra-hospitalar 
e o alerta da população para os principais sinais/sintomas 
do AVC. Neste sentido, foi iniciada em 2008 em Portugal, 
a campanha Seja mais rápido que o AVC, dando ênfase 
ao aparecimento súbito de três sinais/sintomas (falta de 
força num braço, boca ao lado e dificuldade em falar) e 
procedimento correcto caso aconteçam - contacto imediato 
com Instituto Nacional de Emergência Médica (INEM/112), 
com a consequente activação da Via Verde externa ou pré-
-hospitalar (VVE).8
 Uma década após o primeiro estudo ACINrpc está a 
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Figura 1 - Metodologia de detecção e inclusão dos casos.
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decorrer, na Região Norte, o projecto ACIN2 – Tendência 
da incidência e prognóstico dos acidentes neurológicos 
(PIC/IC/82858/2007), no qual são registados os acidentes 
neurológicos no período compreendido entre 1 Outubro de 
2009 e 30 de Setembro de 2011 (http://www.acin2.com). 
Utilizando os dados do primeiro ano deste estudo, o objec-
tivo deste trabalho é caracterizar os utilizadores e circuns-
tâncias de utilização da VVAVC no Norte de Portugal. Em 
particular, determinar o perfil sócio-demográfico e clínico 
associado a esta utilização e o prognóstico dos utilizado-
res.
MATERIAL E MÉTODOS
 Neste estudo comparam-se as características na ba-
seline, nomeadamente o acesso a cuidados médicos, dos 
doentes incluídos num estudo de incidência de AVC obede-
cendo aos critérios metodológicos ideias definidos por Su-
dlow and Warlow2 e actualizados mais tarde por Feigin and 
Carter,9 nomeadamente um plano prospectivo com uma 
procura extensiva dos casos usando fontes de informação 
múltiplas em populações enumeráveis e estáveis com di-
mensão adequada, que são seguidos por um período de 
um mês para aferir o estado vital.
 A base comunitária do estudo é a população inscrita em 
Setembro de 2009 no Agrupamento de Centros de Saúde 
(ACES) do Porto Ocidental e nos Centros de Saúde de Vila 
Pouca de Aguiar e Mirandela. Foi pedida autorização e co-
laboração à Administração Regional de Saúde do Norte, de 
modo a ter acesso ao registo informatizado de base popu-
lacional. Seguidamente, o estudo foi apresentado a todos 
os directores dos centros de saúde envolvidos, tendo sido 
referida e explicada a utilização do endereço http://www.
acin2.com, onde todos os médicos e enfermeiros poderiam 
preencher um formulário simples para notificar de forma 
anónima os doentes suspeitos, após obtenção do seu con-
sentimento. O estudo foi divulgado junto dos médicos bem 
como da população abrangida, utilizando os media e reu-
niões cientificas. 
Detecção dos casos de acidentes neurológicos
 A plataforma WEB é a principal fonte de informação e 
a mais expedita para que o doente seja rapidamente ob-
servado pela equipa de neurologia adstrita ao projecto nos 
vários hospitais envolvidos. No entanto a notificação pode 
ainda ser feita por carta, telefone/fax, e-mail ou pelo Alert 
P1 (Fig. 1).
 Para a identificação dos casos suspeitos recorreu-se 
também a pesquisas sistemáticas nos diferentes tipos de 
registos disponibilizados pelas entidades envolvidas - ur-
gências hospitalares, listas de altas (códigos 430 - 438, 342 
e 781), listas de óbitos, VVAVC, serviço de atendimento de 
situações urgentes (SASU) e listas de procedimentos de 
diagnóstico. O recurso a estes registos é efectuado no sen-
tido de minimizar a possibilidade de se perderem casos que 
não tenham sido notificados por outra via (Fig. 2).
 A informação referente aos episódios em que a VVE foi 
activada consta de uma listagem fornecida mensalmente 
pelo INEM. A VVE consiste num trajecto optimizado em ter-
mos de acessibilidade e rapidez de tratamento, que tem por 
base a chamada telefónica pelo cidadão para o número de 
emergência médica (112). Para que seja activada é neces-
sário que o doente preencha cumulativamente os seguintes 
critérios: (a) idade inferior a 80 anos, (b) instalação súbita 
de pelo menos um dos sintomas boca ao lado, falta de for-
ça num dos membros, principalmente num braço e dificul-
dade em falar, (c) sinais ou sintomas com menos de três 
horas de evolução e (d) não ter dependência prévia.7 Ve-
rificados estes critérios, é accionado o protocolo designa-
do por VVE que transmite instruções para o transporte via 
INEM, envolvendo-o directamente no diagnóstico, eventual 
tratamento pré-hospitalar e adequado encaminhamento 
para o hospital com as melhores condições de confirmação 
do diagnóstico, tratamento subsequente e disponibilidade 
logística para a recepção do doente. Foi feita a ligação dos 
episódios/utentes da VVE à população do estudo. Quando 
o doente procura directamente o hospital, pode activar-se 
a VV intra/inter-hospitalar (VVI), um sistema de assistência 
intra-hospitalar que facilita de igual modo a terapêutica fibri-
nolítica, com a minimização do tempo porta-agulha.7 Con-
siderou-se que a VVI foi activada quando esta informação 
constava dos registos dos episódios de urgência.
Critérios de inclusão no estudo
 Foram incluídos todos os AVCs registados entre 1 de 
Outubro de 2009 e 30 de Setembro de 2010, tendo sido 
adoptada a definição de AVC da Organização Mundial de 
Saúde (OMS).10 Os episódios transitórios (défices perma-
necendo menos de 24 horas) e as lesões assintomáticas 
ou enfartes silenciosos detectados imagiologicamente fo-
ram excluídos. O AVC é classificado como: enfarte cere-
bral (EC) quando a tomografia computarizada (TC) e/ou 
ressonância magnética (RM) realizada nos 30 dias após 
o episódio evidencia um enfarte ou nenhuma lesão rele-
vante e/ou autópsia com evidência de lesão; hemorragia 
intracerebral primária (HICP) quando a TC e/ou RM reali-
zada nos 30 dias após o AVC evidencia a hemorragia e/ou 
autópsia com evidência de lesão; hemorragia subaracnoi-
deia (HSA) na existência de história clínica apropriada e/ou 
TC ou RM cerebral evidencia sangue subaracnoideo e/ou a 
punção lombar mostra sangue subaracnoideo e/ou angio-
grafia cerebral mostra fonte de hemorragia subaracnoidea 
e/ou autopsia mostrando hemorragia subaracnoidea com 
ou sem fonte de HSA.11 Considerou-se AVC recorrente um 
novo episódio ocorrendo 28 dias após o inicial ou, se antes 
deste período envolve um território vascular ou anatómico 
diferente, conforme se trate de um EC ou HICP, respectiva-
mente. 
 Todos os casos suspeitos foram observados pela equi-
pa de neurologistas o mais depressa possível após o epi-
sódio, e para os doentes incluídos foi preenchido um proto-
colo com informação sócio-demográfica, acesso (VVE, VVI 
ou outra), modo de acesso (transporte), circunstâncias e 
modo de início e informação clínica referente ao episódio, 
procedimentos de diagnóstico, diagnóstico e tratamentos 
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subsequentes. Foi registado a pontuação na escala Rankin 
modificada, pré e pós-AVC,12,13 bem como a data/hora de 
todos os procedimentos realizados. A informação foi forne-
cida pelo doente e/ou consta do respectivo processo clíni-
co. O estudo foi aprovado pela comissão de ética das insti-
tuições de saúde onde o estudo decorreu, assinando todos 
os participantes o consentimento informado e, em caso de 
incapacidade, este foi dado por um parente presente na 
altura do episódio.
POPULAÇÃO DO ESTUDO
Centro Hospitalar do Porto
ULS Matosinhos
Hospital Vila Nova de Gaia
Hospital de São João
Hospital de Mirandela
‘SASU’ PORTO
Hospital de Vila Real
Hospitais Região Norte(*)
VIA VERDE AVC (INEM)
ACES Porto Ocidental
‘CA’ Vila Pouca de Aguiar
Número Utente
Cu
id
ad
os
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s
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s
Urgências
(*) Nomeadamente os hospitais que também pertencem aos centros hospitalares em que se encontram inseridos os hospitais de Vila Real e Mirandela
Vila Pouca de Aguiar
Mirandela
CERTIFICADOS ÓBITOS
Listas de Altas
Medicina Privada
Alert P1 / CE Neurologia
Outros
Procedimentos
C
entro
s
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C
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ACIN
Listas de Óbitos
Figura 2 - Fontes de informação com registos de casos suspeitos.
NÃO
n = 21 (43,7)
AVC
n = 600
Via Verde Externa
n = 48 (8,0)
Outros
n = 26 (4,3)
SIM
n = 27 (56,3)
CRITÉRIOS VIA VERDE
Critério:
- Idade>80 anos 9 (42,9)
- Dependente 5 (23,8)
- Tempo>3h 6 (28,6)
- Combinações 1 (4,8)
Via Verde Interna
n = 50 (8,3)
Serviço Urgência
n = 476 (79,3)
NÃO
n = 32 (64,0)
SIM
n = 18 (36,0)
CRITÉRIOS VIA VERDE
NÃO
n = 426 (89,5)
SIM
n = 50 (10,5)
CRITÉRIOS VIA VERDE
Critério:
- Idade>80 anos 12 (37,5)
- Dependente 2 (6.3)
- Tempo>3h 9 (28.1)
- Sem sintomas 1 (3.1)
- Combinações 8 (25.0)
Critério:
- Idade>80 anos 21 (4,9)
- Dependente 11 (2,6)
- Tempo>3h 97 (22,8)
- Sem sintomas 20 (4,7)
- Combinações 277 (65,0)
- Não recorreu SU 21 (80,8)
- SU fora da area 4 (15,4)
- Desconhecido 1 (3,8)
Figura 3 - Utilização da Via Verde do AVC segundo os critérios de activação (%).
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Métodos estatísticos
 Procedeu-se à comparação dos episódios de AVC 
ocorridos em utilizadores e não utilizadores da VVAVC, 
utilizando o teste do qui-quadrado ou teste exacto de Fi-
sher (variáveis categóricas) e o teste t-student (variáveis 
contínuas), determinando-se em seguida as características 
subjacentes à utilização da VVAVC descritas pela razão de 
possibilidades (RP) e respectivo intervalo de confiança a 
95% (IC 95%). Descrevem-se os critérios subjacentes à 
activação da VVAVC, comparando-se, em seguida, as ca-
racterísticas e prognóstico dos utilizadores da VVE, VVI e 
restantes doentes com critérios de activação, eliminando 
por restrição o efeito de variáveis confundidoras. Foi utili-
zada a regressão logística para avaliar o prognóstico em 
função do Rankin pós-AVC agrupado em incapacidade mo-
derada (1 - 3) e incapacidade grave (4 - 5) para utilizadores 
e não utilizadores da VVE, ajustando para a idade, sexo e 
diagnóstico. Adoptou-se um valor de p < 0,05 como limite 
do erro tipo I.
RESULTADOS
 A população do estudo é constituída por 241 000 uten-
tes registados em Setembro de 2009 no ACES do Porto 
Ocidental (n = 194 200) e centros de saúde de Vila Pouca 
de Aguiar (n = 16 200) e Mirandela (n = 30 600). No período 
de estudo foram incluídos 600 episódios de AVC, dos quais 
434 (72,3%) foram primeiros na vida, correspondendo a 
uma taxa de incidência de 250 por 100 000 pessoas-ano. 
Considerando o primeiro AVC na vida esta taxa é de 180 / 
100 000, 175 na área urbana e 203 na área rural. Durante 
o mesmo período foram registados 1 380 episódios aten-
didos no âmbito da VVE na Região Norte, dos quais 72 
da população do estudo, o que corresponde a uma taxa 
de activação de 30 / 100 000 habitantes. A idade média 
dos utilizadores foi de 65,2 anos e 52,8% eram homens; 
59,7% foram encaminhados para o Hospital de Santo Antó-
nio, 16,6% para os hospitais que servem a população rural 
(Centro Hospitalar do Nordeste e Centro Hospital de Trás-
-os-Montes e Alto Douro) e os restantes para outros hospi-
tais na região norte (Tabela 1). O sintoma mais frequente 
foi a falta de força (69,4%), seguido da dificuldade em falar 
e boca ao lado (41,7%); o tempo decorrido entre o apareci-
mento destes e a chegada ao SU foi, em média, de 82 mi-
nutos. Não teriam critérios de activação da VVE 36,1% dos 
doentes e no SU foram diagnosticados 68% como AVC/AIT 
(Acidente Isquémico Transitório).
 No registo ACIN, foram incluídos 48 destes doentes 
com diagnóstico definitivo de AVC, e na Tabela 2 compa-
ram-se as suas características com as dos restantes doen-
tes. A idade média dos doentes registados foi de 72,8 anos, 
47,3% são homens e 78% residem em meio urbano, carac-
terísticas não significativamente diferentes nos utilizadores 
Tabela 1 - Características dos 72 utilizadores da Via Verde externa
Idade média (dp), anos 65,2 (16,2)
Tempo médio (dp) de acesso SU, minutos† 82,3 (44,5)
n %
Homens 38 52,8
Hospitais da Região Norte
 Centro Hospitalar do Porto 43 59,7
 Hospital de São João 11 15,3
 Hospital Pedro Hispano 3 4,2
 Centro Hospitalar de Vila Nova de Gaia/Espinho 3 4,2
 Centro Hospitalar do Nordeste 5 6,9
 Centro Hospitalar de Trás-os-Montes e Alto Douro 7 9,7
Sinais
 “Falta de força num dos membros” 50 69,4
 “Boca ao lado” 30 41,7
 “Dificuldade em falar” 36 50,0
Sem critérios 26 36,1
 Dependência prévia 1 3,8
 Tempo > 3h 2 7,7
 Idade > 80 anos 8 30,8
 Nenhum dos sinais 13 50,0
 Dois ou mais 2 7,7
Diagnóstico de admissão
 AVC/AIT 49 68,0
 Alterações estado de consciência 5 6,9
 Crises epilépticas/convulsões 4 5,6
 Enxaqueca com aura 1 1,4
 Outros 13 18,1
†Média e desvio padrão; ‡Registado pelo CODU (Centro de Orientação de Doentes Urgentes); § Dois dos utilizadores não cumpriam dois dos critérios.
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da VVE. A maioria dos doentes que acederam à VVE es-
tavam assintomáticos ou com sintomas não incapacitantes 
antes do episódio, em contraste com os restantes (85,4% 
vs. 58,2%). Globalmente, o transporte por ambulância foi 
usado por 50% dos doentes; 85,4% dos utilizadores da 
VVE chegaram dentro da janela terapêutica, descendo esta 
proporção para 34,8% nos restantes. 
 A discriminação entre utilizadores da VVE e restantes 
é manifesta na proporção que apresenta cumulativamente 
os três sinais de AVC, 47,9% vs. 13,6%, e mais de 95% 
apresentam os sinais mais característicos - falta de força 
e/ou boca ao lado. Globalmente, 72,3% dos doentes tive-
ram o primeiro AVC na vida, sendo a proporção de AVCs is-
quémicos ligeiramente superior nestes (83,4% vs. 81,3%), 
independentemente do acesso ser a VVE. A proporção de 
utentes da VVE internados é muito superior (93,8%) à dos 
restantes (57,2%), particularmente quando o AVC é isqué-
mico (94,1% vs. 53,1%). De notar que 26,3% dos doen-
tes internados utilizaram o acesso pela Via Verde (45 pela 
VVE e 50 pela VVI). Os determinantes de utilização da VVE 
entre as características sócio-demográficas e sintomato-
logia, foram a idade e o número de sintomas, diminuindo 
4% por um aumento unitário na idade (RP = 0,96; IC 95%: 
0,94 - 0,98) e quintuplicando por cada sintoma adicional 
(RP = 5,0; IC 95%: 3,0 - 8,4). (Tabela 2).
 Na Fig. 3 está descrito o acesso aos cuidados de saú-
de após um AVC, nomeadamente a activação da VVE ou 
VVI, serviço de urgência sem VVAVC ou outro. Conside-
rando cumulativamente os quatro critérios de utilização da 
VVAVC, só 95 (15,9%) doentes a poderiam utilizar e, dos 
que utilizaram a VVE (8%), apenas 56,3% satisfaziam es-
ses critérios. Globalmente a janela terapêutica (112 / 574 = 
Tabela 2 - Caracterização dos doentes com AVC, utilizadores e não utilizadores da Via Verde externa
Via Verde externa Outros Total
(n = 48) (n = 552) (n = 600) P
Idade média (dp), anos 68,2 (11,8) 73,2 (13,8) 72,8 (13,7) 0,014
n % n % n %
Homens 27 56,3 257 46,6 284 47,3 0,2
Meio urbano 41 85,4 427 77,4 468 78,0 0,2
Rankin prévio 0,005
 Assintomático 34 70,8 227 43,0 261 45,3
 Sintomas não incapacitantes 7 14,6 80 15,2 87 15,1
 Incapacidade ligeira 4 8,3 83 15,7 87 15,1
 Incapacidade moderada 1 2,1 93 17,6 94 16,3
 Incapacidade moderadamente grave 1 2,1 32 6,1 33 5,7
 Incapacidade grave 1 2,1 13 2,5 14 2,4
 Desconhecido 24
Transporte em ambulância 48 100,0 252 45,7 300 50,0
 Tempo entre episódio e SU < 3h 41 85,4 192 34,8 233 38,9 0,001
Sinais
 “falta de força num dos membros” 46 95,8 323 58,5 369 61,5 0,001
 “boca ao lado” 47 97,9 312 56,5 359 59,9 0,001
 “dificuldade em falar” 24 50,0 116 21,0 140 23,3 0,001
 Com os três sinais 23 47,9 75 13,6 98 16,3 0,001
1º AVC na vida 40 83,3 394 71,4 434 72,3 0,08†
 Isquémico 29 72,5 333 84,5 362 83,4 0,08‡
 Hemorrágico 11 27,5 58 14,7 69 15,9
 Desconhecido - 3 0,8 3 0,7
AVC recorrente 8 16,7 158 28,6 166 27,7
 Isquémico 5 62,5 130 82,3 135 81,3 0,2‡
 Hemorrágico 2 25,0 24 15,2 26 15,7
 Desconhecido 1 12,5 4 2,5 5 3,0
Internamentos 45 93,8 316 57,2 361 60,2 0,001
 AVC isquémico§ 32 94,1 246 53,1 278 55,9 0,001
 AVC hemorrágico§ 12 92,3 66 80,5 78 82,1 0,3
†Média e desvio padrão; ‡comparação do 1º AVC na vida com AVC recorrente; §comparação do diagnóstico; ¶percentagem sobre o total de AVC desse tipo.
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19,5%) e a idade superior a 80 anos (42 / 574 = 7,3%) são 
os critérios que isoladamente impediriam mais frequente-
mente a utilização da VVAVC. 
 Dos não utilizadores da VVAVC, 426 (89,5%) não reu-
niam critérios de activação e destes 97 (22,8%) não seriam 
eventuais candidatos apenas porque não chegariam dentro 
da janela terapêutica e 21 (4,9%) apenas pelo critério da 
idade.
 Restringindo a comparação aos doentes com critérios 
de activação da VVAVC, pode observar-se na Tabela 3 que 
as características sócio-demográficas, período de atendi-
mento e tempo médio de acesso não são significativamente 
diferentes nos utilizadores da VVE, VVI ou não utilizadores. 
A falta de força é o sintoma mais frequente (87,4%), segui-
do da boca ao lado (83,2%) e dificuldade em falar (31,6%). 
Nenhum doente na VVI apresenta cumulativamente os três 
sintomas, em comparação com 22,0% dos não utilizado-
res e 44,4% dos utilizadores da VVE. Cerca de 76,8% dos 
doentes são internados, proporção muito superior (96,3%) 
na VVE, decrescendo na VVI (83,3%) e não utilizadores 
(64,0%). Esta tendência é também manifesta nos doentes 
com AVC isquémico que fazem fibrinólise (77,3%, 36,4% 
Tabela 3 - Caracterização e prognóstico dos doentes com critérios de activação da Via Verde do AVC
Via Verde 
Externa
Via Verde 
Interna
Não
Via Verde Total
(n = 27) (n = 18) (n = 50) (n = 95) P
Caracterização
Idade média (dp), anos 64,2 (9,6) 61,9 (11,6) 64,4 (9,9) 63,9 (10,1) 0,7
Tempo médio (dp) de acesso SU, minutos 82 (44) 93 (43) 91 (47) 89 (45) 0,7
n % n % n % n %
Homens 16 59,3 12 66,7 29 58,0 57 60,0 0,8
Área urbano 23 85,2 16 88,9 38 76,0 77 81,1 0,4
Transporte em ambulância 27 100,0 13 72,2 28 56,0 68 71,6
Período 0,4
      00 - 08h 3 11,1 1 5,6 7 14,0 11 11,6
      08 - 16h 15 55,6 7 38,9 28 56,0 50 52,6
      16 - 24h 9 33,3 10 55,6 15 30,0 3 35,8
Sintomas
      “falta de força num dos membros” 26 96,3 15 83,3 42 84,0 83 87,4 0,3
      “boca ao lado” 26 96,3 14 77,8 39 78,0 79 83,2 0,1
      “dificuldade em falar” 12 44,4 3 16,7 15 30,0 30 31,6 0,1
Número de sintomas 0,004
      1 2 7,4 4 22,2 15 30,0 21 22,1
      2 13 48,1 14 77,8 24 48,0 51 53,7
      3 12 44,4 - 11 22,0 23 2,2
1º AVC na vida 21 77,8 14 77,8 38 76,0 73 76,8 1,0
Tipo de AVC: Isquémico 20 71,4 14 77,8 41 82,0 75 78,9 0,7
Tratamento e prognóstico
 Internados 26 96,3 15 83,3 32 64,0 73 76,8 0,005
      Isquémicos 19 73,1 11 73,3 23 71,9 53 72,6 1,0
      Fibrinólise 14 77,3 4 36,4 4 17,4 22 41,5 0,001
Rankin pós episódio 0,027†
      Sintomas não incapacitantes - 2 11,1 1 2,0 3 3,2
      Incapacidade ligeira 3 11,1 1 5,6 10 20,0 14 14,7
      Incapacidade moderada 5 18,5 8 44,4 22 44,0 35 36,8
      Incapacidade moderadamente grave 8 29,6 5 27,8 10 20,0 23 2,2
      Incapacidade grave 11 40,7 2 11,1 7 14,0 20 21,1
Taxa de letalidade aos 28 dias 3 11,1 2 11,1 3 6,0 8 8,4 0,7
†Média e desvio padrão; ‡Teste exacto de Fisher
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e 17,4%, respectivamente). No total de utilizadores da 
VVE, pode calcular-se uma (sub)estimativa da proporção 
de doentes com AVC isquémico submetidos a fibrinólise de 
41,2% (14 em 34). O Rankin pós-AVC é mais grave nos 
utilizadores da VVE, 70,3% com dependência grave ou mo-
deradamente grave, em comparação com 38,9% na VVI e 
34,0% nos não utilizadores. Ajustando para a idade, sexo 
e número de sintomas, o risco de incapacidade grave pós-
-AVC não está significativamente aumentado (RP = 2,9; IC 
95%: 0,8 - 10,2) no acesso pela VVE, aumenta no entanto 
nos homens (RP = 4,2; IC 95%: 1,1 - 15,6) e com o número 
de sintomas (RP = 24,4; IC 95%: 5,2 - 114).
DISCUSSÃO
 Tendo por base um registo prospectivo comunitário 
decorrido no Norte de Portugal entre Outubro de 2009 e 
Setembro de 2011, este é o primeiro estudo de base popu-
lacional a abordar a utilização da VVAVC, permitindo deste 
modo conhecer as condicionantes e efeito na população 
em geral de um programa destinado a minimizar as con-
sequências do AVC. Neste registo foram usadas fontes 
de informação compreensivas de acordo com os critérios 
estabelecidos internacionalmente,14 salientando-se a infor-
mação recebida do INEM referente à utilização da VVE. 
De um modo geral pode concluir-se que a incidência de 
AVC está a diminuir, de 245 / 100 000 em 19991 para 180 / 
100 000 após dez anos. A taxa de activação da VVE foi de 
30 / 100 000 habitantes, correspondendo a 8% do total de 
AVC’s ocorridos na população, embora apenas 56,3% des-
tes cumprissem os critérios de activação. A restrição impos-
ta pelos actuais critérios faria com que apenas 95 (15,8%) 
dos casos de AVC pudessem ter um acesso regulamentar à 
VVAVC. Mesmo atendendo a este facto, apenas 27 (28,4% 
dos que cumpriam critérios) foram conduzidos ao hospital 
pela VVE. 
 Tem sido descrito como factor importante associado à 
VVE a chegada breve ao serviço de urgência (SU) e sub-
sequente tratamento, sendo este um dos seus objectivos 
principais.7 Neste estudo, o tempo decorrido entre o apa-
recimento dos sintomas e a chegada ao SU foi, em média, 
82 minutos, menos nove do que verificou Quain et al15 num 
estudo na Austrália, mas ainda elevado. Podem apontar-
-se alguns factores responsáveis por esta demora, como a 
falta de conhecimento dos sintomas mais comuns do AVC e 
dos procedimentos para solicitar uma ajuda mais imediata 
(112). Estes foram já descritos em vários estudos interna-
cionais,16-18 referindo o papel preponderante desempenha-
do pelas campanhas de alerta da população e também de 
uma adequada interacção/comunicação entre o Centro de 
Orientação de Doentes Urgentes (CODU) e o INEM. No 
SU, 68% dos episódios foram classificados como AVC/AIT, 
valor semelhante aos 70% de uma triagem correcta objec-
tivados para a VVE,7 assim como noutros estudos interna-
cionais.19 Por outro lado, a proporção de falsos positivos 
neste estudo é quase seis vezes superior à encontrada por 
Robert et al20 num estudo semelhante realizado em Barce-
lona. Provavelmente, este facto deve-se ao receio de atra-
sar o acesso em caso de possível AVC e, mais uma vez, a 
dificuldades na realização da triagem pré-hospitalar. A sin-
tomatologia mais frequente na activação da VVE foi a falta 
de força num dos membros, seguida da dificuldade em falar 
e boca ao lado, idêntico ao relatado noutros estudos.21,22 
Uma explicação é ser uma alteração mais perceptível para 
quem vê primeiro o doente e contacta o CODU. No entanto, 
quando nos restringimos aos episódios de AVC, a dificul-
dade em falar é mais frequente nos utilizadores da VVE23 
comparados com os restantes, talvez por ser um sintoma 
mais reconhecido pelos pacientes, uma vez que é caracte-
rístico da afectação do lobo esquerdo, permitindo, teorica-
mente, ao doente reconhecer melhor os seu défices (em 
comparação com o lobo direito) e, desta forma, pedir mais 
rapidamente ajuda. Por outro lado a falta de força num dos 
membros parece ser desta forma um sintoma mais comum 
no diagnóstico diferencial de AVC.
 A VVE teve uma taxa de activação de 8%, inferior aos 
17,9% de Robert et al20 Este valor mais elevado foi, no en-
tanto, encontrado numa situação mais restritiva, nomeada-
mente após exclusão dos doentes em que o episódio ocor-
reu no próprio hospital e dos transferidos de outros hospi-
tais. Por outro lado, no relatório da VVAVC24 é mencionado 
um valor de 26% a nível nacional em 2010 para a percenta-
gem de doentes internados em Unidades de AVC em que a 
VV (externa ou interna) foi activada e, neste estudo, o valor 
foi semelhante (26,3%). Como seria de esperar, o Rankin 
prévio foi mais baixo quando foi utilizada a VVE, o que pode 
ser explicado pelo critério de activação da independência 
prévia. A maioria dos utilizadores da VVE chegaram den-
tro da janela terapêutica, contrastando com pouco mais de 
um terço dos não utilizadores, padrão também verificado 
noutros estudos,23,25,26 sendo esta percentagem superior à 
verificada por Derex et al, em França,27 assim como por 
Kleindorfer et al, nos EUA.22 A discriminação entre utiliza-
dores da VVE e restantes foi manifesta na proporção que 
apresenta cumulativamente os três sinais de AVC, o que 
poderá estar relacionado com a maior exuberância do qua-
dro clínico traduzida, na subsequente chamada do 112. O 
facto de a idade média dos utilizadores da VVE ser inferior 
aos restantes pode novamente estar relacionado com o cri-
tério do limite da idade, mas também com o facto dos doen-
tes mais velhos terem tendencialmente mais comorbilidade 
e, por isso, um crescente grau de dependência, o que res-
tringe novamente a activação da VVAVC. Resultados se-
melhantes foram encontrados no estudo de Robert et al.20 
Embora se esperasse que doentes com um AVC recorrente 
reconhecessem melhor os sintomas e por isso ligassem 
mais frequentemente para o 112, a VVE foi mais utilizada 
por doentes com o primeiro AVC na vida. Esta tendência 
foi também relatada por outros autores21 e pode ser devida 
ao facto de subsistirem alterações cognitivas sequelares ao 
primeiro AVC ou a uma dependência para as actividades de 
vida diária que não permita aos doentes com AVC recorren-
te preencher os critérios de activação da VVE.
 Nem um quinto de todos os AVC’s satisfizeram os crité-
rios da VVE e, mesmo nos utilizadores da VVE, pouco mais 
Moutinho M, et al. Avaliação da via verde do acidente vascular cerebral no norte de Portugal, Acta Med Port 2013 Mar-Apr;26(2):113-122
A
R
TIG
O
 O
R
IG
IN
A
L
Revista Científica da Ordem dos Médicos          www.actamedicaportuguesa.com                                                                                                                121
Moutinho M, et al. Avaliação da via verde do acidente vascular cerebral no norte de Portugal, Acta Med Port 2013 Mar-Apr;26(2):113-122
A
R
TI
G
O
 O
R
IG
IN
A
L
de metade satisfaziam os critérios diminuindo este valor 
para aproximadamente um terço na VVI. O actual proto-
colo da VVAVC abrange assim uma percentagem reduzida 
de todos os episódios de AVC registados na população em 
geral, não atingindo o valor mencionado nos relatórios da 
VVAVC7 pois neste o denominador só inclui os doentes in-
ternados. A janela terapêutica e a idade superior a 80 anos 
foram os critérios que isoladamente impediriam com mais 
frequência a utilização da VVAVC. Pode aqui referir-se que 
a campanha de alerta da população Seja mais rápido que o 
AVC não está ainda a resultar num efeito desejado, ou por-
que a população não reconhece ainda os principais sinais/
sintomas de AVC ou porque, embora reconhecendo, não 
adopta uma acção rápida e adequada. Este ponto é tam-
bém focado num estudo realizado no distrito de Viana do 
Castelo, chamando a atenção para o facto da idade avan-
çada e/ou escolaridade baixa serem barreiras para que 
este alerta funcione adequadamente.28 Mesmo nos doentes 
que preenchiam os critérios da VVAVC a taxa de activação 
(externa) foi de apenas 28,4%. Em pouco mais de metade 
destes doentes não foi activada nem a VVE nem a intra-
-hospitalar, com a agravante de 56,0% destes terem usado 
o transporte em ambulância para se deslocarem ao SU. 
Carecemos de uma informação importante referente aos 
doentes com AVC que recorreram ao CODU para os quais 
não foi activada a VVE, que poderá eventualmente vir a ser 
alvo de futura análise com inquérito aos próprios utentes. 
Mas, por outro lado, há ainda a questão de não ter sido 
activada a VVI, possivelmente devido ao facto do doente 
não preencher os critérios clínicos mais restritivos para a 
realização da fibrinólise, à falta de segurança/experiência 
de alguns profissionais para a realização deste tratamen-
to ou ainda à falta de formação da equipa de realização 
da triagem hospitalar. Nos doentes com critérios de aces-
so à VVAVC, o tempo médio entre o início dos sintomas 
e entrada no SU não foi significativamente diferente nos 
utilizadores da VVE, VVI ou não utilizadores, resultados se-
melhantes aos encontrados por Robert et al.20 A proporção 
de doentes internados e de doentes com AVC isquémico 
que fazem fibrinólise vindos pela VV justifica amplamente 
a operacionalização da VVAVC, pois é muito superior nes-
tes doentes. Resultados semelhantes foram encontrados 
noutros estudos, mas esta proporção é superior à encon-
trada em alguns deles, sobretudo nos realizados em Espa-
nha.15,20,22,25,29,30 Em termos de prognóstico a curto prazo, o 
Rankin pós-AVC foi mais grave nos utilizadores da VVE, a 
exemplo de outros estudos.20,31 Note-se, no entanto, que, 
após ajustamento para as características sócio-demográ-
ficas e sinais/sintomas, este facto é explicado não pelo 
acesso ter sido pela VVE mas por estes doentes terem um 
maior número de sintomas e serem do sexo masculino. 
 Como limitação deste estudo podemos apontar o facto 
de não terem sido analisados em detalhe outros critérios 
constantes das recomendações da VVE,7 entre outros, o 
tempo entre o acesso ao SU e a avaliação por um neurolo-
gista, realização de TAC, assim como de fibrinólise. Dado 
não haver diferenças no tempo decorrido entre os sinto-
mas e a entrada no SU nos utilizadores (com critérios) da 
VVE em comparação com os restantes tal como em outros 
estudos,20 a exemplo destes, esta análise mais detalhada 
poderia ser indicativa de intervalos de tempo intrahospita-
lares mais baixos e adequados quando a VVAVC é utiliza-
da. Um possivel viés de informação pode surgir do facto 
de nem sempre ter sido registava no episódio de urgência 
a utilização da VVI. No entanto, é pouco provável que isso 
tenha acontecido porque o número de activações da VVI 
é superior ao da VVE e além disso foi até mesmo mencio-
nada em mais doentes que não obedeciam aos critérios 
de activação (64,0% na VVI vs 43,7%). Será necessário 
realizar mais estudos de base populacional para definir os 
riscos reais do uso de fibrinólise em doentes com mais de 
80 anos de idade, bem como sobre a eventual extensão da 
janela terapêutica.32 Outro aspecto importante é o facto de 
a VVE estar a ser mais frequentemente utilizada nos AVC’s 
mais graves, impedindo um eventual tratamento fibrinolíti-
co por contra-indicações clínicas. Atendendo a que existe 
uma alta taxa de ocorrência de AVC após um AIT,1 também 
o critério referente ao tipo de sintomas poderia ser mais 
abrangente, seguindo, por exemplo, a campanha ameri-
cana Suddens,33 acrescentando nomeadamente a perda 
súbita de visão, tal como acontece no Código Ictus em 
Espanha.34 Deste modo, poderá ser possível aumentar ou 
mesmo eliminar o cut-off da idade, como sugerido noutros 
estudos,32,34 ou aumentar a janela terapêutica pelo menos 
para quatro horas e meia, considerando os resultados de 
estudos mais recentes.32,35-37
 Poderá também sugerir-se a intensificação das campa-
nhas populacionais, uma vez que a sua eficácia foi já po-
sitivamente avaliada por vários estudos.16,18,38,39 Devem ser 
dirigidas a públicos diversos utilizando meios e argumentos 
compreensivos, pelo menos focando os sintomas e activa-
ção da VVAVC. Uma abordagem educacional alternativa, já 
verificada em alguns estudos,40-42 seria a dos profissionais 
de saúde responsáveis pela triagem quer em relação ao 
quadro clínico objectivado pela VVAVC quer em relação à 
adequada comunicação entre os responsáveis. 
CONCLUSÃO
 Embora durante uma década a incidência de AVC tenha 
diminuído, este estudo mostra que os efeitos de alguns pro-
gramas nacionais para diminuir as repercussões do AVC a 
nível comunitário, nomeadamente a VVAVC, poderiam ser 
mais abrangentes quanto aos critérios de acessibilidade, 
cobrindo actualmente apenas uma proporção estimada 
em 16% de todos os casos. Considerando os doentes que 
cumprem estes critérios, pode concluir-se que os utilizado-
res da VV têm um espectro sintomatológico/clínico mais 
grave e são também mais frequentemente internados e 
tratados por fibrinólise em comparação com os restantes. 
Mesmo assim, após ajustamento para estas característi-
cas, a incapacidade pós-AVC não difere significativamente 
nos utilizadores e não utilizadores da VV.
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Introduction: Changes in meteorological parameters have been associated with stroke 
occurrence. The incidence of primary intracerebral haemorrhages (PICH) seems to increase in 
days with cold/mild outdoor temperature. In Portugal, neurologists forward the hypothesis that the 
incidence of PICH increases in rainy days and not particularly low temperatures. This study aims 
to study the association between occurrence of PICH and weather parameters. 
Methods: Data from ACINrpc-project, involving 78 patients suffering a first-ever-in-the-lifetime 
PICH over a 2-year period in the city of Porto was used. Information on daily weather parameters 
was obtained from the National Meteorological Office. A Poisson model was used to estimate the 
association between weather parameters and PICH incidence. Using a conditional logistic 
regression model, a case-crossover design was then used to estimate the risk of PICH following 
specific exposures associated with PICH incidence: low diurnal temperature range (DTR) and 
rainy days. For each subject, the case period was matched with 4 control periods, the same 
weekday in the previous four weeks. 
Results: PICH incidence increases by 11.8% (95%CI: 3.8-20.4%) for 1ºC drop in DTR and 3.1% 
(95%CI: 1.1-5.1%) for a 1mm/m² in precipitation. Following a day with a DTR<4ºC the odds ratio is 
2.9 (95%CI: 1.4-5.8), increasing to 8.8 (95%CI: 1.7-44.8) after a 48h exposure. Following days 
with low DTR and rain, the odds ratio is 3.2 (95%CI: 1.3-8.1) and 9.5 (95%CI: 1.1-88.9) for a 
precipitation>10mm/m² and 40mm/m², respectively. 
Conclusion: Precipitation by itself is not associated with PICH incidence, nevertheless has a 
synergistic effect in low DTR days. 
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Table A1.  Distribution of vascular risk factors in 78 patients with PICH 
Vascular risk factor  N % 
Age  65y  46 59.0 
Women  48 61.5 
High blood pressure (HBP)  54 69.2 
Cardiac disease (CARD)  23 29.5 
Diabetes  19 24.4 
Smoking habits  14 17.9 
Table A2. Estimated percentage of daily variation in Intracerebral haemorrhage by unit variation 
in the preceding 24 hours of weather parameters  
Season/Weather parameter  %  95%CI 
Season vs. Summer       
 Autumn  32.0  -31.6 to 54.8 
 Winter  16.9  -40.4 to 29.1 
 Spring  53.3  -18.6 to 88.5 
Temperature (decrease 1ºC)       
 Maximum  4.7 * -0.4 to 10.1 
 Minimum  -0.3  -5.1 to 4.7 
 Diurnal range  11.8 ‡ 3.8 to 20.4 
Relative humidity (%)  1.6  -0.6 to 3.8 
Precipitation (mm/m
2
)  3.1 ‡ 1.1 to 5.1 
Atmospheric pressure (hPa)  0.1  -3.0 to 3.4 
*p<0.05; 
‡
p<0.01       
Table A3. Assessment of interaction between DTR and precipitation on overall PICH incidence 
and in the presence of vascular risk factors 
DTR (ºC) Precipitation (mm
2
) Cases Controls OR 95%CI 
All patients 
 4 < 10 56 259 1.0  
 4  10 6 27 1.0 0.4-2.5 
< 4 < 10 7 13 2.6 0.9-7.1 
< 4  10 9 13 3.2 1.3-8.1 
 Expected OR: Additive model: 2.6 + 1.0 – 1.0 = 2.6 Multiplicative model: 1.0 x 2.6 = 2.6 
 Oldest ( 65 years) 
< 4  10 7 6 5.0 1.6-16 
 Expected OR: Additive model: 0.3 + 1.1 – 1.0 = 0.4 Multiplicative model: 0.3 x 1.1 = 0.3 
 with high blood pressure 
< 4  10 6 7 4.1 1.3-13 
 Expected OR: Additive model: 1.3 + 3.2 – 1.0 = 3.5  Multiplicative model: 1.3 x 3.2 = 4.2 
All patients 
 4 < 40 61 282 1.0  
 4  40 1 4 1.3 0.1-2.2 
< 4 < 40 12 22 2.5 1.1-5.3 
< 4  40 4 4 9.5 1.1-89 
 Expected OR: Additive model: 2.8  Multiplicative model: 3.2 
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Figure A1. Lowess smoothed values of daily incidence and meteorological parameters at Porto 
during the study period. 
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Background: One decade ago Portugal had one of the highest stroke incidences among the 
Western European countries. Based on the population ageing stroke incidence is predicted to rise, 
but on the other hand much has changed since 2000. Population awareness measures were 
implemented, hopefully reflected in a widen use of preventive strategies, and acute treatment 
approaches are being constantly tested and innovated. The objective of this study is the 
comparison of stroke incidence and case-fatality ten years apart, 2000-2010. 
Methods: All suspected first-ever-in-a-lifetime strokes occurring between October 2009 and 
September 2011 in 46775 residents in rural areas and 193349 urban residents were entered into a 
stroke registry. Based on standard definitions, both hot and cold pursuit sources of information 
were used for case ascertainment. Patients were observed at onset and at three months. All data 
is currently being validated and by March 2012 the definitive results will be available. Meanwhile 
the results presented refer to the preliminary results of the first year (September 2009-10). 
Results: Based on the first year results, it is expected a decrease in the annual incidence of 
stroke, 2.8/1000 (95%CI, 2.6-3.0) to 1.8/1000 (95%CI, 1.6-2.0), though still higher in rural 
compared to urban populations. Mean age at onset increased from 71 to 73 years, the proportion 
of women is lower (54.5 vs. 58.7%) and among patients with a definite diagnosis the proportion of 
ischaemic events increased slightly from 80% to 84% contrasting with primary intracerebral 
haemorrhages (17 to 13%). The overall 28 days case-fatality decreased from 16.1% (95%CI, 13.6-
19.1) to 10.6% (95%CI, 8.0-13.8). 
Discussion: Both, incidence of stroke and case-fatality are decreasing ten years apart. The 
population ageing is also shown in the ageing of patients, but the efficacy of treatment in the acute 
phase may underlie the decline of case-fatality. 
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Table A4. Characteristics of patients included 
Patients characteristics  Period Rural Urban 
Median age, years (IR)  1st 74 (67-80) 72 (63-81)
  2nd 76 (66-83) 75(62-83)
Women, %  1st 51.8 62.1 
  2nd 51.1 55.7 
Stroke type   
 Cerebral infarction  1st 77.9 75.3 
  2nd 84.8 83.9 
 Intracerebral Haemorrhage  1st 14.6 16.3 
  2nd 11.8 13.1 
Table A5. Evolution of overall stroke incidence (/1,000) 
 1998-2000 2009-2011 
Characteristics n rate 95% CI n rate 95% CI 
Residence       
 Rural 226 3.1 2.7-3.4 237 2.5 2.2-2.9 
 Urban 462 2.7 2.4-2.9 697 1.8 1.7-1.9 
Gender       
 Male 284 2.6 2.3-2.9 425 1.9 1.7-2.1 
 Female 404 3.0 2.7-3.3 509 2.0 1.8-2.2 
All 688 2.8 2.6-3.0 934 1.9 1.8-2.1 
ASR Portugal  2.3 2.1-2.5  1.6 1.5-1.7 
ASR Europe  1.8 1.6-2.0  1.2 1.1-1.3 
ASR – Indicates age-standardized rate 
Table A6. 28-day case-fatality in rural and urban patients 
 1998-2000 2009-2011 
Residence % 95% CI % 95% CI 
 Rural 14.6 10.2-19.3 16.0 11.9-21.4 
 Urban 16.9 13.7-20.6 10.2 8.2-12.7 
All 16.1 13.6-19.1 11.7 9.8-13.9 
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Figure A2. Overall stroke incidence by age-group 
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Figure A3. Stroke incidence by age-group and gender 
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Background: One decade ago stroke incidence in Portugal was higher than in most Western 
European countries. The objective of this study is to know how much it has been achieved in the 
incidence and short term prognosis of primary intracerebral haemorrhages (PICH) from 1999 to 
2011 in urban and rural areas. 
Methods: All suspect first-ever-in-a-lifetime stroke occurring between October 2009 and 
September 2011 in 46775 residents in rural areas and 193349 residing in the city of Porto were 
registered and are compared to those ascertained in the 1998-2000 study. Based on standard 
definitions, both hot and cold pursuit sources of information were used for case ascertainment. 
Patients were observed at onset and at three months. 
Results: During a 24-month period, 115 patients with a first-ever PICH, 27 in rural and 88 in urban 
areas were registered. The first PICH happens on average 4 years after (67 and 71 years) in the 
city and 6 years in rural areas (67 and 74 years). There was a decrease in the annual incidence 
rate of PICH per 100000, from 45 (95% CI, 37-53) to 24 (95% CI, 20-28), and from 33 to 16 after 
standardization to the European population. In the rural population the incidence dropped from 
44/100000 (95% CI, 31-62) to 29 (95% CI, 19-42) and in the urban population from 45/100000 
(95% CI, 36-57) to 23 (95% CI, 18-28). Age-specific incidence decreased following similar patterns 
in rural and urban populations, reaching a relative reduction of 75.7% in urban populations aged 
55-64 years. Case-fatality at 28 days decreased from 30.6% (95% CI, 22.8-39.7) to 28.7% (95% 
CI, 21.2-37.6) and from 33.3 to 22.7% in urban patients; in rural patients increased from 24.2 to 
48.1%. 
Conclusion: The incidence and case-fatality of PICH decreased ten years apart, in particular in 
urban populations. The ageing of patients in rural areas could be responsible for their high case-
fatality.  
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Table A7. Patient's characteristics and case-fatality 
 1998-2000 2009-2011 
Patients  95% CI  95% CI 
Mean age 67.3 64.7-69.9 71.3 68.8-73.8 
 Rural 67.5 63.1-71.8 73.6 70.0-77.2 
 Urban 67.2 63.9-70.5 70.6 67.5-73.7 
Gender: % Male 42.3 33.5-51.6 59.1 49.9-67.7 
 Rural 51.5 35.2-67.5 66.7 47.8-81.4 
 Urban 38.5 28.5-49.6 56.8 46.4-66.7 
Case-fatality, % 30.6 22.8-39.7 28.7 21.2-37.6 
 Rural 24.2 12.8-41.0 48.1 30.7-66.0 
 Urban 33.3 23.9-44.4 22.7 15.2-32.5 
Table A8. Evolution of PICH incidence (/100,000) 
 1998-2000 2009-2011 
 n rate 95% CI n Rate 95% CI 
Residence area        
 Rural 33 44.5 30.6-62.5  27 28.9 19.0-42.0 
 Urban 78 45.3 35.8-56.6  88 22.8 18.3-28.1 
Gender        
 Male 47 42.6 31.3-56.7  68 30.4 23.6-38.5 
 Female 64 47.1 36.3-60.1  47 18.4 13.5-24.4 
All 111 45.1 36.7-53.5  115 24.0 19.6-28.3 
ASR Europe  32.8 26.1-40.9   15.8 12.5-19.8 
ASR – Indicates age-standardized rate 
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Figure A4. Evolution of PICH incidence by age-group 
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Figure A5. Evolution of PICH incidence by age-group, according to residence area 
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Background: One decade after the first community-based prospective incidence study, we intend 
to describe current trends in the incidence and short-term prognosis of subarachnoid haemorrhage 
(SAH) in northern Portugal. 
Methods: Data from the second prospective community-based study are presented and compared 
to the first one. All suspect first-ever-in-a-lifetime stroke occurring between October 2009 and 
September 2011 in about 240,000 residents were entered into a stroke registry. Based on 
standard definitions, both hot and cold pursuit sources of information were used for case 
ascertainment. Patients were observed at onset and at three months. 
Results: A total of 30 patients were included, half of them were man compared with 78.3% in the 
first study (p<0.04) and the average age increased from 60 to 63 years (p>0.5). The overall crude 
annual incidence rate decreased from 9.3/100000 (95% CI, 5.9-14.0) to 6.3/100000 (95% CI, 4.2-
8.9), and after standardization to the European population from 7.3 (95% CI, 4.3-11.6) to 4.5 (95% 
CI, 2.9-6.9). The age-specific incidence rates were stable or lower than in the first study, with the 
previous peak at 65-74 years (29/100000) shifting for the 74-85 years (21/100000). The highest 
values for those 85 years or older were stable (37.3 and 36.6/100000), but there was an increase 
in the oldest women, from 26 to 41/100000. Case-fatality at 28 days decreased from 30.4% (95% 
CI, 15.6-50.9) to 23.3% (95% CI, 11.8-40.9). 
Conclusion: Compared to other studies in European countries the incidence of SAH in Portugal is 
one of the lowest after the decrease in the last decade. The age-sex incidence pattern is changing, 
mainly by the increase in incidence in the oldest women. Despite being now more common among 
the oldest, the short-term prognosis remained stable in the last decade. 
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Table A9. Patient's characteristics and case-fatality 
 1998-2000  2009-2011 
Patients  95% CI   95% CI 
Mean age 59.7 51.5-67.8  62.8 55.4-70.1 
 Rural 58.8 38.1-79.5  63.3 49.0-77.5 
 Urban 59.9 50.2-69.7  62.6 53.3-71.9 
Gender: % Male 21.7 9.7-41.9  50.0 33.2-66.8 
 Rural 0.0 0.0-39.0  50.0 21.5-78.5 
 Urban 29.4 13.3-53.1  50.0 30.7-69.3 
Case-fatality, % 30.4 15.6-50.9  23.3 11.8-40.9 
 Rural 16.7 3.0-56.4  25.0 7.2-59.1 
 Urban 35.3 17.3-61.4  22.7 10.1-43.4 
Table A10. Evolution of SAH incidence (/100,000) 
 1998-2000 2009-2011 
 n rate 95% CI n rate 95% CI 
Residence area        
 Rural 6 8.1 3.0-17.6  8 8.6 3.7-16.9 
 Urban 17 9.9 5.8-15.8  22 5.7 3.6-8.6 
Gender        
 Male 5 4.5 1.5-10.6  15 6.7 3.8-11.1 
 Female 18 13.2 7.9-20.9  15 5.9 3.3-9.7 
All 23 9.3 5.9-14.0  30 6.3 4.2-8.9 
ASR Europe  7.3 4.3-11.6   4.5 2.9-6.9 
ASR – Indicates age-standardized rate 
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Figure A6. Evolution of SAH incidence by age-group 
